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ABSTRACT
Following the Leaders:
Issue Attention and Agenda Dynamics in Women’s Health Care Policy
Kara Fisher

This dissertation focuses on shifts in issue attention in the policy process and examines
policy changes. Describing agenda setting is important not only for understanding congressional
behavior in general but also for understanding the institutional context of other political
behavior. I focus on the processes of positive feedback to explain periods of dramatic policy
changes observed over a long period of time.
The purpose of this study is to examine the changes in the politics of health policy which
opened the door to women’s health care as an important feature of health politics. Thus, my
research is motivated by three questions: (1) How do women’s health concerns get on the
agenda? (2) Does positive feedback through legislative entrepreneurship and composition of
Congress shift attention? (3) How has women’s health care policy evolved over time? The
results of this study not only contribute to the agenda setting literature but also have important
implications for practitioners, professional organizations and associations, researchers,
patients, and others who contribute to the policy community.
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CHAPTER 1: Introduction
On June 18, 2019 women in Congress played against the women in media as part of the
11th annual Congressional Women's Softball Game. This annual bipartisan softball game is a
powerful symbol for many of the key players in women’s health care policy. The event brings
together influential women focused on this common cause, and it benefits the Young Survival
Coalition, an organization that raises money to address the unique needs of young adults
affected by breast cancer. According to the Center for Disease Control (2019), breast cancer is
the most common cancer in women and the second most common cause of death for women.
Congressional and public attention to breast cancer, however, extends beyond the
playing field. In 2017 Congress passed key funding legislation (H.J. Res. 31) that required the
Food and Drug Administration to include patient notification of breast density in the
Mammography Quality Standards Act (first passed in 1992) regulations. Unfortunately, Nancy
Cappello, PhD, who led the push for legislation to provide women with more information about
breast density did not get to share in this victory. She founded the advocacy group Are you
Dense? and was considered by many as the leader of a movement to educate women about
breast density. Nancy Cappello died in November 2018 of complications from cancer treatment.
These and other issues of women’s health policy are of critical importance across the spectrum
of health care providers, policymakers, and those impacted by its effects.
In order to study how women’s health policy has developed and continues to evolve, I
turn to the literature of agenda setting and issue attention. Much of the early research in public
policy, or more specifically policy change, focuses on either periods of rapid change or relative
1

stability. Baumgartner and Jones’ (1993; 1995; 2002) treatment combines both periods to
integrate the nuances of positive feedback and negative feedback models, or rather the
explanations for major disruptions in the policy landscape and the mechanisms to maintain
stability. They also argue that the policy process itself can alter the performance of institutions.
This research focuses on shifts in issue attention in the policy process and its importance
in deriving policy changes. Previous research in agenda setting demonstrates that effective
definition (Rochefort & Cobb 1994) of a policy problem creates opportunities for change across
a policy area (Baumgartner & Jones 1993; King 1997). Not only change in how the policy is
defined but also in the narratives that tell the story of winners, losers, victors, and victims
(Stone 1989). These “causal stories” can be used to further competition for a championed
solution and expand the audience so that those previously uninvolved become interested
(Schattschneider 1960; Stone 1989; Rochefort and Cobb, 1994). In this study, I propose an
investigation of the long-term (post WWII) policy dynamics focused on the area of women’s
health care policy.
Women’s health care was initially defined in the literature and understood by
policymakers as a part of social welfare policy (Gordon 1990). As individual leaders and as
group participants, women were influential in organizing and nationalizing movements for
public health. In the late nineteenth and early twentieth centuries women who supported the
general welfare movement advocated specifically for women's welfare (Sapiro 1990).
The secondary status of women ensured that there was little information about women
(and children) as a separate class much before 1900. Even as individuals and institutions began
to consider that the medical and welfare needs for women and children might require special
2

consideration, information was intermittent and inconsistent historically. Initial concerns about
the health and welfare of women and children grew out the hazards caused by forced proximity
in urban centers at the turn of the twentieth century. Industrialization and labor demands
brought women and children to the forefront of these concerns.
The creation of the Maternal and Child Health Bureau (MCHB) was one of the first
federal efforts to address child mortality and the general welfare of children. Born out of
concerns over endemic child labor and the dangers to the livelihoods of children in its initial
organization in 1912, this association has grown in complexity and scope through time. The
Social Security Act of 1935 and the advent of Title V ensured that the MCHB would serve to
address the broad welfare concerns of women and children throughout the last century and
beyond (Schuman 2017).
Similarly, in 1909, the White House held its first ever meeting related to the welfare of
women and children titled: The White House Conference on the Care of Dependent Children.
This conference led to the establishment of the Children’s Bureau in 1912 which was charged
with children’s welfare matters including health, childcare, child labor, fostering and adoption,
juvenile delinquency, neglect and abuse, among many other such related topics (The Children’s
Bureau 2018). The Children’s Bureau has improved the lives of children since its inception by
raising awareness, promoting best practices, and influencing policy on such critical issues as
nutrition, hygiene, and health education. Additionally, the Children’s Bureau contributed
significantly to the surveillance of births (National Birth Registry), as well as promotion and
cataloguing of maternal and infant and mortality and morbidity. The 1914 Pamphlet on Infant
Care, a publication of the Children’s Bureau, was created to advise parents about breastfeeding,
3

nutrition, infant care, and the medical needs of children (Children’s Bureau 2018). This
pamphlet was adapted to reflect best care practices for over 50 years and distributed some 45
million times (Deavers and Kavanaugh 2010).
In 1921, the Sheppherd-Towner Act was passed by Congress as one of the first efforts to
formalize best practices to promote maternal and infant health. This policy initiative grew
directly out of the work of the Children’s Bureau. It was the first major federal grant program
related to health and was the first federally funded effort to ensure monies were available to
promote maternal and child care welfare issues (Haeder and Weimer 2015). Further, over 3000
prenatal clinics were established through this program and its creation transformed access to
antenatal care. It was one of the first acts of Congress that fully addressed women as a distinct
group with distinct needs and tied health policy to motherhood making social protection a
gender benefit. Federal funds were expressly intended to address dismal rates of maternal and
infant mortality (Schlesinger 1967, 1034). For example, providing for professional instruction of
expectant mothers in prenatal and infant care (Mink 1990).
The Social Security Act of 1935 and its amendments further expanded the federal
government’s role in health care (Haeder and Weimer 2015). During World War II, utilizing
funds from the Maternal and Child Health Program through the Social Security Act, Congress
authorized the Emergency Maternal Infant Care (EMIC) program. The goal of EMIC was to
address the emergent, wartime needs for the infants and children of those married to
servicepeople (men) who had been deployed. Sentiment in this nationalistic time prioritized the
family as an “integral component of national security” (Tempkin 1999, 588). At the time of its
inception, the EMIC program was considered the largest public health program ever
4

undertaken in the United States. Before World War II, most bills introduced either ignored
women as a class or focused on a narrow margin of their concerns. Over time, government has
identified women's traditional activities as guardians of health and morals through their roles as
wife and mother (Mink 1990).
Understanding of women’s health care, however, has expanded to include health
concerns for women beyond motherhood. The National Academy on Women’s Health Medical
Education defines women’s health to include the screening, diagnosis, and management of
conditions that are unique in women, more common in women, and are more serious in
women (Charney, 2000). Though this definition is broad in its scope, it is particularly applicable
for this general study of the comprehensive policy umbrella. Policymakers and practitioners are
influenced by problems of coverage, access, and affordability of health care for women as
evidenced by the 2017 Kaiser Women’s Health Survey. This survey is a nationally representative
survey of women ages 18 to 64 on their coverage, use, and access to health care services
(Kaiser Women’s Health Survey 2017).

ORGANIZATION OF THE DISSERTATION
The purpose of this study is to examine the changes in public policy in women’s health
care post World War II. My research is motivated by three questions: (1) How do women’s
health concerns get on the agenda? (2) Does positive feedback through legislative
entrepreneurship and composition of Congress shift attention? (3) How has women’s health
care policy evolved over time? The results of this study not only contribute to the agenda
setting literature but also have important implications for practitioners, professional
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organizations and associations, researchers, patients, and others who contribute to the policy
community.
My dissertation is informed by three connected areas of scholarship. In chapter two, I
highlight the broader context of agenda setting to illuminate how an issue is placed on the
agenda and discuss the general features of issue attention. Also, I concentrate on political
entrepreneurship as it relates to women’s health policy. I use the findings from this literature to
describe periods of increased activity and rapid change fueled by policymaker's behavior and
their ability to shift attention. Finally, I focus on the composition of legislatures and the
influence of women in Congress as legislative entrepreneurs.
The creation, manipulation, and transformation of public policy, however, is not limited
to activity in Congress. Sometimes it is best understood through the nature of relationships
between political institutions (Sheingate 2001). Women’s health policy clearly originates in
many other venues. The courts, executive, federal agencies, and states are all prominent actors.
New policy proposals may be advanced through the legislature or entirely through bureaucratic
channels and mechanisms. It is not always the case that Congress imposes meaningful
restrictions on bureaucratic policymaking, as it leaves many blanks to be filled at the discretion
of bureaucratic agencies (Moe 1994; Kettl 2000; Huber, Shipan, and Pfaler 2001; Volden 2002;
Boehmke et. al 2005; Peters 2018). This is demonstrated through the use of tools ranging from
sunshine laws to public notice and comment as part of administrative rulemaking, which allows
citizens to interact directly with public agencies without politicians serving as policy mediators
(Krause 2013).

6

Although I am chiefly concerned with arenas for issue attention, it is equally important
to note Congress’ relevance in controlling the budget (Banks 1989; Bendor, Taylor, and Van
Gaalen 2001). Congressional activity is necessary to authorize and fund programs and to set
the expectations for intended outcomes. While acknowledging this means of control, it’s not
without consideration that each member of Congress has policies that he or she is primarily
interested in and consequently attempts to expand through substantial appropriations
(Ferejohn and Krehbiel 1987; Wehner (2010). The interaction of multiple institutions in the
policy process impacts the roles that each play in policy making (Boehmke, Gailmard, & Patty
2006).
Congress, however, is a powerful force in controlling and shaping the agenda over time
(Baumgartner and Jones 1993; 2002). For my specific research interests, Congress is the
appropriate venue considering the availability of analytical tools and resources and the rich
literature supporting it. The Policy Agendas Project, in particular, allows researchers to
investigate trends in policy making across time and between multiple indicators of attention. It
classifies policy activities into a single, universal, and consistent coding scheme in over twenty
major policy areas and nearly two hundred sub categories. The Policy Agendas Project uses a
reliable and valid procedure for describing and tracking attention to the content of public
policies as they change over time.
Baumgartner and Jones’ Policy Agendas Project has been an important tool for
evaluating issue attention in multiple venues, for various policy topics, and over a long period of
time. Most would agree that the process of coding public, congressional, and presidential
attention is not without error, and Baumgartner and Jones’ tool is not without limitations. My
7

work not only helps to expand understanding of women's health policy and bolster the
available data, but I also carefully consider the study of issue attention to identify areas for
more nuanced analysis.
Considering the policy dynamics of women’s health care on the agenda, I first examine
what proportion of the United States health debate is taken up by topics that deal with women.
In chapter three, I map the women’s health policy agenda using Baumgartner and Jones’ (2002)
Policy Agendas Project. In order to track issue attention for health, specifically women’s health
care, I begin with policy related to infants and children, which casts women as caregivers. The
Policy Agendas Project data does not distinguish women’s health as a discrete subtopic. I will
supplement what is available in The Policy Agendas Project to create a fuller and more
complete look at the area of women’s health care. Using indicators outlined by the Kaiser
Women’s Health Survey as a guide, I collect data using “women’s health” as a general search
term. I trace public attention using ProQuest Historical digitized newspaper archives of The New
York Times. Additionally, I collect data demonstrating congressional attention (bill
introductions, bill referrals, committee hearings, and passed legislation) using ProQuest
Congressional and Congress.gov. Finally, I track presidential attention using presidential papers
through data available in The American Presidency Project. To further investigate the dynamics
of the health care agenda, I compare The Agendas Project data for other subfields of health and
the data I compile on women’s health care. Given that the congressional agenda has a limited
capacity, I describe how much room there is (and isn’t) for women’s health issues.
However, describing the agenda is important not only for understanding congressional
behavior in general but also for understanding the institutional context of other political
8

behavior. I specifically focus on the processes of positive feedback among elites to explain
periods of dramatic policy changes observed over a long period of time. Positive feedback has
been characterized as conflict expansion, mobilization of enthusiasm, and punctuated
equilibrium (Schattschneider 1960; Downs 1972; Cobb & Elder 1972; Baumgartner & Jones
1993; Kingdon 1995). Past research indicates that positive feedback processes often arise when
issues are redefined, when institutional arrangements are transformed, and when policymakers
recognize that other policymakers may be looking at old issues in new ways (Baumgartner &
Jones 2002).
To expand this discussion, chapter four focuses on indicators of legislative
entrepreneurship in the area of women’s health care policy and specifically examines whether
entrepreneurial activity and gender distribution matter. Entrepreneurship can occur at the
committee level as well as the individual level, so I consider both the behavior of congressional
committees and individual members. I analyze entrepreneurial activity in three stages including
the following: committee referrals and bill sponsorship, congressional hearings and testimony,
and passed legislation.
Congressional scholars also consider “who” holds office, descriptive representation, and
whether it affects the types of policies supported (Pitkin 1967; Childs & Krook 2009; Swers
2013). From subsystem politics, we know that as the cast of characters changes, so do the
policy dynamics (Baumgartner & Jones 2002; King 1997; Worsham 1998). As such, I also study
what role gender plays, if any.
In chapter five, I construct a qualitative meta-analysis tracing the evolution of the
women’s health care policy. I focus on the discussion in Congress detailing shifts in policy image
9

and issue definition using CQ Weekly Reports (CQ Magazine) as an indicator. In order to gauge
the overall picture of women’s health care policy, I also include the influence of outside actors
(Cobb, Ross, and Ross 1976; Kingdon and Thurber 1984; Rochetfort and Cobb, 1994) and focus
on expert and technical media (Walker 1977). I specifically track the attention of the medical
establishment and academic and scholarly publications as an indicator of attention in women’s
health policy. I identify key players in women’s health policy who produce publications as a
measure of expert media attention, professional and scholarly contributions, and agency
activity. I track attention in the professional and expert community from 1945-2018.
The final chapter discusses key findings from the research and summarizes the overall
study. I also offer a discussion the future research that I consider as a result. Ultimately, my
work examines how women’s health care became an important facet of health policy and
continues to evolve today. The research builds on the work of Baumgartner and Jones’ (2005;
2013) Policy Agendas Project, creating a more defined picture of health policy by including
women’s health care. Tracking entrepreneurship and exploring elements of gender in Congress
is especially important as the number of female legislators is increasing. As is the case with any
complex policy environment, the explanation of women’s health policy is most fully understood
in context of its history.

10

CHAPTER 2: Literature Review

My dissertation is informed by three connected areas of scholarship. First, the larger
context of agenda setting helps to answer how an issue is placed on the agenda and the nature
of issue attention. Next, I focus on periods of increased activity and rapid change fueled by
policymakers’ behavior and their ability to shift attention, described as entrepreneurship.
Finally, I focus on the composition of legislatures and the influence of women and legislative
entrepreneurs.

AGENDA SETTING
Roger Cobb, Jeannie Keith-Ross and Marc Howard Ross (1976) describe agenda building
as “the process by which demands of various groups in the population are translated into items
vying for serious attention of public officials” (p. 126). They recognize that there are multiple
avenues for political leaders and the general public to become aware of and participate in
political issues. The literature in agenda setting demonstrates that there are multiple venues by
which political actors and the public become aware of policies.
Similarly, limited agenda space often means that one dimension or single issue will
dominate the public agenda indefinitely (Kingdon 1995; Baumgartner and Jones 2002). Agenda
entrance is often a matter of which policy makers are raising awareness of the issue and how
long it can hold that attention (Hunt, 2002). The question is then, why do some problems
occupy an official’s attention rather than others?
Policy formulation often occurs through a policy community, sometimes referred to as a
subsystem, of specialists including lawmakers, bureaucrats, academics, interest groups, and
specialized media who generate proposals to address a policy problem (Walker 1977; Worhsam
11

1998; Workman & Shafran 2015). Likewise, problems become salient when they attract the
right attention, often as a result of the convergence of what Kingdon (1984, 1995) terms
multiple streams (policy, political, and problem). This convergence described as a policy
window, or an opportunity for asserting proposals when conditions are appropriate for raising
an issue on the agenda (Kingdon 1995). Windows are opened for only a short time, and they
can open and close in the agenda setting cycle. Some solutions are selected while others are
not. Selection could be based on technical feasibility, congruence with the values of community
members, and anticipation of future constraints (Kingdon 1995).
The politics stream, sensitive to swings in national mood, public opinion, changes in
administration or control of Congress, is determined by the nature of its participants and the
availability of “choice opportunities” (Cohen, March, and Olsen 1972). Changes in each stream
occur largely independent of one another, so political environment and timing can impact
whether or not an issue enters the agenda. The streams are constrained further by costs of
attention, which can move items higher or lower on the agenda. The problem stream relies on
institutions such as the media to recognize problems based upon feedback or, in some cases,
critical events.
When the three streams converge solutions are paired, or “coupled,” with problems.
These additions and omissions to the agenda generate periods with the most change,
sometimes through the help of outside actors. Not all issues make the agenda, as individual
actors and groups often work to keep topics from being addressed through the policy process
(Cobb and Ross 1997). Agenda denial, or “the political process by which issues that one would
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expect to get meaningful consideration from the political institution in a society fail to get taken
seriously” (Cobb and Elder 1997, xi).
Cobb, Ross, and Ross (1976) categorize these interests as groups outside the sphere of
government that communicate a problem, block solutions, expand public support, or seek the
support of political leaders in order to help place an issue on the formal agenda for
consideration. They recognize the multiple avenues for political leaders and the general public
to become aware of and participate in political issues. These issues can be separated into two
parts: issues of high public interest and visibility are known as the “public agenda” and the list
of items that political leaders have formally accepted for serious decision-making comprise the
“formal agenda” (Cobb et. al 1976, p. 126).
Cobb, Ross, and Ross (1976) identified three modes for setting the agenda. In the
“outside initiative model” issues arise on the public agenda and then move onto the
government agenda, usually as a result of the efforts of organized interests. In the “mobilization
model” issues are initiated by policymakers who try to expand them to the larger public to gain
support for their policy solution. Lastly, in the “inside initiative model” issues are elevated to
the agenda, often without public feedback. In an attempt to reduce participation of the general
public and gain ready access to the formal agenda, a group or an agency, may work closely with
the government, introducing policy to a small group of legislators (Cobb et. al 1976, p. 126).
Issues are prioritized strategically to widen the scope of conflict or to include more than just the
initial participants (Schattschneider 1960; Nowlin 2016).
Walker (1977) also concludes that outside attention can influence a policy network and
specifically notes the importance of the expert and technical media. According to Walker
13

(1977), those directly involved in the policy area are often best organized in order to shape and
influence congressional behavior. He notes that agencies, professional groups, and clients
exercise a compelling claim on the attention of key members who attempt to control and
oversee legislation.
At times, however, policymakers may be forced to focus on one dimension they had
previously ignored because of a crisis or because of the behavior of other policymakers
(Birkland 1998; Baumgartner & Jones 2002; Birkland 2017). Swers (2005) notes that changes in
the exogenous political environment often alter the legislative priorities of members of
Congress. Nevertheless, new policy alternatives gain momentum when preferences begin to
change or attentions shift (MacLeod 2002). Shifts in attention for policy decision makers can
lead to volatile and disruptive changes in policy (Baumgartner & Jones 1993). Baumgartner and
Jones (1993; 2002; 2005; 2009) categorize these periods of rapid change through the process of
positive feedback. These mechanisms include escalating behaviors that heighten rather than
stabilize a trend. Research indicates that positive feedback processes often arise when issues
are redefined, when institutional arrangements are transformed, and when policymakers
recognize that other policymakers may be looking at old issues in new ways (Baumgartner &
Jones 2002).

POLICY IMAGE AND ISSUE ATTENTION
Given my attention to women’s health care in particular, it is important to consider how
a policy image evolves. Hunt (2002) points out, “policy issues are inherently multi-dimensional”
(p.73). In order to study agenda setting for women’s health care, I turn to Baumgartner and
Jones (2002). Rather than review the policy trajectory for a single institution, they examine how
14

various institutions shift their attention throughout the policy realm. Further, it is clear in any
policy area, the dominant public policy image is often one-dimensional, while the underlying
issues of concern are multi-dimensional (Baumgartner & Jones 2002; MacLeod 2002; Kingdon
1984; Nelson 2016). The policy image, therefore, can be defined as the contributing set of ideas
shaping how policymakers depict and debate a policy (Baumgartner & Jones 2002).
Considering the policy image in a complex policy area requires not only understanding
what is important but also who creates its importance. Issue attention and agenda entrance are
only one part of the policy process. Issue framing focuses on how particular frames, or how
issues are explained and identified, come to control the policy discussion (Plein 1991).
Metaphors, symbols, and “causal stories” can be used to widen the scope of the policy area so
that political actors previously uninvolved become interested (Schattschneider 1960, Cobb and
Ross 1997, Rochefort and Cobb 1994; Stone 1989; Jones & Mortensen 2018). In her study of the
political nature of public policy choices, Stone (1997) noted that, “problem definition is a
matter of representation because the description of a situation is a portrayal from only one
many points” (p. 133). Individuals actors, issue groups, and government agencies will portray an
issue strategically in order to promote the course of action they perceive to be most to their
advantage. In turn, the process of issue redefinition enables a policy to attract the attention of
new groups by expanding the conflict associated with a particular dimension, narrative, or
question (Stone, 1989).
In particular, media attention can encourage or contribute to shifts in attention, positive
feedback, and large-scale policy change (Wolfe 2012; Nelson 2016). In measuring attention in
the agenda setting process, tracking press coverage offers a measure of salience as well. Using
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the New York Times offers a way to track public attention, and tracking attention in
professional journals offers an indicator of expert attention (Baumgartner & Jones 2009; Wolfe
2012).
Recognizing that shifts in attention and agenda entrance are only a part of the policy
process, those who study framing are interested in how particular frames or explanations for
some phenomena come to dominate the debate. Cobb and Elder (1972) describe a connection
between agenda setting, or inclusion in the list of issues that demand attention of a
governmental entity, and issue expansion, or the number of people mobilized around an issue.
As we know from the cannon in agenda setting literature, the government agenda is comprised
of issues of concern to policymakers and is often derived from the public agenda (Baumgartner
& Jones 2005; Kingdon and Thurber 1994). Members of Congress are highly motivated by
reelection (Mayhew 1974) and creating good public policy (Arnold 1990; Fenno 1973; Hall
1996). Baumgartner and Jones (2002; 2005) note that one key to the policy process is the way
that issues are defined and debated because issue definition will determine the groups that
receive policy benefits.
Schneider and Ingram (1993), focus on the importance of social constructs for target
populations, or the popular images of the person whose well-being and behavior are affected
by public policy. The constructs become embedded in policy and are transferred through
modes of socialization. Ultimately, those who have the power to frame an issue often
determine whether it is considered a public or private concern (Schneider and Ingram 1993).
This seems particularly applicable in the case of women’s health policy as questions of
motherhood, public and domestic spheres of work, and androcentric research practices helps
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to explain shifts in the policy image and low allocation of benefits provided to this population in
early legislation.

POLITICAL ENTREPRENEURSHIP
Political entrepreneurship can encompass a variety of activities, (Schneider, Teske and
Mintrom 1995; 2000; Miroff 2003), originate in multiple venues (Wawro 2000; Sheingate 2003),
and lead to rapid policy change (Mintrom and Norman 2009). According to Sheingate (2003),
“entrepreneurs are individuals whose creative acts have transformative effects on politics,
policies, or institutions” (p. 185). This idea of political entrepreneurship is recognized across the
discipline in various forms with relation to Congress, the executive, policy innovation, and
collective action. Pioneering the use of the term, Kingdon (1984) distinguished that policy
entrepreneurs “could be in or out of government, in elected or appointed positions, in interest
groups or research organizations. But their defining characteristic, much as in the case of a
business entrepreneur, is their willingness to invest their resources– time, energy, reputation,
and in some cases money– in the hopes of a future return” (p. 122).
For Sheingate (2003), however, the general understanding of political entrepreneurship
focuses more on the interactions between institutions than the rules that exist within them.
Considering these complex relationships, policy innovations, and institutional changes can help
us draw conclusions about the facets of the institutions that enable or prevent political
entrepreneurship (Sheingate, 2003).
In addition to the institutional environment ripe for entrepreneurship is the shared
qualities of political entrepreneurs. Schneider et al. (1995) note that entrepreneurs, both public
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and private actors, perform three general functions: discover unfulfilled needs, bear the “risk”
whether it be emotional, personal, or financial, and the coordination of network of resources.
Entrepreneurs share the ability to perceive opportunities for political and policy change, and
ultimately, they are embedded in the system they are seeking to alter (Schneider et al. 1995;
Woon 2008).
Sheingate (2003) describes the more general understanding of political
entrepreneurship, and Scheinder et al. (1995) make the distinction between public and private
entrepreneurs. Legislative entrepreneurship, on the other hand, “is a set of activities that a
legislator engages in, which involves working to form coalitions of other members for the
purpose of passing legislation” (Wawro 2000, p. 5). Legislative entrepreneurs, issue owners
(Petroick 1996), policy advocates (Kingdon 1984), and coalition leaders (Arnold 1990) invest
time, staff, and other resources to gain expertise in a policy area. Wawro’s concept of the
legislative entrepreneur, like Arnold’s (1990) concept of the coalition leader, outlines the
process by which policymakers “design policy proposals and selective strategies for enacting
them” (5). In Congress, this is characterized by four key activities: acquiring information, bill
drafting, coalition building, and pushing legislation (Price 1989; Wawro 2000; Binder, Lee,
Mansbridge, & Martin 2016).
It is important to note that entrepreneurship in legislatures is a unique example of
political entrepreneurship because lawmakers have the advantage of resources and access to
the policymaking process, but they are burdened by the pressures of reelection. As a result,
members sometimes seek to mobilize support through entrepreneurial activity on issues that
are particularly important to their constituents (Price 1989). Similarly, the increased attention
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that members obtain through legislative entrepreneurship may enable them to attract voters
who might not otherwise support them (Wawro 2000). The scarcity of time and agenda space
often means that no single issue can dominate the public agenda indefinitely and further
indicates that the policy choices members of congress make are telling (Kingdon 1984;
Baumgartner & Jones; 1993).
Members of Congress build their portfolio by capitalizing on opportunities afforded by
committee assignments, institutional context, and shifts in attention (Miler 2017). A member’s
choice of bill sponsorship is a strong indicator of which issues he or she wants to be associated
with and the reputation he or she wants to acquire among colleagues (Schiller 1995). Bill
sponsorship and the subsequent fate of the proposed legislation has been used as an indicator
of legislative activity and success through the literature (Matthews 1960; Frantzich 1979;
Wawro 2000 Anderson et al. 2003; Cox & Terry 2008; Binder et. al 2016). However, these
measures have evolved beyond the simplistic inspection of roll call votes and bill sponsorship.
Similar to other comprehensive measures, Volden and Wiseman (2012; 2014) have developed a
metric of legislative effectiveness that they designate as a Legislative Effectiveness Score (LES).
More succinctly, not only is a member’s attachment to a proposed bill important, but also the
subsequent legislative activity. Volden and Wiseman (2012; 2014) track how successfully
members move legislative agenda items through the major stages in the legislative process,
telling any even greater part of the policy story.

WOMEN AS POLICY ENTREPRENEURS
The very first woman elected to Congress was Representative Jeanette Rankin (R-MO)
who initially served from 1917 to 1919. She also served in the 77th Congress from 1941 to 1943
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and was a noted suffragist and women’s rights advocate. The first woman to serve in the
Senate Was Rebecca Latimer Felton (D-GA) in 1922; she was appointed and served for only one
day. From these humble beginnings, it is hard to imagine the most heavily female Congress of
all time as sworn into service on January 3, 2019 (CAWP). The past thirty years in Congress has
seen the largest spike in-service of women in congress, and the largest gains have been among
Democratic representatives and senators (Bump, The Washington Post, January 3, 2019).
However, there have been some smaller spikes of Republican women as was the case in
previous election cycles. And for all the progress that has been made, including increased racial,
ethnic, and religious diversity, this historically female Congress is notably still more than 75%
male (CAWP).
Although women are experiencing increased electoral success, the United States has yet
to elect a woman president, and the percentage of women serving in Congress is about 20% of
the 535 members (CAWP). However, in congressional behavior studies defining women’s
interests “as women” separate from their partisan ideology is complex. Past research shows
that Democratic candidates, male or female, are more likely to support liberal policies that
appeal to women (Dodson 1998; Swers 2002; Childs & Krook 2009). Despite this complexity, the
progression of current research demonstrates that women do have an impact on politics.
Initially, this was characterized by how gender identification shapes representation (Pitken
1967; Swers 1998; 2001; Dolan 2008; Huddy, Cassese, and Lizotte 2008).
We know that political participation is determined in part by gender socialization, which
shapes women’s political interest, knowledge, and ambition (Paxton, Kunovich, and Hughes,
2007). In short, constituents are more likely to get involved when they see themselves in the
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political leaders in elected office (Mansbridge, 1999; Phillips, 1995). For women, this means
that as the number of female officeholders increase, so does the legitimacy of the legislature as
perceived by women (Schwindt-Bayer and Mishler, 2005). As a result, women in elected office
actively seek to represent the needs of women in their districts, as well as women in general.
Vega and Firestone (1995) studied behavior in the form of roll call voting and bill introduction
between 1981 and 1992. They find that in Congress women sponsor and cosponsor more
feminist legislation and bills related to women’s traditional role as caregiver than men. Often,
women feel compelled to pursue feminist initiatives and legislation, as well as legislation
traditionally coined as women’s issues including education, health, and welfare (Angevine
2017).
As such, it is reasonable to assume that the characteristics of political parties are
important to women. Democrats are generally more egalitarian and more likely to promote
traditionally underrepresented groups such as women (Matland 1993). Women in the United
States have been more successful achieving power in the Democratic Party than in the
Republican Party. When women have the opportunity to frame debates, they tend to speak on
behalf of marginalized constituencies more than men, as well as speak to their experiences in
ways only women can, thus effectively expanding the debate (Cramer Walsh 2002).
Though Swers (2013; 2016) reports some influence of gender as a predictor for women’s
issue bills, ideology remains a stronger predictor. However, a pattern does emerge among
Republican women deviating from party lines and voting for women’s issues more than their
male Republican colleagues. In order to consider the combination of women's health care
policy, issue attention, and legislative entrepreneurship, a discussion of legislative composition
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in regard to gender is essential. A critical facet of this literature is whether “who” holds office,
descriptive representation, affects the types of policies passed, substantive representation
(Pitkin 1967; Childs & Krook 2009; Swers 2013).
Women may and may not be changing the culture of Congress. Conventional wisdom
has long held that by increasing the number of women serving in Congress, the culture of
bipartisanship will be encouraged. Gender expectations of female compromise perpetuate such
notions. However, scholars find that the historic traditions of party loyalty are much more
important in predicting the behavior of legislators (Lawless & Theriault, 2016). Though the
tendency of women to collaborate in professional environments is well documented in other
fields, the role and pressures of party in Congress is too important to advancement,
encouraging reelection, achieving desirable committee assignments, and more (Lawless,
Therriault, & Gunther 2018).

INSTITUTIONAL DIMENSION
Over the last half century, the role of the federal government has expanded to
encompass more important policy decisions, and in turn, the practical demands on Congress
have risen in number and intensity (Loomis and Schiller 2018). However, even before the policy
explosion of the New Deal and the Great Society, there were many instances of intense,
sophisticated, and frequently successful lobbying efforts by organized interests. For example, in
the years immediately following World War I, the farm lobby, demonstrated its influence in
terms of information and support (Polsby 2004). For dozens of legislators, who repaid the
agricultural interest with increasing access to the process of lawmaking, the farm lobby would
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often work with farmers in legislator’s home districts. The political and policy information that
they provided gave members of Congress good reason to listen (Polsby 2004).
By the 1950s, however, committees served as the binding agent in cultivating close-knit
relationships (Thurber 1991), also referred to as subsystems (Worsham 1998; Worsham and
Stores 2012), or advocacy coalition frameworks (Sabatier and Jenkins-Smith 1999).
Congressional committees serve as anchors of policy subsystems and link key outside interests
to particular agencies in bureaucracy (Workman 2015). For example, those involved with sugar
interests worked with the appropriate agricultural committee and subcommittees in the House
and Senate and US Department of Agriculture officials. This arrangement helped to maintain
domestic sugar prices that were consistently higher than those in other markets around the
world (Polsby 2004). However, by the 1960s other various interests began to challenge the
sugar subsystem. Consumer and environmental groups were chief among those interested. In
1974, the sugar iron triangle broke apart and the subcommittee could not maintain control
over price support policies (Polsby 2004).
While the power structures from the 1960 to 1980s continued to evolve, so too did the
political environment in Congress (Schiller and Loomis 2018). Bureaucracy consistently engaged
with Congress in an effort to define policy problems (Baumgartner and Jones 1993; King 1997;
Workman 2015). As such, both bureaucrats and organized interests permeated the policy
process in varying degrees over time and across multiple dimensions (Workman 2015). Interest
groups became politically active as more government policies prompted them to action. This
period is marked by significant interest group proliferation was fueled by advances in
technology and the civil rights movement among other reasons (Nownes and Neely 1996;
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Hrebenar and Scott 2015). The 1960s also saw an increase in new programs for targeted
constituencies, such as women, the poor, and the elderly that changed the distribution of
benefits. As a result, federal programs, budget deficits, and distributive politics have grown
exceedingly (Schiller and Loomis 2018). Lawmakers seek to deliver concentrated benefits to
their constituencies and the ceiling for government spending has become difficult to hold
down.
Members of Congress favor a broad distribution of power within the chamber, as the
committee system provides the membership disproportionate influence over jurisdiction
specific policy and its agenda (Evans, 2013). This promotes the interest of individual members,
but also increases the costs of collective action and the legislature’s ability to compete with
other institutions, mainly the president (Godwin and Llderton 2014). It was not until President
George H.W. Bush raised taxes and President Clinton did the same, that deficit spending was
managed (Polsby 2004). Budget rules since then require that tax cuts, as well as increases in
entitlement and other mandatory spending, must be offset by tax increases or cuts in
mandatory spending. Thus, creating a system of winners and losers for each decision, referred
to as PAYGO (Schiller and Loomis 2018).
This restriction has made it difficult for Congress to respond to new issues as they arise,
especially defense spending. The costs of fighting the war on terror have been particularly
strenuous (Schiller and Loomis 2018). What has now resulted is a hostile relationship and a
decline in trust between Congress, the president, and the public. There is often a disconnect
between public approval for individual members in their districts and Congress as an institution
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(Evans 2013). Similarly, the growing partisanship in Congress has resulted in partisan control of
the agenda.
Given the continuing budgetary constraints in creating new programs and institutional
reluctance to eliminate old ones, members of Congress have invited public distrust and
cynicism (Evans 2013). According to Schiller and Loomis (2018), ironically, when Congress does
“rise to the occasion and act as a decisive policymaking body the normally skeptical and cynical
public often embraces legislative action” (p. 11). For example, there was a significant increase
in popular support after the September 11, 2001 terrorist attacks. However, voters are often
suspicious of policies proposed by the opposite party, which was true in the case of the
Affordable Care Act (2010). The legislation was passed unanimously along party lines and
Republicans are still threating to repeal the act.
Congress is a majority-rule institution organized by parties and committees and since
the founding, these ideals have prevailed even through constitutional amendments and
reorganization (Shepsle and Weingast 1995). Congress has a deliberately slow approach to
policy making built into the institutional rules and traditions of its processes. Similarly, the U.S.
federal system purposefully makes widespread national change more difficult than a more
centralized system. The features of our constitutionally prescribed separation of power are
designed to prevent government from acting without carefully considering the outcomes and
benefits of policy change (Robertson and Judd 1989). The contemporary congressional
legislative process still appears broken and largely fragmented. As a result of huge deficits and
extreme partisan polarization, the House and Senate typically fail to enact appropriations bills
before the deadline. The agenda setting power of the committee is the right to halt or support
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proposals to change the status quo, or what Aldrich (1994) refers to as structure-induced
equilibria (p 179). As such, committees are granted the power to kill legislation in their policy
jurisdiction. Committees and subcommittees are organized by the majority party and help to
shape the overall congressional agenda.
The political context of the institution is not only shaped by the preferences of
individual members but also through the group characteristics of its membership. For example,
in 1992 when a record number of women were elected to Congress. This period was marked by
an expectation for attention to women’s issues and a strong feminist agenda. Then just a few
short year later in 1994, Republicans took control of Congress for the first time in forty years.
These shifts in group characteristics are indicative of a group dynamic that alters the political
environment and the policy context. While the institutional constraints (and sometime
freedoms) of Congress help to shape the agenda, so does the makeup of induvial membership

CONCLUSION
Now having considered the literature of agenda setting, entrepreneurship, and the
impact of gender in Congress, I will explore how the policy women’s health care might be
applied as a test case. The research builds on the work of Baumgartner and Jones’ (2005; 2013)
The Policy Agendas Project, contributing a broader picture of health policy by including
women’s health care. In the following chapter I connect the literatures of issue attention,
legislative entrepreneurship, and gender in Congress to map the health policy agenda and
determine how attention to women’s health care is altered.
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CHAPTER 3: Mapping the Agenda

Women’s health care was initially defined in the literature and understood by policy
makers as a part of social welfare policy (Gordon 1990). As individual leaders and as group
participants, women were influential in organizing and nationalizing movements for public
health, and in the late nineteenth and early twentieth centuries women who supported the
general welfare movement also advocated specifically for women's welfare (Sapirio 1990).
Before WWII, most bills introduced in Congress either ignored women as a class or focused on a
narrow margin of their concerns. Government first established women's traditional activities as
guardians of health and morals through their roles as wife and mother (Mink 1990).
Post WWII, however, the definition of women’s health care has expanded to include
health concerns for women beyond motherhood. The National Academy on Women’s Health
Medical Education defines women’s health to include the screening, diagnosis, and
management of conditions that are unique in women, more common in women, and more
serious in women (Charney 2000). I purposely use this broad definition of women’s health in
order to capture the various facets of women's health policy across multiple measures. Cobb
and Elder (1972) contend that issue expansion requires broad definition and Baumgartner and
Jones agree that policy image is key in understanding punctuations in attention (1993).
Attention shifts as particular actors focus on narrow dimensions of the policy and attention is
altered.
This chapter focuses on how the issue of women’s health gained space on the agenda.
First, I map the health agenda using data available through The Policy Agendas Project, which
allows me to illustrate how health care in general fits into the overall policy landscape. As
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women’s health care was first defined through policy related to infants and children, I will then
discuss The Policy Agendas Project data available for health specifically related to health care
for infants and children. The final section of the chapter uses original research to track the entry
of women’s health on the health agenda.
The Policy Agendas Project is an archive of policymaking activity since 1946. Data is
available across multiple subjects and is linked through a common policy topic coding system.
For this study I use the available data for the United States including executive orders, New York
Times index records, public laws, congressional bills, and congressional hearings. The Policy
Agendas’ data, however, does not distinguish women’s health as a discrete subtopic. I
supplement what is available in The Policy Agendas Project
(https://www.comparativeagendas.net) to better understand the place of women’s health care
in relation to other health agenda items. Using “women’s health issue” as a search term, I trace
public attention through ProQuest Historical (https://www.proquest.com) digitized newspaper
archives of the New York Times; map congressional attention by tracking bill introductions,
committee hearings, and passed legislation through ProQuest Congressional
(https://www.proquest.com) and Congress.gov; and track presidential attention using data
available in The American Presidency Project (https://www.presidency.ucsb.edu).

MAPPING THE HEALTH CARE AGENDA
To begin, I am interested in what portion of the agenda is taken up by attention to
health policy in general. I then map attention to infants and children health, a subset of health
policy from the Policy Agendas’ data. Finally, I supplement what is available in The Policy
Agendas Project by developing a measure of attention to women’s health care.
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Public Attention
As an indicator of public attention, I use data from the New York Times (NYT) index from
The Policy Agendas Project to track mentions for health policy. 1 Figure 3.1 indicates the number
of mentions for news related to health policy generally. Attention to health is relatively stable
from 1950 to the late 1960s with upticks occurring in 1973, 1994, and the early 2000s. The
highest frequency of health mentions, 55, occurs in 2005 and the least, 9, in 1963. Attention to
health policy mirrors the attention to all types of policy, which both generally increase over
time and exhibit the same bumps in attention. For example, just as attention to health shows a
dramatic increase in 1973, so does attention to all policy issues. Though not an overwhelmingly
dominant topic, health is still a policy consideration for the public ranging between 1.69% and
6.39% of all stories.
Figure 3. 1 Health New York Times Index

Figure 3.1 Health New York Times Index
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The Policy Agendas Project dataset utilizes a systematic random sample of the New York Times Index. The sample
includes the first entry on every odd-numbered page of the Index. Each entry is coded using the major topics
identified across all datasets and includes other variables such as the length, date and location of the story and
whether it addresses government actions. There are 54578 observations spanning the years 1946 to 2014.
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Congressional Attention
In order to get a feel for the place of health on the congressional agenda, I track bill
introductions in the U.S. House of Representatives and Senate (Figure 3.2), using data coded
through The Policy Agendas Project. The series peaks in the 1973 congressional session with
bills introduced between both chambers representing roughly 7% of the 21,950 total bills
introduced that year. Bill introductions for health policy follow a similar increasing and
decreasing pattern that is observed for bill introductions for all topics, with one difference.
There is a steady increase in such activity until 1965, when discussion of government sponsored
health care was a regular topic on the agenda, culminating in the creation of Medicare and
Medicaid in 1965 as amendments to the Social Security Act. The largest spike in the series
occurs from 1967-1973, when the discussion of the rising costs of public health and the topic of
abortion were particularly salient. The decline in attention in the 1975 congressional session is
followed by a relatively stable continuation of the pattern through 1981. However, the 104th
Congress (1995-1996) shows a more substantial decrease in the number of bills introduced
after a slight bump in the 1989 congressional session. This period is followed by steady increase
again with the largest peaks occurring in the 1999, 2007, and 2013 congressional sessions.
House and Senate attention mirror one another with one exception. It appears there is a more
dramatic rise in attention in the House between 1960-1979 than is the case in the Senate. As I
consider other measures of attention and the agenda capacity for women’s concerns, this will
be an important issue.
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Figure 3. 2 Health Bill Introductions
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Bill introductions, however, only paint a portion of the activity on the congressional
agenda. Congressional hearings fill out the portrait. Hearings have been used as an indicator of
activity on the decision agenda (Cobb and Elder 1972; Kingdon 173; Walker 1977; Light 1982;
Stores and Worsham 2012), as a measure of turf control (King 1997), and to get at formulation
and adoption (Wilkerson et. al 2002). Using The Policy Agendas Project, I initially tracked all
congressional hearing activity to get a feel for the variety of topics on the agenda and then
focused on health related hearings to see how much agenda space was allotted to health
concerns. The rise and fall in hearings mirror the pattern in legislative introductions. Figure 3.3
maps health policy hearings in relation to all hearings, while Figure 3.4 maps health hearings in
each chamber as well as joint committee hearings. There are similar periods of increase and
decline in all hearing activity and health hearing activity. Health-related hearings never exceed
10% of total hearings in a congressional session (Figure 3.3), ranging between .86% and 9.6% of
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all hearings. Health hearing activity in both chambers picks up in the late 1970s and continues
to climb through the early 1990s with a sharp decline after 1993 (Figure 3.4). In terms of the
level of attention, health as a subtopic is about in the middle of all the topics coded by the
Agendas Project.
Figure 3. 3 Hearings Health vs. All Topics
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While bill introductions and hearings are indicators of congressional attention,
legislation passed by Congress is perhaps the ultimate measure of attention. As was the case
with bill introductions and hearing activity, I tracked both all legislation passed and health
legislation passed (Figure 3.3 and Figure 3.4). Figure 3.5 indicates that the passage of legislation
declines over time, leading some to conclude that it is getting harder to legislate (Binder and
Lee 2013).
Figure 3. 5 All Topics Passed Legislation
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The passage of health policy legislation (Figure 3.6) does not seem to follow the pattern
of overall decline. The series is fairly steady, punctuated by a flurry of activity between 1983
and 1991 when Congress grappled with the growing cost of health care. The drop-off in 2010, I
would conjecture, is a result of the passage of the comprehensive health care reform bill, the
Patient Protection and Affordable Care Act (2010). Overall, there is another period of increase
from 2005-2009 and a small rise again in 2013. It should be noted that tracking the total
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number of bills passed obscures the importance of landmark legislation such as Medicare and
Medicaid (1965) and the Affordable Care Act (2010).
Figure 3. 6 Passed Health Legislation
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Presidential Attention
In addition to public and congressional attention, the president’s ability to set the
agenda, which varies by historical context and policy type, is a potential driver of health policy
change (Light 1999; Skowronek 1982; Canes-Wrone 2006). In order to evaluate the presidential
role in health care, I review executive orders, State of the Union (SOU) addresses, and public
discussion on health issues from data collected using presidential papers available in The
American Presidency Project (APP). The APP (https://www.presidency.ucsb.edu) is a database
of public presidential documents and related key historical documents and advanced search
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tools maintained by John Woolley and Gerhard Peters through the University of California Santa
Barbara. Documents are tagged with descriptive information employed to locate similar
subjects or categories. I utilize the search subject term “health care.” A review of 25 randomly
selected results indicates that generally appropriate documents related to health care are
returned.
Figure 3.7 traces the frequency of presidential mentions in public discussion, SOU
addresses, and executive orders. For the purpose of this research, public discussion includes
presidential mentions derived from interviews, news conferences, press briefings, inaugural
and farewell addresses, other oral addresses (including Weekly and Saturday Addresses), and
Fireside Chats.
Figure 3. 7 Presidential Mentions Health
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Presidential attention to health policy appears nearly non-existent but relatively stable
until 1992. There is a major punctuation in 1992 followed by a sustained higher level of
attention, which is subject to a second punctuation in 2008. This period is followed by a return
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to the previously established equilibrium, which ends with a sharp drop-off in 2017. The
punctuations are possibly related to the Clinton Health Care Plan (formally introduced Oct.
1993) and the passage of the Affordable Care Act (passed Mar. 2010). While public attention to
health policy spiked in 1973, 1994, and the early 2000s (Figure 3.1), only the latter two spikes
are associated with increased presidential attention.

INFANTS AND CHILDREN
As a first pass at mapping the agenda for women’s health care, I begin by examining
infants and children’s policy. I use data for infants and children as a surrogate for women’s
health because a look at the policy history indicates that women’s health was initially defined
through childbirth and child care. I compare this data to data collected for all health policy
coded in The Policy Agendas Project in order to better understand what portion of the health
agenda is defined by topics concerning infants and children.
Public Attention
As a measure of public attention, I track the number of mentions for infants and
children policy, using The New York Times index available through ProQuest Historical
(https://www.proquest.com) cataloged from 1945-2015. There is not data available to track
public attention for infants and children policy in the The Policy Agendas Project, so I have
supplemented what is available with my own search.
ProQuest Historical Newspapers is a tool that allows researchers to search the collection
of The New York Times index from 1851 to 2014. ProQuest advanced search tool retrieves
documents containing all search terms, appearing in any field including document titles,
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authors, subjects, as well as the full text. Using the autocomplete feature, the advanced search
tool provides suggestions from the subject index that are similar to my search. While this does
not ensure that all results will align perfectly, some margin of error is expected.
I employed the following search terms as suggested in the advance search feature:
infants and health, children health, children’s health, child and health, and children health care.
I limited results to only include: articles, features, general information pieces, front page or
cover stories, editorials, and news. A review of 25 randomly selected documents across
multiple time periods yields appropriate results concerning women’s health.
Figure 3.8 illustrates the frequency of mentions and indicates that the greatest number
of mentions occurs in 2001 and the least in 1958. The overall trend of the data indicates an
increase over the time period studied. There are slight bumps in attention in 1966-1967, 1984,
and 2001. In comparing this data to the data coded in The Policy Agendas Project for all health
policy (Figure 3.1), I find substantial inconsistency. The Policy Agendas Project reports a total of
1,798 mentions for health policy for the total time period studied. A cursory search using
ProQuest Historical (New York Times index) yields over two million results. I use “health” as a
search term with the same document type filters (articles, features, general information pieces,
front page or cover stories, editorials, and news). Given the refined coding system used in the
Policy Agendas Project, this may simply be a limitation of the available data and a function of
the specificity of results. However, this discrepancy is worth noting.
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Figure 3. 8 Infants and Children New York Times
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Congressional Attention
Figure 3.9 tracks the number of bills introduced in the House and Senate related to
infants and children, using data available through The Policy Agendas Project (Health, subtopic
Infants and Children). It appears that initially the House is more active and, not surprisingly,
introduces more legislation (not surprising since there are more potential authors of legislation
in the House). What is surprising is that the Senate actually matches the House levels during
select periods. I am interested if a similar result is observed when tracking uniquely identified
women’s health legislation, as opposed to using infants and children as a substitute. Bill
introductions in both chambers steadily increase over time, with a dramatic uptick in the mid1960s in the House and again in the mid- 1980s. The year with the greatest number of bill
introductions for both chambers is the 2007 Congress, with 75 in the House and 66 in the
Senate, totaling 141 out of 1,445, or roughly 10% of all bills introduced concerning health policy
(Figure 3.2).
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Figure 3. 9 Bill Introductions Infants and Children
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Also using data available through The Policy Agendas Project, I track congressional
hearings in both the House and Senate using the health subtopic infants and children. The
number of hearings concerning infants and children begins to increase after 1969 and
experiences an uptick in 1973, 1987, 2001, and 2007 (Figure 3.10). The greatest number of
hearings for all health policy topics occurs in the 1991 Congress, (343 hearings, Figure 3.4). Only
16, or 4.7%, of those hearings can be attributed to policy concerning infants and children.
Hearings for infants and children policy, specifically, are most frequent in 1987 totaling 20
(Figure 3.8), or 6.8% of all health-related hearings.
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Figure 3. 10 Congressional Hearings Infants and Children
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In addition to bill introductions and hearings, I map congressional attention using data
collected in The Policy Agendas Project by examining passed legislation (Figure 3.11) for health
policy concerning infants and children as compared to health policy generally. The greatest
number of passed laws in health policy occurs in the 99th congressional session (1985-1986),
totaling 79 (Figure 3.6). In that Congress, passed legislation specifically related to health for
infants and children accounts for only five laws passed, or 6.3%. We also see this number of
laws passed concerning health of infants and children in the 2007 and 2013 Congresses. In each
instance, it is clear that infant and children’s health represent only a small portion of
congressional attention to health policy. Measuring attention by the frequency of passed
legislation demonstrates the limited agenda capacity (Tan and Weaver 2007) and competition
among crowding policies (Baumgartner and Jones 2004), but it does not suggest that instances
of passed legislation are not significant.
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In the 99th Congress for example, Congress passed the most health-related legislation,
which included particularly salient measures for the health of infants and children and women
by extension. On November 14, 1986, President Reagan signed into law a major package of
health bills (S 1744 — PL 99-660). Congress cleared the bill, which included nine separate
measures, just before the session adjourned. The final package was put together by Rep. Henry
Waxman, D-Calif., chairman of the Energy and Commerce Subcommittee on Health and the
Environment, and Orrin Hatch, R-Utah, chairman of the Senate Labor and Human Resources
Committee, along with Rep. Edward Madigan, R-Ill., and Sen. Edward Kennedy, D-Mass., and
the respective ranking minority members (“Congress Clears Omnibus Health Legislation” 1986).
The bill included key provisions to establish the National Commission to Prevent Infant
Mortality. This commission would be responsible for identifying and examining federal, state,
local, and private resources which affect infant mortality; identifying health care barriers to
reducing infant mortality; and promoting the health of childbearing women and their infants (S.
1744).
Also wrapped into an omnibus package was legislation strengthening federal standards
for the testing and monitoring of infant formula (“Infant Formula Regulation" 1986). Both
versions of the proposed bill toughened standards created by the 1980 Infant Formula Act (PL
96-359), which set minimum nutritional requirements for infant formulas. The approved
measure was attached to omnibus drug legislation (HR 5484 — PL 99-570) signed into law
October 27, 1986. Although Senator Orrin Hatch, R-Utah, expressed that the new regulatory
burdens were unnecessary and would drive up the cost of formula, he admitted that it was

41

“pretty hard not to vote for something that looks like motherhood and apple pie” (“Infant
Formula Regulation" 1986).
Notably, health care for children hit a critical peak as the poverty rate for children
reached a record high. In 1985, more than one out of every five children in the United States
lived in a family whose income was below the poverty line (Rovner, 1986). Just before the 99th
Congress adjourned, members approved a three-year reauthorization of five child nutrition
programs that had been delayed in conference for the previous year. The act extended
authorization through 1989 for five critical child nutrition programs, including the supplemental
feeding program for needy pregnant women, infants and children (WIC) (S 2638 — PL 99-661).
Figure 3. 11 Passed Legislation Infants and Children
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Presidential Attention
Finally, I map presidential attention to health policy for the subtopic infants and children
by examining executive orders, using data available in The Policy Agendas Project. Illustrated in
Figure 3.12, health policy appears in executive orders several times over the period studied, but
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health policy related to infants and children is only mentioned three times: 1997, 2001, and
2003. This indicates very little presidential action regarding health policy explicitly for infants
and children. Potentially, this is a function of the limited data available for this subtopic in the
Policy Agendas database and the specificity of coding. Infant and children’s health may also be
defined more broadly to include child labor and working conditions or as wards of the state.
Figure 3. 12 Executive Orders Infants and Children vs. All Health
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MAPPING WOMEN’S HEALTH POLICY
As a final step in mapping the health care agenda, I look specifically at attention to
women’s health care and what proportion of the total health agenda is dedicated to women’s
health. I add to the data available in The Policy Agenda’s Project to further examine attention.
As evidenced by the previous discussion of the health agenda and infants and children policy,
the current tools for analysis are useful but limited. My research will help to expand
understanding not only by focusing on attention to women’s health in a more specific context
but also evaluating the limitations of the current analytical tools available.
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Public Attention
To map public attention, I use data available through ProQuest Historical Newspapers
(https://www.proquest.com) cataloging the New York Times index from 1945-2015. Again, I use
the advanced search tool with suggested subject terms within my search. I employ the
following search terms: women’s health issue, asian women’s health, black women’s health,
older women’s health, rural women’s health, global women’s health, and women’s heart
health. I limited results to only include: articles, features, general information pieces, front page
or cover stories, editorials, and news. I reviewed 25 randomly selected results and the
documents are appropriate returns related to women’s health. While the ProQuest tools are
not perfect, its use is widely accepted among research and academic institutions. The databases
are reliably constructed and maintained in regard to accuracy and time sensitivity and the
conditions of my search can be replicated.
While public attention to health policy indicated by mentions in the New York Times
experiences periods of increase and decline, there is a steady increase from the 1950s to the
early 1980s (Figure 3.13). Attention to women’s health care experiences an uptick in 1984,
1995, and 2000. Comparing public attention observed for infants and children policy, it appears
that both indicate an increase from the early 1960s to early 2000s followed by a period of
decline.
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Figure 3. 13 New York Times Index Women’s Health
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Congressional Attention
To examine attention to women’s health as part of the overall health agenda, I compiled
data utilizing the query tool available through Congress.gov. Congress.gov is maintained by the
Library of Congress and is a reliable source for U.S. federal legislative information. The
advanced search tool provides access to accurate, timely, and complete legislative information
and allows the researcher to create custom search parameters. Combined data from the Office
of the Clerk of the U.S. House of Representatives, the Office of the Secretary of the Senate, the
Government Publishing Office, Congressional Budget Office, and the Congressional Research
Service are included.
Using the advance search feature, I included data from 1945 to 2016 (the 93rd to 114th
Congress) and limited my search with the legislative subject term “women’s health.” Legislative
analysts from the Congressional Research Service (CRS) closely examine the content of each bill
and resolution to assign Policy Area Terms and Legislative Subject Terms. Women’s health has
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been identified as a discrete Legislative Subject Term, and bills may be assigned more than one
term. Currently, there are over 1,000 terms in use (Congress.gov). I conduct a search for all
legislation including introduced bills, resolutions, concurrent resolutions and joint resolutions.
In Figure 3.14, I examine introduced legislation concerning women’s health in both the
House and Senate. For all health legislation, The Policy Agenda’s Project data indicates the
largest number of bill introductions concerning health (Figure 3.2 House and Senate combined)
occurs in 1973, totaling 1,567. This represents roughly 7% of the 21,950 bills introduced in that
Congress. Women’s health as a discrete subtopic, however, does not appear in bill
introductions until 1975. The greatest number of bills introduced specifically aimed at women’s
health care occurs in the 114th Congress beginning in 2015, with 137 bills originating in the
House and 96 originating in the Senate. Women’s health legislation introduced from 1973 to
2018 totals 2,391 bills (1,450 House and 941 Senate). Given the size and scope of the two
chambers, the proportional activity in the Senate is notable. While many factors contribute to
predicting the behavior of individual senators, activity on the chamber level is surprising.
Committee assignments and institutional position in the Senate come with certain
advantages and disadvantages that a senator must incorporate into legislative and political
strategy (Schiller 1995; Swers 2016). This result is likely part personal and part institutional. I
discuss particular member’s entrepreneurial activity in the Senate in chapter four.
Turning to competition in the overall health agenda, combined bill introductions in the
House and Senate totals 233, or 22% of the 1,053 total bills introduced concerning health policy
generally (Figure 3.2). Introductions for women’s health care policy follow a similar pattern of
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increasing and decreasing that is observed for bill introductions for all health policy and infants
and children’s health. The overall trend indicates an increase. This somewhat resembles the
slight trend of increasing bill introductions for health policy concerning infants and children
(Figure 3.9). Bill introductions related to infants and children also rose steadily in the early
2000s but peaked in 2005.
Considering the trends of public and congressional attention, it is apparent that bill
introductions in Congress show more activity prior to the spike in public attention in 1995.
However, the steady increase in bill introductions, particularly in the House, aligns with public
attention in those years. Public attention and congressional attention do not necessarily
perfectly align, but considering the institutional dynamics, this is not surprising. Preparing a bill
for introduction in either chamber requires allocation of resources. In many ways Congress is a
reactive institution, but it may be the case that members of Congress command public
attention and not the reverse (Cobb and Elder 1983; Birkland 2017).
Figure 3. 14 Bill Introductions Women’s Health
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Central Themes Women’s Health Bills Introduced
While tracking the frequency of bill introductions over time provides considerable
insight into the capacity for Congressional attention, the actual substance and nature of the
intention is equally important. Women’s health legislation can be generally clustered into five
categories. These include expansion of public health services through federal grant programs,
child and maternal health, nationalizing health care, reproductive health, and cancer. Next, I
carefully consider the nature of the bills introduced in these categories and provide a more
substantive review of the legislation and the congressional context.
Expanding Federal Grant Programs

On November 19, 1945, Truman sent to Congress a five-point health program which
included provisions for expansion of public health services and maternal and child health
programs through larger federal grants to the states. In response, the Maternal and Child
Welfare Bill of 1945 was introduced in the Senate (S 1318). The bill would have authorized over
$100 million a year in federal grants to the states to provide maternity and medical care for
women and children under the Social Security Act. A number of other proposals were made but
never gained traction (“Health Proposals in the 79th Congress” 1945).
Four years later, The House Ways and Means Committee began a study of the entire
Social Security program. Following a series of lengthy hearings, the committee reported HR
6000 August 22, 1949 (“Social Security Act Amendments” 1949). The bill proposed expansion of
coverage and liberalized benefits, which included provisions for pregnant women and children.
The House passed the measure without amendment by a 333-14 roll call vote, but the Senate
did not act (“Social Security Act Amendments” 1949).
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For the next six electoral cycles (1950 forward), Congress elected to improve benefits
under the Social Security Act. In 1965 Congress approved several major programs that had long
been championed by the Democratic party, most notably in the case of medical care under
Social Security. In the following years, Congress debated and a series of proposals continuing
the general trend of expansion for federal grant programs. Then in 1979, three years after his
campaign promise for comprehensive changes in health care, President Carter made a proposal
for an all-inclusive health insurance plan, but it too turned out to be very limited. His plan,
however, set the agenda for congressional debate on the issue (Wher and Donnelly 1980).
This debate continued in Congress through the late 1980s when the 100th Congress
produced the most significant overhaul of the welfare system in fifty years. They officially
passed the measure Sept. 30, 1988, when the House approved the conference report (H Rept
100-998) by a vote of 347-53 ("After Years of Debate, Welfare Reform Clears” 1988). The
comprehensive bill specifically expanded provisions for women and children (prenatal and
infant care), the elderly, and poor as part of Medicare and Medicaid. Senator Patrick Moynihan,
who helped steer the bill’s passage, commented, “We are redefining this 1935 program [AFDC]
from a widow's pension to a program that will bring a generation of young American women
back into the mainstream of American life.” ("After Years of Debate, Welfare Reform Clears”
1988). Expansion and alteration of health grant programs impacting women and children
continued through legislative authorization over the next thirty years until broad programmatic
revisions occurred under the Patient Protection and Affordable Care Act (2010).
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Child and Maternal Health

Child and maternal health appear in introduced legislation in many forms post World
War II. As federal grant programs ensuring health benefits for the needy and elderly began to
unfold, President Lyndon Johnson made a very pointed request to Congress to fully fund his
proposed health benefit package. In his “Health in America” message to Congress, President
Johnson proposed expanded grant programs including health programs targeting expectant
mothers (“Message to Congress: Johnson Asks Expanded Medical-Training Programs in "Health
in America" Message” 1968). Johnson recommended a $58 million increase in appropriations
for the maternal and child health care programs, of which $25 million of this increase would
provide for maternity and infant care centers and clinics across the nation (“Message to
Congress: Johnson Asks Expanded Medical-Training Programs in "Health in America" Message”
1968). The Child Health Act of 1968 didn’t pass in Congress, but it did, however, raise
awareness for the critical issues facing expectant mothers especially in rural America.
One such crucial issue reappearing in bill introductions is the rise and decline of infant
mortality. President Kennedy, in an address to Congress, remarked, “Although infant mortality
has decreased 75 percent since 1900, the decline has levelled off in the last ten years, and our
rate is still higher than that, for example, of Sweden. Some states have an infant mortality rate
double that of others” ("Message to Congress: Kennedy's Feb. 14 Message on Youth” 1964). As
the civil unrest of the late 1960s took hold, the plight of the urban poor became a central issue
in Congress and across the country. Much of the debate about the government's role in
meeting social (especially health related) needs centered on the balance between spending for
social programs and the need to finance the war in Vietnam (“Plight of Cities, Poor Americans
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Key Issues in 1968”1968). Again, President Johnson proposed an expanded child health
program that could significantly reduce infant mortality by making health care more readily
available to the poor. This proposal made no headway in Congress, likely in part because of the
high cost that would be involved. Most of the health legislation enacted by Congress in 1968
expanded existing federal programs.
However, nearly twenty years later, on November 14, 1986, President Reagan signed
into law a major package of health bills which created a national commission on infant
mortality (S 1744). The commission’s report generated several legislative proposals concerning
the issue. In 1987, the House and Senate passed similar bills proposing federal programs aimed
at reducing infant mortality. Members were unable to resolve differences before the end of the
congressional session, but the issue was championed by several key players in health policy.
Representative Henry Waxman (D-CA), chairman of the Subcommittee on Health for the House
Energy and Commerce Committee, argued that “the United States had the highest rate of
infant mortality among 20 industrialized nations” and “that studies had shown early prenatal
care was a key factor in ensuring that babies were born healthy” ("Infant-Health Bills Pass”
1987).
Children and infant’s health legislation was also often tied to nutrition. In 1972, as an
amendment to the Child Nutrition Act of 1996, Congress authorized a pilot program to provide
supplemental food assistance for pregnant and nursing women and for infants up to age four
(“Congress Expands School Lunch Program” 1972). This developed into the program we know
today as the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC)
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(Gunderson 2013). In 1975 legislation established WIC as a permanent national health and
nutrition program (PL 94-105).
In the early 1990s, maternal and children’s health legislation focused on funding and
reauthorization of key programs. In 1993, President Clinton signed into law the National
Institutes of Health (NIH) Reauthorization (S 1, HR 4), which reauthorized selected programs at
the NIH. The three-year, $6.2 billion reauthorization included provisions codifying President
Clinton's decision to permit federal funding of fetal tissue research. However, a major focus of
the bill was an emphasis on health research involving women and minorities. The bill required
increased participation of women in clinical studies, ordered the NIH to employ more women
scientists, and increased funding for research on breast cancer, ovarian and cervical cancer,
osteoporosis and reproductive health. Children's health also got more attention. One initiative
focused on the search for more affordable, improved vaccines, including study into an HIV
vaccine for women, infants and children ("National Institutes of Health (NIH) Bill Focuses on
AIDS, Women's Health” 1993).
The road for women’s and children’s health, however, was not always an easy one,
particularly in regard to the contentions State Children’s Health Insurance Program (SCHIP). The
program was established in 1997 (PL 105-33) to provide health care for low-income children
whose parents could not afford private insurance but were not poor enough to qualify for
Medicaid. The federal government provided grants while the states administered the program
and matched a portion of the grant money, including provisions for pregnant women
(“Democrats Unable to Overcome Bush Vetoes of Child Health Bills” 2007).
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Democratic leaders made expanding SCHIP a top priority in the 110th Congress (2007).
They argued that an additional 6 million uninsured children, beyond those already being served,
were eligible for SCHIP or Medicaid but were not enrolled in either program. Lawmakers sent
President Bush a version of the proposed Senate bill, but he quickly vetoed it. After an override
attempt in the House failed, Democrats made a second attempt. They sent President Bush a
revised bill that they hoped would garner some GOP support. When the President vetoed the
second bill, Democrats elected to postpone a vote until 2008 (“Democrats Unable to Overcome
Bush Vetoes of Child Health Bills” 2007). One of the first acts in the 111th Congress was to pass
a significant expansion of the State Children's Health Insurance Program. President Obama
signed the bill into law Feb 4, 2008 (HR 2 — PL 111-3).
Nationalizing Health Care

Women’s health policy is not only present in legislation that expands and constricts
individual programs. It is also part of more comprehensive health initiatives aimed at
nationalizing care. As health programs grew post World War II, so did the cost of health care.
With these rising costs came increased attention in Congress. The House Interstate and Foreign
Commerce Committee opened hearings January 11, 1954, on the “cost of medical services”
(“Health Hearings” 1954). Industrialist Henry J. Kaiser proposed private financing of a national
health program in which, eventually, 30,000 doctors could care for 30 million Americans at low
costs. Kaiser said an initial private outlay of $1 billion could set up 1,000 health centers (“Health
Hearings” 1954). Although this plan never came to fruition, Kaiser’s proposal is particularly
interesting, given the Kaiser Family Foundations continued support of health policy and
research in the women’s health field.
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Similarly, in the 1954 House Interstate and Foreign Commerce Committee hearings,
Gerhard Hirschfeld, director of the Research Council for Economic Security, Chicago, described
his organization's survey of prolonged illnesses. Hirschfeld found there were 37 prolonged
illnesses (of more than four consecutive weeks) per 1,000 employees, with the rate higher
among women than men (“Health Hearings” 1954). As health concerns for men and women
grew among the medical and economic communities, it is evident that Congress was listening.
The role of the federal government in providing health benefits was a major
congressional issue during the entire postwar period. Opponents of a national health insurance
tied to Social Security have tried to limit the government's role. Labor interests supported a
national health insurance program, while the American Medical Association feared socialized
medicine (“Senate Kills Social Security Health Care Plan” 1962). The creation of programs
targeted at large portions of the population have been stepping stones in this process. Haeder
and Weimar (2015) argue that the American grant system used to expand access to health care
has been “a long series of incremental, trial-and-error adjustments to new circumstances” (p.
747). While the National Public Health Service Act of 1944 and its amendments provide for a
wide range of programs, a broad federal health care plan was widely debated. Though often
couched in other terms, Congress considered this idea in various forms. The 1971 Amendments
to Title III Public Health Service Act of 1944 (PL 78-410) directed the Health, Education, and
Welfare (HEW) Secretary to undertake a systematic analysis of national health care plans.
Though the idea of national health care surfaced repeatedly, nationalized health care was most
succinctly addressed in the Clinton Health Reform (1993) proposal.
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The scope of President Bill Clinton's health reform proposal and the decision to appoint
First Lady Hilary Clinton to spearhead the effort, coupled with Congress’ response, marked a
critical and volatile period in the history of health policy legislation. Although Congress did not
actively address President Clinton’s proposal until he introduced legislation at the end of the
congressional session, the issue was not far from public and congressional debate. President
Clinton formally submitted the health care reform bill October 27, 1993 (1994 “Health-Care
Debate Takes Off” 1994). Immediately following the bill’s introduction, several alternative
proposals emerged.
A viable health reform bill as the President envisioned never emerged. While the
literature is divided as to a single issue that prevented the success of the Clinton health reform
plan (Rushefsky and Patel 2016), it opened the door to a series of smaller health (and women’s
health) concerns to emerge on the congressional agenda. Similarly, it opened the door for
comprehensive legislation to be considered under the Obama administration (Rushefsky and
Patel 2016).
Passage of the Patient Protection and Affordable Care Act (ACA) (2010) was a purely
partisan effort. Over a period that stretched nearly six months, five committees (three in the
House and two in the Senate) considered and approved versions of the bill (“Landmark Health
Care Overhaul: A Long, Acrimonious Journey” 2009). Citing issues of a public option, individual
mandate, employer mandate, abortion funding, and tax expenditures, the bill remained in
committee and with competing versions. In an unusual move, President Obama appeared
before a joint session of Congress to renew his appeal for a health care overhaul (“Landmark
Health Care Overhaul: A Long, Acrimonious Journey” 2009). Ultimately, Congress passed the
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Senate version of the bill in order to avoid a lengthy debate process. The ACA was not only the
broadest expansion of health care coverage since the creation of Medicare in 1965 but also
represented a victory for women’s health preventative medicine. Although some gains were
made for women’s health coverage, research, and access, one key part of the debate focused
solely on abortion coverage. In order to win key democratic votes, the law restated the existing
statute that prevents the use of federal funds to cover abortions except in the case of rape,
incest, and endangers the woman's life (“Landmark Health Care Overhaul: A Long, Acrimonious
Journey” 2009).
Reproductive Health

The issue of abortion has separated itself from women’s health legislation in many
respects. Though first understood in terms of the health and well-being of mothers, abortion
has also come to be framed as a civil rights issue, a states’ rights issue, religious rights, or
question of sex and gender policy among many other things (Rebouché 2016). Abortion,
nevertheless, fits into a faction of women’s health policy related to reproductive health.
Nearly a decade before the landmark Roe v. Wade (1973) decision, Congress, for the
first time, turned its attention to the controversial issue of birth control. Acknowledging
growing public concern for population problems, hearings by the Senate Government
Operations’ Subcommittee on Foreign Aid Expenditures were intended to gather information
about and focus attention on the subject of birth control. The hearings were specifically related
to legislation introduced in the Senate by Subcommittee Chairman Ernest Gruening (D- AK). The
bill (S 1676) proposed establishment of Offices for Population Problems in the Department of
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State and the Department of Health, Education and Welfare to collect and disseminate
information on family planning and population growth.
Although the Roman Catholic Church also expressed concern that world population
would outpace food production, its position in opposition to artificial birth control methods did
not change. At the Senate hearings the spokesman for the U.S. Catholic hierarchy condemned
all government support of birth control programs. Though pressure from the Church remained
an important political force, President Kennedy, the first Catholic U.S. President, said in 1963
that government-sponsored studies in reproductive biology were “important” and information
on the subject should “be made available to the world so that everyone can make their own
judgment…” ("Population Control: Increased Federal Concern” 1970).
Before 1965, however, the Federal Government participated in birth control programs
only on an indirect basis. State and local governments, through their health departments and
hospitals, participated in the birth control education and practice significantly before the
federal government. Many made a practice of referring patients to local clinics of the Planned
Parenthood Federation of America ("Population Control: Increased Federal Concern” 1970). The
Office of Economic Opportunity (OEO), as part of its “war on poverty” campaign, indicated
attention early in 1965 to provide funds for local birth control projects if recommended by local
organizations and approved by general community consensus ("Population Control: Increased
Federal Concern 1970). Funds were used for information campaigns, mobile clinics, and medical
supplies (including contraceptives). OEO policy stipulated that projects must assist married
women only; include information on all types of birth control, consistent with a person's
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conscience and religious feelings; and provide services on a strictly voluntary and unconditional
basis.
The Health, Education, and Welfare (HEW) Department (Children’s Bureau) also
participated in support of local birth control services through grants to state and city hospitals
and clinics. These family planning services generally operated as part of maternal and child care
programs funded under Title V of the Social Security Act (“Govt Programs in 1967” 1967). As
support among vital service providing programs began to increase, the political nature of birth
control legislation began to shift. In a 1965 congressional hearing, Katherine Oettinger, head of
the Children's Bureau commented “that birth control services should be available to all parents
as a matter of right” ("Senate Holds Hearings on Birth Control" 1965). Senator Joseph D.
Tydings (D-MD) also noted, “the only way for Congress to ensure that substantial additional
funds would be spent on family planning was to earmark them because family planning lacked
the necessary bureaucratic champions to safeguard its funds” ("Senate Holds Hearings on Birth
Control" 1965).
Just a few short years later, President Nixon urged Congress to adopt “the provision of
adequate family planning services within the next five years to all those who want them but
cannot afford them.” In response, Congress approved $218 million for family planning services
in the 1971 budget, 2.2 million of which was budgeted for an estimated five million low-income
women who needed and wanted birth control information but did not have access to family
planning services. The rest was to go to research and international population activities
(“Population Control: Increased Federal Concern” 1970). Senate bill 2108, introduced by
Senator Tydings (D-MD.), consolidated the family planning programs of the Department of HEW
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into a single National Center for Population and Family Planning. The bill authorized a five-year
program, beginning in 1971, for the use of grants for family planning services and population
research. Elimination of unwanted births, championed by the Nixon administration as a
national goal, would alleviate problems for all economic classes, especially the poor
(“Population Control: Increased Federal Concern” 1970).
Congressional attention to reproductive health, and reproductive rights by extension,
turned almost exclusively to abortion by 1974. The politically volatile issue of abortion surfaced
in Congress in several areas in 1974.The Supreme Court ruled on January 22, 1973, that states
could not interfere with the decision of a woman and her doctor to terminate a pregnancy by
abortion during its first three months (Roe v. Wade 1973). The decision led to the introduction
of several constitutional amendments guaranteeing the right to life for unborn children. The
Senate Judiciary Constitutional Amendments Subcommittee held intermittent hearings on the
amendments in 1974 but took no further action (“Hearings Air Abortion Controversy” 1974).
Notably, in 1976 the Senate voted 47–40 against action to start debate on a proposed
constitutional amendment (S J Res 178) to guarantee unborn children the right to life
(“Abortion Amendment” 1976). It was the first time either house of Congress had given even
procedural consideration on the floor to proposed anti-abortion amendments to the
Constitution since the Supreme Court struck down restrictions on abortion in early 1973.
However, abortion became involved in debate over the 1977 Health, Education, and
Welfare Appropriations Bill. In question was whether to permit the use of Medicaid funds for
abortions for low-income women. Debate on this topic was an issue in Congress for over half
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the year. Passage of a $60-billion appropriations bill for the Departments of Labor and HEW was
held up until Congress negotiated the conditions under which federally funded abortions would
be allowed. After months of debate and roll-call votes, Congress finally agreed on a provision
that would permit Medicaid abortions when the mother's life was endangered or when two
doctors certified that severe and long-lasting physical health damage would result from
continued pregnancy (“Health, Education, Welfare 1977” 1977). The compromise also
permitted “medical procedures” for victims of rape or incest, if the offense were reported
promptly to police or a public health agency (“Health, Education, Welfare 1977” 1977).
In this respect, abortion was understood in terms of funding, but in the 1984 State of
the Union address, President Reagan called on Americans to “come together in a spirit of
understanding and helping” and find “positive solutions to the tragedy of abortion” (“Federal
Abortion Alternatives Cut by Reagan” 1984). For those who viewed abortion as health concern
or even a civil right, this was a major shift in the policy image (Stone 1989). When he took office
in 1981, President Reagan sought cuts in the government's three main programs related to
family planning, reproductive health, and assistance for pregnant women (“Federal Abortion
Alternatives Cut by Reagan” 1984). Congress balked at President Reagan's proposed cuts in two
of the three programs that provided alternatives to abortion. In 1981, however, Reagan was
successful in cutting by almost one fourth the money available for the government's most
significant family planning program, Title X of the Public Health Service Act of 1970.
One proponent of legalized abortion was Representative Henry Waxman, (D-CA)
chairman of the House Energy and Commerce Subcommittee on Health and the Environment.
Waxman continued to support legislation that promoted safe practices in regard to women’s
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health, Medicaid funding, and protections for the poor (“Federal Abortion Alternatives Cut by
Reagan” 1984).
In 1990, congressional support for abortion rights was gaining traction even in light of
the 1989 Supreme Court decision (Webster v. Reproductive Health Services) which gave states
broader authority to restrict abortions. Family planning advocates were optimistic that 1990
would be the year they could break the stalemate that had prevented Title X from being
reauthorized since its last renewal expired in 1985 (Rebouché 2016). However, Senate bill 110
to reauthorize Title X was pulled from the Senate floor by its sponsor, Edward Kennedy (D-MA),
after supporters failed to rally enough votes (Rubin and Zuckman 1993).
Abortion remained as part of the women’s health agenda through the 1990s with
presidents George W. Bush, Bill Clinton, and George H.W. Bush facing off with Congress.
President Clinton, in a message to Congress vetoing bill HR 1833 that would have banned an
abortion procedure, commented
“the bill does not allow women to protect themselves from serious threats to their
health. By refusing to permit women, in reliance on their doctors' best medical
judgment, to use this procedure when their lives are threatened or when their health is
put in serious jeopardy, the Congress has fashioned a bill that is consistent neither with
the Constitution nor with sound public policy.” (“Presidential Veto Message: Threat to
Previous Women's Health Cited in Abortion Veto” 1995).
In 2002, abortion opponents in the House succeeded in passing several bills aimed at
restricting the availability of abortion, but only one measure survived the Senate. The one bill
that became law (HR 2175, PL 1072-07) protected infants who are born alive at any point, even
if the birth occurs during an attempted abortion (House Acts to Limit Abortion” 2002). The
abortion debate, however, seemed to take a backseat during most of the following Bush
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administration. As the War on Terror waged on, Congressional priorities (especially in regard to
health) seemed to focus in other directions. That is not to say that abortion does not remain a
salient congressional issue. Issues of abortion funding resurface again prominently during the
debate over passage of the Affordable Care Act (2010) in 2008 and 2009.
Cancer in Women

Breast cancer, the leading form of cancer in women (CDC 2019), dominated medical
news in 1974 after President Ford's wife, Betty, underwent surgery for removal of a malignant
tumor. Ironically, Mrs. Ford's operation coincided with the publication of three new studies on
breast cancer by the National Cancer Institute. Based on a two-year national survey, one of the
studies tentatively concluded that the traditional kind of surgery (“radical” mastectomy)
performed on Mrs. Ford may be no more effective than a “simple” mastectomy ("Health Policy
1974: Overview" 1974). Those working on the study stressed that the findings were preliminary
but predicted that they would hold up after long-term, follow-up results. A second report in
1974 by the Cancer Institute Task Force indicated that early screening might save 22 more lives
among every 100 women who develop breast cancer ("Health Policy 1974: Overview" 1974).
These findings and unfortunate circumstances lead to a new dimension of attention as to the
nature of cancer legislation in Congress.
A decade later, Congress passed legislation (HR 3979 -PL 98-474) in spite of the tobacco
lobby, requiring new warnings for cigarette packages and advertisements which identified risk
of cancer and harm to unborn children (“New Cigarette Labels” 1984). Congress was cautiously
favorable toward legislation that proposed funding to support cancer research in women’s
health. However, by the early 1990s legislation to authorize certain programs at the National
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Institutes of Health (NIH) was passed by both houses, but only after the bill (S 2857) was
stripped of all controversial provisions ("Stripped-Down NIH Authorization Passed "1990).
The provisions to overturn an NIH ban on certain types of fetal research were removed.
Both the House and Senate versions included measures to authorize new research centers to
study infertility and contraception, but the Bush administration and other critics objected on
grounds that they might encourage abortions ("Stripped-Down NIH Authorization Passed
"1990). Also removed were provisions intended to eliminate sex and race discrimination in NIHfunded research studies and to provide new research attention to women's health concerns.
This was particularly devastating to those who championed these issues.
These provisions were added at Senator Barbara Mikulski's (D- MD) insistence. They
were among the nearly twenty initiatives included in the Senate version of the Women's Health
Equity Act. Representatives Patricia Schroeder (D- CO) and Olympia Snowe (R- ME), co-chairs of
the Congressional Caucus for Women's Issues, introduced the House version of the Women's
Health Equity package (HR 5397). Senator Mikulski commented, “NIH has let us down and we're
asking for a new prescription,” noting that in 1987 less than 14% of the NIH’s research funds
were spent on women's health projects ("Stripped-Down NIH Authorization Passed "1990).
While reproductive issues dominated committee debate over the NIH bill, more than half of the
original legislation was aimed at research into women's health and women’s cancer research
overall.
In 1991, legislation to expand federal disease prevention and health promotion was
approved by both chambers late in the session, but it did not clear before the session
adjourned. Provisions in the bill called for the creation of a federal Office of Adolescent Health
63

and authorized programs to screen for prostate cancer and an $80 million program to prevent
diseases that caused infertility in women (Disability, Alzheimer's Programs Considered in
1991”). However, the 1993 National Institutes of Health Reauthorization (S 1, HR 4) saw a
three-year, $6.2 billion reauthorization. The measure authorized $3.2 billion in 1994 for the
National Cancer Institute, including $2.7 billion for the cancer institute in general; $325 million
was specifically marked for breast cancer research and $75 million for research on other
reproductive cancers (“National Institutes of Health (NIH) Bill Focuses on AIDS, Women's
Health” 1994). The enactment of this bill reauthorizing the National Institutes of Health (NIH)
marked another in a string of victories for advocates of increased spending for breast cancer
research.
In the same year, Congress cleared a bill (HR 2202) reauthorizing several programs at
the Centers for Disease Control (CDC), including $150 million for early detection of women's
reproductive and breast cancers. HR 2202 also included provisions to allow the Department of
Health and Human Services to issue temporary quality standards for mammography. In many
ways, women’s health policy saw advancement through congressional appropriation of funds
and recognition in the law.
While these categories represent important topics, which reappear in introduced
legislation, many other more specific concerns relating to access to health care, affordability of
health care and prescription drugs, and medical training are included. I provide a continued
policy history in chapter five, outlining the important role of outside actors as well.
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Presidential Attention
To further consider the dynamics of women’s health care, I map presidential attention
based on all presidential mentions, using data available through The American Presidency
Project (https://www.presidency.ucsb.edu). Again, I review executive orders, State of the Union
(SOU) addresses, and public discussion on women’s health issues from data collected using
presidential papers with the search term: women’s health.2
Figure 3.15 traces the frequency of presidential mentions in public discussion, SOU
addresses, and executive orders. For the purpose of this research, public discussion includes
presidential mentions derived from interviews, news conferences, press briefings, inaugural
and farewell addresses, other oral addresses (including Weekly and Saturday Addresses), and
Fireside Chats. Presidential attention to women’s health is relatively stable from 1945-1991.
This is followed by a period of increase from 1993 to 2016. It appears that presidential
attention to women’s health has only been particularly relevant over the past twenty-five
years.
Figure 3. 15 All Presidential Mentions Women’s Health
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2

Refer to the discussion of the American Presidency Project database advanced search methodology on pages 42.
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Congressional Attention: Hearings
Next, I track attention as evidenced by congressional hearings. I report data collected
through ProQuest Congressional (https://www.proquest.com ), using the subject search term
“womens health.” Also, in the umbrella of searchable database through ProQuest
Congressional, offers a database of searchable abstracts and indexing for congressional
publications including the Hearings Digital Collection. This database is a primary source
collection of reports with documents available from 1824 to 2010. Using the advanced search
feature, the ProQuest autocomplete tool prompted me to search using the term “womens
health” as it is referenced in the data as such (note the omission of an apostrophe). I reviewed
record of published hearings, which are the official record of committee hearings proceedings.
A random sample of 25 records indicated the returned results were germane to women’s
health. Results include spellings with and without an apostrophe.
Attention marked by congressional hearings for women’s health care is demonstrated in
Figure 3.16. There are not instances of congressional hearings related to women’s health policy
before 1981, and it appears that the most active period occurs in the 1989 and 1991
Congresses. As women’s health was originally defined by maternal roles or through infants and
children, women as a stand-alone group were not recognized in dedicated legislation until 1975
(see Figure 3.12). It seems likely that committees may not consider women’s health until
several years following its initial discussion in Congress. In the late 1980s, advocates fought to
increase the representation of women in clinical studies of diseases, disorders, and drug
treatments utilizing federal funding. To address the exclusion of women from clinical research,
the National Institutes of Health (NIH) Office of Research on Women's Health was established in
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1990. This aligns well with the increased number of congressional hearings during this period.
Similarly, hearings related to infants and children policy also experience an uptick during this
period. Attention throughout the early 2000s is relatively stable and attention in the House and
Senate seem to follow the same pattern.
Figure 3. 16 Women’s Health Hearings
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In order to determine how women’s health fits into the overall context of health policy, I
compare the frequency of women’s health hearings to the total number of hearings for health
policy generally. Figure 3.17 provides a closer look at the trend of congressional hearings for
health policy (including all subtopics), separated by chamber. There appears to be a steady
increase from the late 1960s until 1993 and a slight rise occurring again in 2007. Again, the
House is generally more active, but surprisingly a relatively higher frequency of hearings occurs
in the Senate in 1993, which is when the Clinton Care Plan was introduced. The greatest
number of congressional hearings concerning all health policy occurs in 1991 (341) and
women’s health accounts for about 15.8%. While women’s health care is not overwhelmingly
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dominant among all health-related topics vying for space on the agenda, attention does
indicate interest among Congress and political elites.
Figure 3. 17 Health Hearings
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Following the leaders?
Considering these trends, it is interesting to note the connections (and in some cases
lack of connection) to other avenues of attention. Beginning with public attention (Figure 3.11),
it appears that there is no relationship between The New York Times mentions of women’s
health and the number of bill introductions per Congress (Figure 3.16). A Pearson correlation
coefficient was computed to assess the relationship (r= -0.04). Bill introductions experience a
steady increase from the late 1970s until a peak in 2009, and this is followed by a decline until
2013. This may simply be a function of limitations in data collection or represent a lag time
between shifts in attention on the public and congressional attention (Birkland 2017).
There is a slight increase in bill introductions in 1992, which aligns with the steady rise of
congressional hearings until 1991 (Figure 3.16). However, I computed a Pearson correlation
68

coefficient to assess the relationship between bill introductions and congressional hearings
over the total time period studied, and there is a strong negative correlation (r= -0.49).
Congress and expert witnesses open a dialogue about women’s health in the late 1980s to early
1990s but do not demonstrate spikes in attention again until 2007 and 2015 (Figure 3.16). This
result is curious, as I expected the opposite to occur. There may be some issues of data coding
in terms of the difference between the use of Legislative Subject Terms from Congress.gov and
the suggested use of the term in ProQuest Congressional. However, it is not out of the question
to conclude that a flurry of attention may occur when several bills are introduced, but that
attention is not sustained through an entire session or at least in the amount of time to be
considered during a committee hearing (Feinstein 2017).
Hearings, while an indicator of attention, are not a perfect measure of intensity. A
measure of frequency of committee hearings does not account for intensity. That is to say, the
length of the hearing, the number of witnesses, and the number of questions asked, or even
the number of people attending. While most would agree that committee hearings are prime
opportunities for members to demonstrate and develop policy expertise, participation among
members varies (Taylor 2013). Given the increased partisanship of the last decade, Patashnik
and Peck (2016) call into question the utility of committee hearings in the legislative process,
calling the exercise symbolic.
Turning to the relationship between measure of public attention and congressional
attention (or bill introductions and congressional hearings), there does not appear to be a
relationship (r= 0.09). I also consider the relationship between public attention (NYT: Figure
3.11) and congressional hearings (Figure 3.14). I computed a Pearson correlation coefficient,
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indicating there appears to be a strong correlation between New York Times mentions (r= 0.49)
and presidential attention (Figure 3.13), but in the case of presidential attention and bill
introductions, there is a stronger correlation (r= 0.73). There is a negative correlation between
presidential attention and congressional hearings (r= -0.53). This is an interesting result as one
might expect a positive relationship between shifts in presidential attention and bill
introductions, the inverse relationship between presidential attention and congressional
hearings is puzzling. Considering Marvel and McGrath’s (2016) recent work, I would conjecture
that lags in presidential attention open the door for greater bureaucratic oversight on the part
of congressional committees in this area. Using these opportunities of seeming presidential
indifference as an opportunity to shape policy. Marvel and McGrath (2016) findings support
that levels of congressional oversight is primarily determined by political and policy
motivations.
Congressional Attention: Legislation Passed
Finally, in order to gain greater insight to the outcomes of attention in women’s health
care, I also track passed legislation, using data derived from my legislative information search
through Congress.gov. As with other measures, attention could be characterized by periods of
increase followed by immediate periods of decline (Figure 3.18). There are slightly higher
increases in 1993, 2009, and 2015.
Passed legislation for all health policy (Figure 3.6) generally follows the same pattern of
increase and decrease that is observed for women’s health, but it experiences a period of more
sustained increase from 1983-1991. The greatest number of health laws passed occurs in 1985,
totaling 79, and women’s health care represents about 9% of those laws passed.
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Now, I consider the trajectory of attention marked by passed legislation but with a lens
focused on a connection to other measures. There is no relationship between New York Times
mentions and the frequency of passed legislation (Figures 3.13 and 3.18). A Pearson correlation
coefficient was computed with a result of r= 0.07. And the years with most legislation passed
(1993, 2009, and 2015) do not align with peaks of increased public attention in 1984, 1995, and
2000. It seems plausible that there would be a significant lag time between any increased
attention as a result of shifts in public attention, given the very truncated nature of the current
legislative process. Volden, Wiseman, and Wittmer (2016) study trajectory of “women’s issues”
in Congress over a forty-year period. As expected, they find that only 2 percent of bills
introduced concerning women’s issues are passed and to only 1 percent of women’s issue bills
sponsored by women themselves are passed. They conclude that the committee process in
particular has a negative impact.
Considering passed legislation and bill introductions, both experience an overall
increase from the early 1980s. I calculate a Pearson correlation coefficient with a result of r=
0.72. It seems reasonable to conclude that an increase in the number of bills sponsored also
yields an increase in legislation passed. Congress appears to take the lead in elevating women’s
health policy in the late 1970s and experiences periods of increased attention in the early 1990s
and from approximately 2001-2015. Passed legislation for women’s health policy also increased
surrounding those periods (Figure 3.18).
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Figure 3. 18 Women’s Passed Legislation
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AGENDA DYNAMICS
The Policy Agendas Project provides some insight as to the dynamics of the health care
agenda, but less information is currently available concerning attention to women’s health.
Data focused on infants and children in the Agendas Project, utilizing women as caregivers,
demonstrates the dynamics of limited agenda space in this policy area. A look at women’s
health in its own right reveals a back and forth rotation where punctuations in attention
bounce between Congress and the public. Baumgartner and Jones (2004) describe this
occurrence as agenda crowding, or policy spillovers. When the public and Congress are focused
on separate issues or even different facets of the same issue, the agenda becomes crowded and
trade-offs in attention or policy activity are likely to occur.
Using the data collected to measure attention, it appears that 22% of all health bill
introductions are women’s health related, which is a little more than one in five. In regard to
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congressional hearings, women’s health represents about 16% of all health hearings, and less
than 10% of all health laws passed are directly related to women’s health.
Similarly, public attention does not appear to coincide with congressional attention, as
New York Times women’s health mentions appear to have no relationship to the number of bills
introduced, congressional hearings, or passed legislation. There is, however, a correlation
between public attention and presidential attention. In the case of presidential attention and
bill introductions, there is a stronger correlation. I found that when presidential attention
increases so does the amount of legislation regarding women’s health care. Interestingly,
though, it appears as the number of bill introductions increases, the number of congressional
hearings decreases. In the next chapter, I narrow my focus in examining attention and consider
how committee and individual attention shapes the agenda.
The findings in this chapter used to map the agenda for women’s health care provide a
clearer picture of the limited space on the health care agenda and certainly lead to plausible
conclusions as to the most favorable venue for expanding attention.
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CHAPTER 4: Entrepreneurship in Women’s Health
Narrowing my focus on attention in women’s health policy, I now concentrate on
activity in Congress observed at the committee and individual levels. As I established in
previous chapters, it seems appropriate to investigate attention paid by members of Congress,
as authorizing legislation and the critical role of funding, are central tenets of the institution.
Women’s health policy is most certainly curated and altered in other venues, but for the
purpose of my research, I will turn to attention in Congress. To further investigate attention in
Congress, I focus on periods of increased activity and rapid change fueled by policymakers’
behavior and their ability to shift attention. This phenomenon is described in the literature as
entrepreneurship. Legislative entrepreneurs, issue owners (Petroick 1996), policy advocates
(Kingdon 1989), and coalition leaders (Arnold, 1990) invest time, staff, and other resources to
gain expertise in a policy area. Using this policy knowledge, entrepreneurs will draft or support
legislation (Wilkerson et al. 2002) concerning issues in that area and use coalitions (Sabatier &
Jenkins Smith, 1999) to help guide their policy proposal through the legislative process. This
chapter will focus on developing indicators of legislative entrepreneurship in the area of
women’s health care policy. Additionally, as some researchers have also focused on whether
“who” holds office (descriptive representation) impacts the types of policies supported, I will
also consider the gender composition of congressional committees and the chamber as a
whole. (Pitkin 1967; Childs & Krook 2009; Swers 2013).
Entrepreneurship can occur at the committee level as well as the individual level. In
order to capture both dynamics, I will consider both the behavior of congressional committees
and individual members. I analyze entrepreneurial activity in three stages. First, I consider bill
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sponsorship and legislative introductions. I am interested in which committees received
referrals and are struggling for turf control in women’s health (King 1997). Similarly, I track who
is sponsoring women’s health legislation and whether subsequent bills are referred to the
committees on which they serve. Next, as a parallel to the legislative process, I track hearing
activity. At the committee level, I am interested in which committees are holding the greatest
number of hearings concerning women’s health. Alternately, I also track which members are
testifying in congressional hearings concerning women’s health. Serving as a witness in
congressional hearings signals that a member has considerable policy knowledge and has
developed policy expertise (Wawro 2000; Mintrom 2009).
Finally, I am interested in entrepreneurial activity related to legislation passed. Which
committees report out the most bills and how many bills are passed? Likewise, which members
sponsor the most passed legislation, and is the number of cosponsors related to whether a bill
passes? After considering these measures of entrepreneurship, I also study what role gender
plays, if any. In subsystem politics we know that as the cast of characters changes, so do the
policy dynamics (Baumgartner & Jones 2002; King 1997; Worsham 1998). I am interested if the
gender of top entrepreneurs matters and also how the gender makeup of the chamber shapes
receptivity to making an issue of women’s health.

BILL INTRODUCTIONS
Committees
As a first look at entrepreneurship in women’s health, I track committee referrals in
both the House and Senate. Using the advanced search function in Congress.gov, I limited my
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results with the Legislative Subject Term “women’s health. 3” I include data from all Congresses
beginning with the 93rd (1973) through the 115th (2018). This returns 2,391 results for all
introduced legislation with 1,450 originating in the House and 941 originating in the Senate. (I
use the download results feature to further sort and divide the data). In the report of my
findings, I exclude the House and Senate Committees on Appropriations, which is consistent
with the literature and provides a clearer picture of actual entrepreneurship activity.
Figure 4.1 tracks bills referred to House committees between 1973 and 2018. Energy
and Commerce receives the most referrals by far—some 1006—or forty-one percent of all
legislation introduced. Ways and Means (395), Education and Labor (256), and Foreign Affairs
(148) account for another thirty-three percent, with the remaining bills spread among a variety
of committees. This is a fairly strong indicator of clearly defined turf in women’s health policy,
suggesting Commerce exercises near monopoly control over the consideration of women’s
health legislation.
Figure 4. 1 House Committees Bills Referred 1973-2018
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Figure 4.1 House Committees Bills Referred 1973-2018

A more detailed explanation of this search process is offered in chapter three pg.36
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Figure 4. 2 Senate Committees Bills Referred 1973-2018
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Figure 4.2 indicates similarly defined turf in the Senate, as the Committee on Health,
Education, Labor and Pensions clearly receives the most bill referrals. With 400 bills referred
from 1973-2018, Health, Education, Labor, and Pensions receives more than double of any
other committee. The other major Senate player, Finance, received 192 referrals. After that, a
cluster of committees including, Judiciary (75 bills), Foreign Affairs (70 bills) and Veterans’
Affairs (61 bills) round out the most active players. Attention to health is reflected in the
creation of subcommittees focused on health in Education and Labor, Energy and Commerce,
Foreign Affairs, Veterans’ Affairs and Ways and Means.
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Individual Members
Turning to individual bill sponsorship, Figure 4.3 identifies the members in the House
who sponsored 10 or more health-related bills from 1973-2018. Table 4.1 incorporates the
fraction of bills sponsored as compared to the total of women’s health bills introduced.
Representative Carolyn Maloney (D-NY) sponsors the most women’s health bills at 45, which
represents 3.05% of the total number of bills introduced in the House over the time studied.
Maloney (45 bills), DeLauro (D- CT) (42 bills), and Waxman (D- CA) (39 bills) are grouped
together as the greatest contributors. In the total group, 19 are Democrat and 3 are Republican.
Representative Carolyn Maloney (D- NY) was elected to the One Hundred Third and to
the thirteen succeeding Congresses. She has established herself as an advocate for women's
and family issues, particularly in regard to women's health needs, reproductive freedom, and
family planning. During her first term in office, Rep. Maloney helped to pass landmark
legislation that provided coverage for annual mammograms for women under Medicare and
she later worked on legislation to create Women’s Health Offices in five federal agencies, which
was part of the Affordable Care Act (2010) (“Carolyn Maloney” 2006). During this time she
served as co-chair of the Women's Caucus.
Though not always finding legislative success, her work in introducing legislation and
through committee service has helped to earn the reputation as a standout women’s rights
advocate. She introduced the Saving Women's Lives Act of 2002 to try to pressure the Bush
Administration to release the $34 million budgeted for the United Nations Population Fund
(“Carolyn Maloney” 2006). Maloney has reintroduced legislation that would amend the
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Constitution and guarantee equal rights for women, and over 200 members have signed onto
the Women's Equality Amendment (“Carolyn Maloney” 2006).
She hasn’t been shy about her positions on controversial programs. During the floor
debate in 1994 about the proposed act “Law Protects Abortion Clinic Access,” Maloney said
those who committed violent acts or physically obstructed women's access to abortion clinics
had to be “deterred by the strongest means possible” and “the right to choose is meaningless
without the access to choose” (“Carolyn Maloney” 2006). While other abortion rights initiatives
remained dead-locked, Congress this bill criminalizing violence at abortion clinics (S 636 made it
a federal crime to use force, or the threat of force, to intimidate abortion clinic workers or
women seeking abortions).
In her 2008 book, Rumors of Our Progress Have Been Greatly Exaggerated: Why
Women's Lives Aren't Getting Any Easier--And How We Can Make Real Progress For Ourselves
and Our Daughters, Maloney writes, “ based on some indicators, one might think that women
have never been better off,” but “there are many areas in which women’s rights are being
eroded and women’s vital needs are not being met” (Maloney 2008, p. 7). It is interesting that
much of her reputation is not based on large-scale legislative wins, but rather on her tenacity
and ability to persevere and continue to rally support for the causes she champions.
Arriving in Congress just two years earlier, Representative Rosa DeLauro (D- CT) boasts a
similar record related to women's health advocacy. Representative DeLauro was elected to the
One Hundred Second and to the fourteen succeeding Congresses (“Rosa DeLauro” 2006). She
currently serves in the Democratic leadership as Co-Chair of the Democratic Steering and Policy
Committee, and she is the Chair of the Labor, Health and Human Services, and Education
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Appropriations Subcommittee (“Rosa DeLauro” 2006). Rep. DeLauro has become known as a
leader in fighting to improve and expand federal support for child nutrition and for modernizing
the food safety system.
Notably, she worked to reauthorize Johanna’s Law, which ensures that women and their
health care providers have access to information about gynecologic cancer for earlier detection
(“Rosa DeLauro” 2006). She also introduced legislation to ensure that women and their health
care providers have access to all medically relevant information in order to make informed
health care decisions. Specifically, she introduced the Breast Density and Mammography
Reporting Act (2017), which ensures that women and their health care providers have access to
the information about an individual’s breast density (“Rosa DeLauro” 2006). Although the bill
did not pass in its original form, she opened the debate for this important legislation, and she
played a critical role in the measure’s eventual cultivation. She also continues to advocate for
passage of the Breast Cancer Patient Protection Act, a controversial bill that would ensure
decisions about a woman’s hospital stay are made by the woman and her health care provider,
not an insurance company (“Rosa DeLauro” 2006).
She has been a staunch advocate for breast cancer research and funding since the early
1990s and supported Clinton health care reform in 1993 and 1994, championing preventative
health care measures for women. She has worked independently as well as with other women
in the House and Senate. When asked about the difference the presence of women has made in
Congress, she observed “It’s been remarkable. I mean historically remarkable,” but “we are in
an institution that runs by numbers. You have to have votes, and there's just not enough of us
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here, we need to have more people here, women have changed the agenda and focus which is
what I think is critical” (Dittmar, Sanbonmatsu, and Carroll 2018).
Even considering the long legislative history of both Maloney and DeLauro,
Representative Henry Waxman (D- CA) is certainly considered the elder statesman in health
policy. First elected as a Democrat to the Ninety-fourth and to the nineteen succeeding
Congresses, for over forty years Rep. Waxman played a leading role in the enactment of major
health, consumer protection, environmental, and telecommunications policy (Waxman 2009).
Although most would consider Waxman’s attention focused on health policy more generally,
Waxman took on Women’s Health Initiative. These included the laws establishing standards for
mammography, requiring the inclusion of women in clinical trials, and creating the Office of
Research on Women’s Health at NIH (Waxman 2009). Waxman was Chairman of the Health and
Environment Subcommittee of the Energy and Commerce Committee from 1979 through 1994,
which also aided in facilitating his role in the expansion of Medicaid in the 1980s and early
1990s.
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Members who sponsored 10 or more bills in the House
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Table 4. 1 House Bill Sponsorship and % Sponsored of Total Bills Introduced in House 4
Member (House)
Rep. Maloney, Carolyn B. [D-NY]
Rep. DeLauro, Rosa L. [D-CT]
Rep. Waxman, Henry A. [D-CA]
Rep. Lowey, Nita M. [D-NY]
Rep. Lee, Barbara [D-CA]
Rep. Schroeder, Patricia [D-CO]
Rep. Morella, Constance A. [R-MD]
Rep. Slaughter, Louise McIntosh [D-NY]
Rep. Nadler, Jerrold [D-NY]
Rep. Schakowsky, Janice D. [D-IL]
Rep. Pallone, Frank, Jr. [D-NJ]
Rep. Oakar, Mary Rose [D-OH]
Rep. DeGette, Diana [D-CO]
Rep. Jackson Lee, Sheila [D-TX]
Rep. Smith, Christopher H. [R-NJ]
Rep. Burgess, Michael C. [R-TX]
Rep. Collins, Cardiss [D-IL]
Rep. Miller, George [D-CA]
Rep. Dellums, Ronald V. [D-CA]
Rep. Meng, Grace [D-NY]
Rep. Mikulski, Barbara A. [D-MD]

# Sponsored

%
Sponsored

# of Terms
Served

Average per
Term

45
42
39
28
22
22
21
21
16
16
15
15
12
12
12
11
11
11
10
10
10

3.05%
2.84%
2.64%
1.90%
1.49%
1.49%
1.42%
1.42%
1.08%
1.08%
1.02%
1.02%
0.81%
0.81%
0.81%
0.74%
0.74%
0.74%
0.68%
0.68%
0.68%

14
15
20
16
12
12
8
16
15
11
8
17
12
13
20
9
12
20
14
4
5

3.21
2.8
1.95
1.75
1.83
1.83
2.63
1.31
1.07
1.45
1.88
0.88
1
0.92
0.6
1.22
0.92
0.55
0.71
2.5
2

Figure 4.4 tracks those Senators who sponsored 10 or more bills between 1973 and
2018. Table 4.5 incorporates the fraction of bills sponsored as compared to the total of
women’s health bills introduced in the Senate. Senator Edward Kennedy (D-MA) and Senator
Barbara Boxer (D-CA) sponsor the most legislation with 40 and 39 respectively. Senator
Kennedy sponsors 4.19% of all women’s health legislation introduced in the Senate and Senator
Boxer sponsors 4.09%. Senator Olympia Snowe (R-ME) follows closely with 3.25%, and there is
a steady and stable decline among other members’ sponsorship.

4

A complete listing of bills sponsored per member per term in the House is listed in the Appendix.

82

Senator Edward Kennedy (D-MA) was elected in a special election on November 6, 1962,
as a Democrat to fill the vacancy caused by the 1960 resignation of his brother, John Fitzgerald
Kennedy. He served from November 7, 1962, until his death in August 2009 (Austin 2009).
Many of his health legislative victories were fought and won in the Health, Education, Labor and
Pensions Committee, where Kennedy had been both chairman or ranking Democratic member.
Kennedy quickly capitalized on his assignment in 1971 as chairman of the health panel on what
was then known as the Labor and Public Welfare Committee, pressing for a vast expansion in
spending on medical research and advocating for universal health care (Austin 2009).
Using his family’s name and personal success and losses to his advantage, Senator
Kennedy was a powerful force in the Senate for health, and in turn women’s health, legislation.
But despite his record of promoting women's equality, Kennedy kept quiet during the debate
over Clarence Thomas' nomination to the Supreme Court, leading most to believe that he was
in no position politically, to take the lead against a nominee accused of sexual harassment.
However, with the election of President Bill Clinton, Kennedy had a potential Democratic ally in
the White House for the first time in decades. The first notable legislation Clinton signed into
law was Kennedy's bill to require employers to provide their workers unpaid family and medical
leave (Austin 2009).
Senator Kennedy endorsed Barack Obama for president in January 2008 but was
diagnosed with a brain tumor the following May. Passage of the Affordable Care Act (2010)
would become the last piece in his long legislative legacy. After his health condition began to
take a toll, Kennedy’s staff for the Health, Education, Labor, and Pensions (HELP) Committee
held meetings and continued to make his support public. The committee members marked up
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the first version of the health reform bill that would be signed into law by President Obama and
was the first committee in Congress to draft legislation to providing a patients’ bill of rights.
While this was a great victory for health care advocates, it was also an important step for
advancing women’s health care research and access.
Senator Barbara Boxer (D-CA) also amassed a lengthy legislative legacy, serving in
Congress for 34 years (including 10 years in the House and 24 years in the Senate). She was a
vocal advocate for families, children, consumers, and the environment (“Barbara Boxer” 2015).
She retired from the Senate at the end of the 114th Congress (2015–2017). Senator Boxer was
known for her understated, straightforward approach to the legislative process, which she
described in one of her farewell interviews. “It’s very easy,” she said. “You introduce legislation
that moves us forward. You fight bad legislation” (“Barbara Boxer” 2015).
As a member of the House, she was part of a bipartisan group of women members who
marched on the Senate to demand extended hearings on the sexual-harassment charges
against Supreme Court nominee Clarence Thomas in 1991. Among her women’s health policy
priorities was the protection for a woman's right to choose. In 2004, Senator Boxer sponsored
S.2020, the Freedom of Choice Act (2004), which provided that every woman has the
fundamental right to choose to: (1) bear a child; (2) terminate a pregnancy prior to fetal
viability; or (3) terminate it after fetal viability when necessary to protect her life or her health.
This bill was referred to the Senate Judiciary Committee, but no further action was taken. When
asked why she is so passionate about women’s reproductive health, Senator Boxer elaborated
“It’s not that women are better than men. We’re not; we’re equal to man, equally good
and equally bad. But we bring with us a life story experience and you know when the
men get out there on the floor and talk about the joys of childbirth, fine, but they never
gave birth, and we know how joyful it is, but also how difficult it is and what you face
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when there is a problem with your pregnancy. So just there alone… we
[Congresswomen] can authenticate the experience that women are having” (Dittmar,
Sanbonmatsu, and Carroll 2018).
In a similar way, Senator Olympia Snowe championed the reproductive health of women
and worked to bring Democrats and Republicans together on issues that benefitted both
parties. Snowe was a member of the Congressional Caucus for Women’s Issues for her entire
career, chairing the caucus during the 98th Congress. Snowe’s moderation and willingness to
compromise won her bipartisan respect, and she used this strength as the GOP deputy whip in
1984 (Carey 2002).
Throughout her career, Senator Olympia Snowe supported women’s health issues,
including reproductive rights, allying with Democrats against a proposed GOP ban on “partial
birth” abortion. She also joined her colleagues across the aisle to support a proposal to cover
contraceptives under federal employees’ health insurance plans (Carey 2002). In July 1999,
after Democratic efforts to strengthen patients’ rights were rejected, Snowe was able to pass a
measure that gave women who underwent mastectomies the right to longer hospital stays as
long as their doctor deemed it medically necessary. She sponsored the Senate version of the
Breast Cancer Patient Protection Act (2006), which was mirrored by Representative Rosa
DeLauro in the House (Carey 2002).
In 2008, Snowe successfully shepherded legislation that banned job and health
insurance discrimination based on genetic testing. Having worked with Democratic
Representative Louise Slaughter of New York for more than a decade on this issue, Snowe
called the measure one of the “major satisfactions of my career” (Carey 2002). Snowe has not
been afraid to make lasting partnerships or to break ranks with her party when necessary. She
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voted in favor of the Finance Committee’s version of the Patient Protection and Affordable Care
Act, becoming the only Republican senator to support the legislation at any level.
These members and others in the top tier of bill sponsorship not only demonstrate a
willingness to support women’s health issues, but also, long standing careers in which they
have established policy expertise.
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Table 4. 2 Senate Bill Sponsorship and % Sponsored of Total Bills Introduced in Senate 5
# Sponsored

% Sponsored

# of Terms
Served

Average Per
Term

Sen. Kennedy, Edward M. [D-MA]

40

4.19%

9

4.44

Sen. Boxer, Barbara [D-CA]

39

4.09%

5

7.8

Sen. Snowe, Olympia J. [R-ME]

31

3.25%

3

10.33

Sen. Murray, Patty [D-WA]

28

2.94%

5

5.6

Sen. Mikulski, Barbara A. [D-MD]

26

2.73%

5

5.2

Sen. Durbin, Richard J. [D-IL]

23

2.41%

4

5.75

Sen. Harkin, Tom [D-IA]

23

2.41%

5

4.6

Sen. Stabenow, Debbie [D-MI]

21

2.20%

4

5.25

Member (Senate)

5

A complete listing of bills sponsored per member per term in the Senate is listed in the Appendix.
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Sen. Inouye, Daniel K. [D-HI]

17

1.78%

9

1.89

Sen. Hatch, Orrin G. [R-UT]

16

1.68%

7

2.29

Sen. Clinton, Hillary Rodham [D-NY]

15

1.57%

2

7.5

Sen. Feinstein, Dianne [D-CA]

13

1.36%

3

4.33

Sen. Leahy, Patrick J. [D-VT]

13

1.36%

3

4.33

Sen. Casey, Robert P., Jr. [D-PA]

13

1.36%

6

2.17

Sen. Menendez, Robert [D-NJ]

13

1.36%

8

1.63

Sen. Daschle, Thomas A. [D-SD]

13

1.36%

3

4.33

Sen. Bingaman, Jeff [D-NM]

12

1.26%

7

1.71

Sen. Biden, Joseph R., Jr. [D-DE]

12

1.26%

5

2.4

Sen. Gillibrand, Kirsten E. [D-NY]

11

1.15%

3

3.67

Sen. Akaka, Daniel K. [D-HI]

10

1.05%

4

2.5

Sen. Chafee, John H. [R-RI]

10

1.05%

4

2.5

Sen. Cranston, Alan [D-CA]

10

1.05%

4

2.5

Sen. Dodd, Christopher J. [D-CT]

10

1.05%

5

2

Sen. Klobuchar, Amy [D-MN]

10

1.05%

3

3.33

Sen. Murkowski, Lisa [R-AK]

10

1.05%

4

2.5

Sen. Rockefeller, John D., IV [D-WV]

10

1.05%

5

2

Sen. Shaheen, Jeanne [D-NH]

10

1.05%

2

5

In addition to the committees that monopolize bill referral, and thus control health turf,
and the members that sponsor the most legislation, it is important to note how individuals and
committees intersect. In Table 4.3, I track sponsors and their committee assignments, using
member profiles available on ProQuest Congressional (www.proquest.com)l and the “people
search” by last name available through History Art & Archives of the United States House of
Representatives (https://history.house.gov). Table 4.3 lists member committee assignments for
the top tier of bill sponsors. Although this is not a perfect measure, it is an indicator of the
connections between bill sponsorship/committee membership activity and committee turf.
One would expect that members write legislation so that it is referred to committees on which
they serve (King 1997; Wawro 2000; Wilkerson, Smith, & Stramp 2015).
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Table 4. 3 Top Bill Sponsors (House) Committee Assignments
Member (House)

Committees

Rep. Maloney, Carolyn B. [D-NY]

Financial Services, Oversight and Reform

Rep. DeLauro, Rosa L. [D-CT]

Homeland Security, Budget

Rep. Waxman, Henry A. [D-CA]

Oversight and Reform, Energy and Commerce

Rep. Lowey, Nita M. [D-NY]

Homeland Security

Rep. Lee, Barbara [D-CA]

Science, Space, & Tech, Budget, Financial Services, Foreign Affairs

Rep. Schroeder, Patricia [D-CO]

Homeland Security, Judiciary

Rep. Morella, Constance A. [R-MD]

Science, Space, & Tech, Oversight and Reform

Rep. Slaughter, Louise McIntosh [D-NY]

Homeland Security, Rules, Budget, Oversight and Reform

Rep. Nadler, Jerrold [D-NY]

Trans & Infrastructure, Judiciary

Rep. Schakowsky, Janice D. [D-IL]

Budget, Financial Services, Oversight and Reform, Energy and Commerce

Rep. Pallone, Frank, Jr. [D-NJ]

Natural Resources, Energy and Commerce

Rep. Oakar, Mary Rose [D-OH]

House Administration, Post Office & Civil Serv, Financial Services

Rep. DeGette, Diana [D-CO]

Natural Resources, Energy and Commerce

Rep. Jackson Lee, Sheila [D-TX]

Homeland Security, Science, Space, & Tech, Budget, Judiciary, Foreign Affairs

Rep. Smith, Christopher H. [R-NJ]

Veterans' Affairs, Foreign Affairs

Rep. Burgess, Michael C. [R-TX]

Rules, Science, Space, & Tech, Trans & Infrastructure, Oversight and Reform, Energy and
Commerce

Rep. Collins, Cardiss [D-IL]

Oversight and Reform, Energy and Commerce

Rep. Miller, George [D-CA]

Natural Resources, Education and Labor

Rep. Dellums, Ronald V. [D-CA]

Homeland Security, District of Columbia, Post Office & Civil Serv, Armed Services, Foreign Affairs

Rep. Meng, Grace [D-NY]

Small Business, Foreign Affairs

Rep. Mikulski, Barbara A. [D-MD]

Merch Marine & Fish, Energy and Commerce

As expected, Energy and Commerce shows the most committee membership among top
bills sponsored, and notably, the other committees demonstrating the most entrepreneurial
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activity have higher membership (ex. Foreign Affairs). This is also true for the Senate (Table
4.4). The Committees on Heath, Education, Labor and Pensions and Judiciary have the highest
membership (10) among top sponsors and demonstrate higher levels of entrepreneurship
across each of the measures. This distribution of committee membership among top sponsors
indicates that individual member entrepreneurship is related to committee level
entrepreneurship.
Table 4. 4 Top Bill Sponsors (Senate) Committee Assignments
Member (Senate)

Committee Assignment

Sen. Kennedy, Edward M. [D-MA]

Armed Services, Judiciary, Health, Ed, Labor, & Pen

Sen. Bo1er, Barbara [D-CA]

Comm, Science, & Trans, Envi & Public Works, Foreign Relations

Sen. Snowe, Olympia J. [R-ME]

Small Business & Entr, Budget, Comm, Science, & Trans, Armed Services, Foreign Relations

Sen. Murray, Patty [D-WA]

Budget, Health, Ed, Labor, & Pen

Sen. Mikulski, Barbara A. [D-MD]

Health, Ed, Labor, & Pen

Sen. Durbin, Richard J. [D-IL]

Foreign Relations, Judiciary

Sen. Harkin, Tom [D-IA]

Small Business & Entr, Agr, Nutrition, & For, Health, Ed, Labor, & Pen

Sen. Stabenow, Debbie [D-MI]

Energy & Natl Resources, Budget, Agr, Nutrition, & For, Finance

Sen. Inouye, Daniel K. [D-HI]

Indian Affairs, Comm, Science, & Trans

Sen. Hatch, Orrin G. [R-UT]

Energy & Natl Resources, Indian Affairs, Judiciary, Finance, Health, Ed, Labor, & Pen

Sen. Clinton, Hillary Rodham [D-NY]

Budget, Agr, Nutrition, & For, Envi & Public Works, Health, Ed, Labor, & Pen

Sen. Feinstein, Dianne [D-CA]

Comm, Science, & Trans, Judiciary

Sen. Leahy, Patrick J. [D-VT]

Agr, Nutrition, & For, Judiciary

Sen. Casey, Robert P., Jr. [D-PA]

Agr, Nutrition, & For, Foreign Relations, Finance, Health, Ed, Labor, & Pen

Sen. Menendez, Robert [D-NJ]

Banking, Housing, & UF, Comm, Science, & Trans, Foreign Relations, Finance

Sen. Daschle, Thomas A. [D-SD]

Agr, Nutrition, & For, Finance

Sen. Bingaman, Jeff [D-NM]

Energy & Natl Resources, Armed Services, Finance, Health, Ed, Labor, & Pen
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Sen. Biden, Joseph R., Jr. [D-DE]

Foreign Relations, Judiciary

Sen. Gillibrand, Kirsten E. [D-NY]

Agr, Nutrition, & For, Armed Services, Envi & Public Works

Sen. Akaka, Daniel K. [D-HI]

Energy & Natl Resources, Banking, Housing, & UF, Homeland Sec & Gov Affairs, Armed Services

Sen. Chafee, John H. [R-RI]

Envi & Public Works, Finance

Sen. Cranston, Alan [D-CA]

Homeland Sec & Gov Affairs

Sen. Dodd, Christopher J. [D-CT]

Banking, Housing, & UF, Budget, Foreign Relations, Health, Ed, Labor, & Pen

Sen. Klobuchar, Amy [D-MN]

Comm, Science, & Trans, Agr, Nutrition, & For, Envi & Public Works

Sen. Murkowski, Lisa [R-AK]

Energy & Natl Resources,Indian Affairs,Envi &Publi Works,ForeignRelations,Health,Ed,Labor,&Pen

Sen. Rockefeller, John D., IV [D-WV]

Energy & Natl Resources, Comm, Science, & Trans, Foreign Relations, Finance

Sen. Shaheen, Jeanne [D-NH]

Energy & Natl Resources, Small Business & Entr, Armed Services, Foreign Relations

COMMITTEE HEARINGS
As a second indicator of committee entrepreneurship, I track those committees that
hold hearings focused on women’s health issues. Using the advanced search feature of
ProQuest Congressional, I search by witness and “womens health” as a subject term. I also
consider sponsor’s participation in hearings, looking for sponsors who also show up as
witnesses at hearings. While legislators testifying at hearings is rare, when they do it is often a
sign of their expertise and investment in an issue (Fenno 1973; Marvel and McGrath 2016). I
use ProQuest Congressional (https://www.proquest.com) and the subject search term
“womens health” to identify 414 hearings concerning women’s health from 1945-2018.
Committees
Figure 4.5 (and Table 4.5) represent the total number of House committee hearings held
from 1945-2018. The committee on Oversight and Reform was most active (34 hearings or
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17%), during the period studied followed by Energy and Commerce (30 hearings), Veterans’
Affairs (28 hearings), and Judiciary (28 hearings) which combined account for 43% percent of
hearing activity. A variety of other committees makeup the remaining 26%. Oversight and
Reform holds the most hearings, yet the Committee on Energy and Commerce received far
more bill referrals (Figure 4.1), 1006 as compared to 71.
Figure 4. 5 House Committee Hearings Women’s Health

House Committee Hearings Women's Health
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17%

Small Business
4%
Natural Resources
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Table 4. 5 House Committee Hearings (Excluding Appropriations)
House Committee Hearings
Oversight and Reform
Energy and Commerce
Judiciary
Veterans' Affairs
Foreign Affairs
Ways and Means
Natural Resources
Small Business
Armed Service
Transportation & Infrastructure
Agriculture
Education and Labor
Science, Space, and Technology
Financial Services
Budget

Total 198

% of
Total

34
30
28
28
19
13
8
8
6
6
5
5
5
2
1

17.17%
15.15%
14.14%
14.14%
9.60%
6.57%
4.04%
4.04%
3.03%
3.03%
2.53%
2.53%
2.53%
1.01%
0.51%

In the Senate (Figure 4.6 and Table 4.6), committee hearings closely match bill referrals.
The Committee on Health, Education, Labor, and Pensions holds the most hearings, 21, and
Veterans’ Affairs (16 hearings) is also an expected result. The Senate Special Committee on
Aging held 11 hearings, which is interesting as specific bills are not referred to this committee.
The overall number of hearings are less in the Senate than the House, and this will be
particularly notable as I also evaluate passed legislation.
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Figure 4. 6 Senate Committee Hearings Women’s Health
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Table 4. 6 Senate Committee Hearings (Excluding Appropriations)
Total 80

% of
Total

Health, Education, Labor, and Pensions

21

26.25%

Veterans' Affairs

16

20.00%

Judiciary

14

17.50%

Finance

8

10.00%

Foreign Relations

6

7.50%

Commerce, Science, and Transportation

5

6.25%

Homeland Security and Governmental Affairs

5

6.25%

Armed Service

2

2.50%

Agriculture, Nutrition, and Forestry

1

1.25%

Budget

1

1.25%

Environment and Public Works

1

1.25%

Senate Committee Hearings
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Individual Members
Table 4.7 lists the members who testified two or more times at hearings. Representative
Patricia Schroeder (D-Co) testified 20 different times, which is significantly more than any other
member in the House. She was also among the top sponsors with 22 bills, or 0.92% of all
women’s health bills.
Table 4. 7 House Hearing Testimony
Member (House)

# of Times Testified

Schroeder

20

Hyde

4

Lowey

4

Oakar

4

DeLauro

3

Morella

3

Archrer

2

Bilirakis

2

Johnson

2

Leland

2

Elected as a Democrat to the Ninety-third and to the eleven succeeding Congresses,
Representative Pat Schroeder (D- CO) made many issues shared by middle–class Americans her
top priority. She advocated for women’s health care, child rearing, expansion of Social Security
benefits, and gender equity in the workplace. She was known as a hard-working and straightshooting ally to her colleagues (Lowy 2003).
From her seat on the Armed Services Committee, she once told Pentagon officials that if
they were women, they would always be pregnant because they never said “no” (Lowy 2003).
When another asked how she could be a mother of two small children and a member of
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Congress at the same time. She replied, “I have a brain and a uterus and I use both” (Lowy
2003). She was a vocal pro–choice advocate and a supporter of the Equal Rights Amendment. In
1977, Schroeder co-founded the Congressional Women’s Caucus, subsequently co–chairing it
for 10 years. She helped pass the 1978 Pregnancy Discrimination Act, which mandated that
employers could not dismiss women employees simply because they were pregnant or deny
them disability and maternity benefits. Later she created and chaired the Select Committee on
Children, Youth and Families (but it was dismantled in 1995).
In 1993, Schroeder garnered significant legislative success with the passage of the
Family and Medical Leave Act and the National Institutes of Health Revitalization Act. For nearly
a decade, she worked on and petitioned for the Family and Medical Leave Act, which in its final
form provided job protection of up to 18 weeks of unpaid leave for the care of a newborn, sick
child, or parent. (Lowy 2003).
She supported many facets of women’s health policy and participated in committee
hearings on health care reform, pregnancy- related services under Title X of the Social Security
Act, NIH research and training programs for women’s health research, discrimination in
insurance practices, Global Human Rights Abuses and sexual assault against women,
mammography benefits coverage and standards guidelines, and fetal-alcohol syndrome. One of
her long-championed cases was veteran women’s health.
In June 1993, alongside Representative Rosa DeLauro (D- CT), she testified before the
Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs (House)
in support of a bill (HR 2285) that she sponsored to alleviate deficiencies in women veteran’s

95

health care services (HRG-1993-VAH-0019). Although the committee helped to pass previous
legislation expanding benefits for female veterans, Rep. Schroeder was determined to see
quality programs established and maintained. Noting that the Inspector General’s report
indicated women's health care services at the VA are much worse than previously suspected.
She explained to the committee, “It is not just the lack of coordinators, it trickles right out into
all the services. Of the 166 facilities surveyed, 75 offered no on-site women's health care clinics,
and that is really amazing” (HRG-1993-VAH-0019). She expressed her deep concern saying, “I
was even appalled that some of those who said that they did have women's health clinics,
when they pressed them, they found out they were every other week and maybe for four
hours. So if you didn't know when that window was open, you were in real trouble” (HRG-1993VAH-0019).
The proposed bill provided for in-house, gender-specific services, reallocating staff in
the Central Office to support women's health programs, developing quality indicators for
gender-specific services, and training programs. Schroeder noted, “we just can't implement
them fast enough.” She also warned the committee,
“I am soon going to be also offering another piece of legislation that will provide women
veterans a basic primary care and preventive care package and expand research on
women's health at the VA. We need the tough quality standards for mammography, and
we also need to look much more at research for women who have been in the military.”
The proposed bill garnered twelve cosponsors, including the committee chairman. The bill
never made it out of the committee, but a Senate version of the bill, sponsored by Senator John
D. Rockafeller (D- WV), passed in the Senate, but it was a similar bill (Veterans Health Programs
Extension Act of 1994 HR 3313) that was finally signed into law later that year.
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Other members with active participation in committee hearing include Representative
Mary Rose Oakar (D- OH), Representative Nita Lowey (D-NY), Representative Constance Morella
(R-MD), and Representative Rosa DeLauro (D- CT). They also rank among top bill sponsors in the
House, with Representative Nits Lowey sponsoring nearly 2% of all women’s health legislation
(Table 4.1).
Supporters of women’s health legislation are not all necessarily Democrats or pro-choice
advocates. This group certainly demonstrates that. During her tenure, Congresswoman Mary
Rose Oakar (D- OH) was dedicated to improving the welfare of women. She was not shy about
her position for women’s rights, though she often came into conflict with national women’s
groups for her pro–life stance (Ruess 1992). Her position caused friction with powerful
women’s groups like the National Organization for Women (NOW), which served to undermine
her potential as a leading public figure in feminist circles. Although frustrated with her inability
to connect with leading women’s organizations, Oakar developed a reputation as a liberal who
worked on behalf of women’s rights issues. Though mainly concerned with economic parity, she
championed particular women’s health causes. Representative Oakar encouraged her female
colleagues on Capitol Hill to work for equality with men. “There are only 24 women in
Congress,” she declared. “It seems to me, beyond all other issues, we’re obligated to correct
inequities toward our own gender. No one else is going to do it” (Ruess 1992).
In a hearing before the Subcommittee on Health for the House Ways and Means
Committee, Rep. Oakar gave an impassioned testimony alongside Senator Barbara Boxer in
support of consideration for HR 3880. The bill included provisions concerning Medicare
coverage of mammography screening for breast cancer, and was sponsored by the committee
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chair, Representative Pete Stark (D-CA) as well as the minority leader, Robert Michel (R-IL)
(Oakar was also a co-sponsor).
She began her statement by reminding the committee of the short-lived victory for
breast cancer prevention under the Medicare Catastrophic Coverage Act (1988), but it was later
repealed. She frankly stated “Mammography coverage saves money and most importantly it
saves lives. One woman is diagnosed with breast cancer every 13 minutes in this country”
(HRG-1990-WAM-0005). Her passion was evident as she closed her speech saying,
“I mean, I am outraged. If I sound a little bit on the outrageous side today, let me tell
you, I have had it with this issue because I feel that if we don't do something about it in
this Congress, and that is why I am delighted that you are having this hearing, and that
you have this aspect in your legislation. Then I think we should be totally ashamed of
ourselves”(HRG-1990-WAM-0005).
Although this bill never made it to the full chamber for consideration, coverage of screen
mammography was included in HR.5835, Omnibus Budget Reconciliation Act of 1990, and
signed into law almost one year later on November 5, 1990.
As the literature indicates, considering the frequency of committee hearings and the
number of times a member testifies, this measure is still imperfect. Capturing the tenacity of
members like Rep. Patricia Schroeder or passion of Rep. Mary Rose Oakar is impossible. Some
hearings may last several days, while others last the entire session and the number of witnesses
varies greatly. While testimony and committee hearings are good measures of
entrepreneurship, it is clear that members establish their policy expertise in a variety of ways.
In the Senate (Table 4.8), Olympia Snowe (R-Ma) is the most active, testifying nine
times. Senator Snowe also sponsors the third most legislation in the Senate (1.3% of all
women’s health legislation). Barbara Boxer (D-Ca) testified at 5 hearings, and sponsors the
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second most bills, 39. Similarly, Richard Durbin (D-Il) also testifies 5 times and sponsors 23 bills.
Alan Cranston (D-Ca) is also quite active as a sponsor but only testifies twice. This is similar to
the remainder of senators who testify more than once, none of whom sponsor more than 10
bills. Similar to the House, the senator who sponsors the most legislation, Senator Ted Kennedy,
only testifies once.
Table 4. 8 Senate Hearing Testimony
Member
(Senate)

# of Times
Testified

Snowe
Boxer
Durbin
Chiles
Bumpers
Cranston
Specter

9
5
5
4
2
2
2

LEGISLATION PASSED
Finally, I consider entrepreneurial activity as it relates to legislation passed. Using the
advanced search function in Congress.gov, I limit my results with the legislative subject term
“women’s health.” I include data from all Congresses beginning with the 93rd (1973) through
the 115th (2018) and all legislative actions. Of the 2,391 results for introduced legislation, 140
became law with 90 originating in the House and 50 in the Senate. I use these results to track
which committees report out the most bills and how many of passed laws come from each
committee. Additionally, I track how many laws passed were sponsored by each member and
the number of co-sponsors on each bill. I calculate whether bills with more co-sponsors
(demonstrating coalition building, Wawro 2000) are more likely to pass.
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Committees
In the House, the Committee on Energy and Commerce is again the leading committee
in legislative activity. Figure 4.7 indicates that the Committee on Energy and Commerce shows
the most activity with regard to laws passed. From 1973-2018, Energy and Commerce passed
almost three times as many bills as any other House committee, but only 4% of all women’s
health bills referred to the committee. Interestingly, the Committee on Small Business holds the
highest percentage of laws passed at 75% (three out of four), and the no longer active
Committee on Merchant Marines and Fisheries passed 40% of bills referred to it (two out of
five). This is particularly interesting as the Merchant Marines was the first of the five military
academies to admit women but unfortunately reports the highest rate of sexual assault and
harassment of any other military school (Kennedy 1978; Rein 2016).
Figure 4. 7 Laws Passed House Committees 1973-2018
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Table 4. 9 Laws Passed House Committees (Excluding Appropriations)
House Committee
Small Business
Merchant Marine and Fisheries
Budget
Transportation and Infrastructure
Natural Resources
Armed Services
Financial Services
District of Columbia
Agriculture
Veterans' Affairs
Oversight and Reform
Foreign Affairs
Judiciary
Energy and Commerce
Ways and Means
Education and Labor
Homeland Security
House Administration
Post Office and Civil Services
Rules
Science, Space, and Technology

Bills
Referred
4
5
41
25
52
71
55
14
43
102
71
148
142
1006
393
256
10
12
27
20
20

Laws
Passed
3
2
12
3
6
6
4
1
3
6
4
7
6
41
15
9
0
0
0
0
0

% Passed
75.00%
40.00%
29.30%
12.00%
11.50%
8.50%
7.30%
7.10%
7.00%
5.90%
5.60%
4.70%
4.20%
4.10%
3.80%
3.50%
0.00%
0.00%
0.00%
0.00%
0.00%

In the Senate, bills referred to the Committee on Health, Education, Labor, and Pensions
also yields the most passed legislation (Figure 4.8). Health, Education, Labor, and Pensions
receives more than double the amount of bills referred, and they also hold the greatest number
of hearings. Foreign Relations (or Foreign Affairs) yields the second highest number of passed
laws and falls in the top half of hearings held (Figure 4.6). There does not appear to be other
instances of struggle for turf control concerning women’s health in the Senate.
Figure 4. 8 Laws Passed Senate Committees 1973-2018
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Table 4. 10 Laws Passed from Senate Committees (Excluding Appropriations)
Senate Committee
Commerce, Science, and Transportation
Homeland Security and Governmental
Affairs
Banking, Housing, and Urban Affairs
Armed Services
Foreign Relations
Agriculture, Nutrition, and Forestry
Health, Education, Labor, and Pensions
Indian Affairs
Judiciary
Veterans' Affairs
Finance
Budget
Energy and Natural Resources
Environment and Public Works
Small Business and Entrepreneurship

Bills
Referred
16

Laws
Passed
3

%
Passed
18.80%

16
7
31
70
23
400
14
75
61
192
10
1
32
1

3
1
4
8
2
30
1
3
1
2
0
0
0
0

18.80%
14.30%
12.90%
11.40%
8.70%
7.50%
7.10%
4.00%
1.60%
1.00%
0.00%
0.00%
0.00%
0.00%

Individual Members
Table 4.11 indicates the number of bills sponsored per member in the House, the
number of bills sponsored that became law (the percentage of those that passed), and the
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percentage of total women’s health bills introduced in both chambers. Twelve members
sponsored more than one passed bill, including Representative Nita Lowey who also appears in
the list of members who sponsor the most legislation, and testify multiple times. Among the
top bill sponsors are Representative Henry Waxman, Representative Nita Lowey, and
Representative Michael Burgess. As indicated by the percentage of bills passed calculation,
sponsoring more bills does not necessarily yield a higher percentage passed.
Table 4. 11 Passed Legislation by Chamber per House Member (top tier)
Sponsored

Passed

%
Passed

% of Total
WH Bills

Rep. Montgomery, G. V. (Sonny) [D-MS]

3

2

67%

0.13%

Rep. Obey, David R. [D-WI]

3

2

67%

0.13%

Rep. Rowland, J. Roy [D-GA]

3

2

67%

0.13%

Rep. Gray, William H., III [D-PA]

4

2

50%

0.17%

Rep. Rostenkowski, Dan [D-IL]

4

2

50%

0.17%

Rep. Dingell, John D. [D-MI]

5

2

40%

0.21%

Rep. Rangel, Charles B. [D-NY]

5

2

40%

0.21%

Rep. Panetta, Leon [D-CA]

7

2

29%

0.29%

Rep. Porter, John Edward [R-IL]

7

2

29%

0.29%

Rep. Burgess, Michael C. [R-TX]

11

2

18%

0.46%

Rep. Lowey, Nita M. [D-NY]

28

2

7%

1.17%

Rep. Waxman, Henry A. [D-CA]

39

2

5%

1.63%

Rep. Bonamici, Suzanne [D-OR]

3

1

33%

0.13%

Rep. Christensen, Donna M. [D-VI]

3

1

33%

0.13%

Rep. Foley, Thomas S. [D-WA]

3

1

33%

0.13%

Rep. Hawkins, Augustus F. [D-CA]

3

1

33%

0.13%

Rep. Issa, Darrell E. [R-CA]

3

1

33%

0.13%

Rep. Kasich, John R. [R-OH]

3

1

33%

0.13%

Rep. McKeon, Howard P. "Buck" [R-CA]

3

1

33%

0.13%

Rep. Myrick, Sue Wilkins [R-NC]

3

1

33%

0.13%

Rep. Rogers, Harold [R-KY]

3

1

33%

0.13%

Rep. Sires, Albio [D-NJ]

3

1

33%

0.13%

Rep. Traficant, James A., Jr. [D-OH]

3

1

33%

0.13%

Rep. Dent, Charles W. [R-PA]

4

1

25%

0.17%

Member (House)
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Rep. Roybal-Allard, Lucille [D-CA]

4

1

25%

0.17%

Rep. Berman, Howard L. [D-CA]

5

1

20%

0.21%

Rep. Bilirakis, Michael [R-F]

5

1

20%

0.21%

Rep. Dellums, Ronald V. [D-CA]

5

1

20%

0.21%

Rep. Granger, Kay [R-TX]

5

1

20%

0.21%

Rep. Stark, Fortney Pete [D-CA]

6

1

17%

0.25%

Rep. Baldwin, Tammy [D-WI]

7

1

14%

0.29%

Rep. Hyde, Henry J. [R-IL]

7

1

14%

0.29%

Rep. Stearns, Cliff [R]

7

1

14%

0.29%

Rep. Greenwood, James C. [R-PA]

8

1

13%

0.33%

Rep. Dingell, John D. [D-MI]

9

1

11%

0.38%

Rep. Maloney, Carolyn B. [D-NY]

9

1

11%

0.38%

Rep. Pallone, Frank, Jr. [D-NJ]

15

1

7%

0.63%

Rep. DeLauro, Rosa L. [D-CT]

42

1

2%

1.76%

In the Senate, the top tier of members with the most bills sponsored and passed into
law is much more defined. A total of six senators sponsor bills that are passed into law with
Senator Edward (Ted) Kennedy sponsoring seven passed laws. Senator Kennedy also sponsors
the most women’s health legislation in the Senate. Unlike the House, however, there is not a
clear connection across all three measurements of entrepreneurship. Appearing in both top bill
sponsorship and laws passed are Senator Patrick Leahy, Senator Diane Feinstein, and Senator
Orrin Hatch. Senator Barbara Boxer appears in the top bill sponsors and testifies multiple times
in congressional hearings, and Senator Olympia Snowe appears in the list of top sponsors and
testifies the greatest number of times but does not get a bill passed. Although these measures
of entrepreneurship are not definitive, they do provide an impression of the subsystem and the
actors at play.
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Table 4. 12 Passed Legislation by Chamber per Senate Member (top tier)
Sponsored

Passed

%
Passed

Sen. Kennedy, Edward M. [D-MA]

40

7

18%

% of
Total
WH Bills
1.67%

Sen. Alexander, Lamar [R-TN]

9

3

33%

0.38%

Sen. Hatch, Orrin G. [R-UT]

16

3

19%

0.67%

Sen. Jeffords, James M. [R-VT]

4

2

50%

0.17%

Sen. Feinstein, Dianne [D-CA]

13

2

15%

0.54%

Sen. Leahy, Patrick J. [D-VT]

13

2

15%

0.54%

Sen. Goldwater, Barry [R-AZ]

1

1

100%

0.04%

Sen. Hagel, Chuck [R-NE]

1

1

100%

0.04%

Sen. Johnson, Ron [R-WI]

1

1

100%

0.04%

Sen. Metzenbaum, Howard M. [D-OH]

1

1

100%

0.04%

Sen. Sullivan, Dan [R-AK]

1

1

100%

0.04%

Sen. Pell, Claiborne [D-RI]

2

1

50%

0.08%

Sen. Rubio, Marco [R-FL]

2

1

50%

0.08%

Sen. Isakson, Johnny [R-GA]

3

1

33%

0.13%

Sen. Kassebaum, Nancy Landon [R-KS]

3

1

33%

0.13%

Sen. Warner, John [R-VA]

3

1

33%

0.13%

Sen. Hutchison, Kay Bailey [R-TX]

4

1

25%

0.17%

Sen. McConnell, Mitch [R-KY]

4

1

25%

0.17%

Sen. Nunn, Sam [D-GA]

4

1

25%

0.17%

Sen. Santorum, Rick [R-PA]

4

1

25%

0.17%

Sen. Dole, Robert J. [R-KS]

5

1

20%

0.21%

Sen. Coons, Christopher A. [D-DE]

6

1

17%

0.25%

Sen. Gregg, Judd [R-NH]

6

1

17%

0.25%

Sen. Lincoln, Blanche L. [D-AR]

6

1

17%

0.25%

Sen. Whitehouse, Sheldon [D-RI]

6

1

17%

0.25%

Sen. Cornyn, John [R-TX]

7

1

14%

0.29%

Sen. Frist, William H. [R-TN]
Sen. Wicker, Roger F. [R-MS]
Sen. Brown, Sherrod [D-OH]
Sen. Levin, Carl [D-MI]
Sen. Akaka, Daniel K. [D-HI]
Sen. Bingaman, Jeff [D-NM]
Sen. Casey, Robert P., Jr. [D-PA]
Sen. Menendez, Robert [D-NJ]
Sen. Inouye, Daniel K. [D-HI]

7
7
8
8
10
12
13
13
17

1
1
1
1
1
1
1
1
1

14%
14%
13%
13%
10%
8%
8%
8%
6%

0.29%
0.29%
0.33%
0.33%
0.42%
0.50%
0.54%
0.54%
0.71%

Member (Senate)
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Sen. Mikulski, Barbara A. [D-MD]
Sen. Boxer, Barbara [D-CA]

26
39

1
1

4%
3%

1.09%
1.63%

COSPONSORS
In addition to bills sponsored and bills passed related to women’s health, I track the
total number of co-sponsors per bill. I am interested in whether the number of cosponsors is an
indicator of whether a bill is more likely to pass or fail. I used a Chi Square test to determine if
there is a relationship between the number of cosponsors and passed legislation. Considering
the distribution of the data, I selected three levels of co-sponsorship (low, moderate, and high).
House
Number of Cosponsors
0 to 10

11 to 50

51 or higher

Total

Passed

Failed

53

531

(35.04)

(548.9)

19

420

(26.34)

(412.7)

17

317

(20)

(313.9)

89

1268

584

439

334

X2=10.78 df=2 p=0.0046
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Senate
Number of Cosponsors
0 to 10

11 to 50

51 or higher

Total

Passed

Failed

24

561

(35.1)

(549.9)

21

230

(15.1)

(235.9)

5

23

(1.68)

(26.3)

50

814

585

251

28

864

X2=13.59 df=2 p=0.0011

Relative
Percentage of House bills

Figure 4.9 Relative Percentage of House and Senate Bills to # of Cosponsors
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In this analysis, I consider whether there is a significant relationship between the pass or
fail status and different levels of co-sponsoring (low, moderate, or high). The null hypothesis for
this test is that there is no relationship, (that is, the number of cosponsors does not relate to
the number of bills passed or failed). For both the Senate and House bills, the p-values are less
than the significance level, thus we can reject the null hypothesis in favor of the alternative that
there is a relationship. Although, as evidenced in Figure 4.9, it is easy to see the relationships
are not the same in the House and the Senate.
Co-sponsorship, specifically, is notable as it is a signal of coalition building, bipartisan
support, and general consensus (Hunt 2002). Wawro (2000) also attributes co-sponsorship to
practices of coalition building and increased entrepreneurship activity. Interestingly, the
relationship is stronger in the Senate than in the House. This result is particularly notable as the
chamber-wide attention to women’s health is generally greater in the Senate (discussed in
chapter three).
Figure 4.10 depicts a broader look at the overall landscape, highlighting the percent of
women’s health bills introduced in comparison to the percent of women's health bills passed by
Congressional session. As established in chapter three, the 1991 and 1993 Congresses were
periods of important policy activity in women’s health in Congress. Figure 4.10 provides a
clearer look at the shifting dynamics over time and greater depth of context for political
entrepreneurship exercised both by individual members and committees.
While the Clinton Health Care Reform (1993) did not succeed, this period saw many
smaller and incremental changes in health care policy and in turn women’s health care policy.
Many Democrats used the opportunity to support the president’s agenda, but the controversy
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surrounding several of the plan’s features was too difficult to overcome. While aligning with the
president was desirable, co-sponsorship with like-minded congressional members proved to be
even more influential.
Previous studies using co-sponsorship as a measure of entrepreneurship, especially as a
signal for coalition building, also consider the nature of co-sponsors (Wawro 2000, Fowler
2006). It seems likely that when congressional and party leadership sign on as a bill’s cosponsor, this signals weighted support for the legislation. To assesses whether co-sponsorship
by congressional and party leaders increases the likelihood of bills passed for women’s health
legislation, I reviewed the congressional session with most laws passed, the 114th Congress
(1995-1996). In order to determine if co-sponsorship by leadership in Congress (both majority
and minority leadership) helped to elevate the status of a proposed bill, I reviewed each of the
seventeen laws passed in 1995-1996 as a sample. Only one bill included congressional or party
leaders as a co-sponsor. While, leadership typically helps to increase the likelihood that a bill
will pass, it does not appear to be a very strong indicator in women’s health policy.
Figure 4. 9 Women’s Health Bills Introduced/Women’s Health Bills Passed Into Law

Figure 4.10 Women's Health Bills Introduced/Women's
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GENDER
To conclude, I am especially interested in the impact of gender in women’s health
entrepreneurship. As indicated in the literature, the effects of substantive representation are
difficult to tease out in this type of study, but I attempt to provide a closer look at
entrepreneurial activity with gender as a focusing lens. Although the impact of gender in
legislative decision making is disputed, there is a perceived impact by the public and the
members, as Senator Barbara Boxer (D-CA) comments that she and her female colleagues
“carry with us the needs of women and their families” (Dittmar, Sanbonmatsu, and Carroll
2018). Tables 4.13 and 4.14 illustrate the gender distribution among the top members engaging
in the most entrepreneurial activity.6
Table 4. 13 House Gender Distribution of Most Entrepreneurial Activity
Gender

Top Bill
Sponsors

Percentage

Most Bills
Passed

Percentage

Most
Testimony

Percentage

Women

13

62%

9

24%

6

60%

Men

8

38%

29

76%

4

40%

Table 4. 14 Senate Gender Distribution of Most Entrepreneurial Activity
Gender

Top Bill
Sponsors

Percentage

Bills Passed

Percentage

Most
Testimony

Percentage

Women

11

41%

6

16%

5

71%

Men

16

59%

31

84%

2

29%

6

Top-tier entrepreneurs have sponsored ten or more bills, testified two or more times, or sponsored one more
bills that passed both houses.
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Especially among those engaging entrepreneurial activity in the House, it appears that
women are generally more active. Similarly, in the Senate, women account for nearly half of the
top bill sponsors and a greater proportion of those who pass the most bills. This, however, is
not congruent with the overall proportion of women in each chamber through time. Using data
collected through the Center for American Women and Politics (Rutgers), I report the
percentage of women in each chamber and the total percentage of women in Congress from
1945-to current (Table 4.15).
Table 4. 15 Proportion of Women by Chamber and Total Congress
Congress
79th
80th
81st
82nd
83rd
84th
85th
86th
87th
88th
89th
90th
91st
92nd
93rd
94th
95th
96th
97th
99th
100th
101st
102nd
103rd
104th
105th
106th

Years
1945-1947
1947-1949
1949-1951
1951-1953
1953-1955
1955-1957
1957-1959
1959-1961
1961-1963
1963-1965
1965-1967
1967-1969
1969-1971
1971-1973
1973-1975
1975-1977
1977-1979
1979-1981
1981-1983
1985-1987
1987-1989
1989-1991
1991-1993
1993-1995
1995-1997
1997-1999
1999-2001

W House
11
7
9
10
11
16
15
17
18
12
11
11
10
13
16
19
18
16
21
23
23
29
28
47
48
54
56

%W
3%
2%
2%
2%
3%
4%
3%
4%
4%
3%
3%
3%
2%
3%
4%
4%
4%
4%
5%
5%
5%
7%
6%
11%
11%
12%
13%

W Senate
0
1
1
1
2
1
1
2
2
2
2
1
1
2
0
0
2
1
2
2
2
2
4
7
9
9
9

%W
0%
1%
1%
1%
2%
1%
1%
2%
2%
2%
2%
1%
1%
2%
0%
0%
2%
1%
2%
2%
2%
2%
4%
7%
9%
9%
9%

W Total
11
8
10
11
13
17
16
19
20
14
13
12
11
15
16
19
20
17
23
25
25
31
32
54
57
63
65

%W
2%
1%
2%
2%
2%
3%
3%
4%
4%
3%
2%
2%
2%
3%
3%
4%
4%
3%
4%
5%
5%
6%
6%
10%
11%
12%
12%
111

107th
108th
109th
110th
111th
112th
113th
114th
115th
116th

2001-2003
2003-2005
2005-2007
2007-2009
2009-2011
2011-2013
2013-2015
2015-2017
2017-2019
2019-2021

59
60
68
72
73
73
80
84
87
102

14%
14%
16%
17%
17%
17%
18%
19%
20%
23%

13
14
14
16
17
17
20
20
23
25

13%
14%
14%
16%
17%
17%
20%
20%
23%
25%

73
74
82
88
90
90
100
104
110
127

14%
14%
15%
16%
17%
17%
19%
19%
21%
24%

As a first pass at evaluating the relationship between gender, political party, and bill
sponsorship, I assess whether there is a difference in the rate of sponsorship between male and
female members of either party. I consider the total number of women’s health bills introduced
over the time period studied. Table 4.16 demonstrates that female Democrats in the House are
almost three times more likely to sponsor women’s health legislation as male Republicans, and
male Democrats are two times more likely to sponsor women’s health legislation than their
Republican counterparts. Similarly, Table 4.17 indicates that both female and male Democrats
are two times more likely to sponsor women’s health legislation than their Republican
counterparts. While these percentages provide an overall account of congressional activity,
future formal modeling by individual session would provide a more nuanced look at the data.
Table 4. 16 House Gender Party Sponsorship
Gender
Female
Male

Democrat
Sponsored
379
649

Passed
22
29

Republican
Sponsored
Passed
137
7
312
33
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Table 4. 17 Senate Gender Party Sponsorship
Democrat
Gender
Female
Male

Sponsored
127
513

Republican
Passed
2
24

Sponsored
60
247

Passed
4
20

CONCLUSIONS
This chapter illustrates the shifting dynamics of women’s health policy in the U.S.
Congress and political entrepreneurship recognized through committee activity and the
behavior of individual members. There is some struggle among committees in regard to turf,
both in the House and Senate, yet each chamber demonstrates clearly dominant players.
Individually, there are some patterns of entrepreneurship activity across the three dynamics
studied. Specifically noting co-sponsorship, it does appear that a greater number of cosponsors
increases the likelihood that a bill passes.
In consideration of gender, there is some discussion among congressional scholars as to
whether “who” holds office, descriptive representation, affects the types of policies passed,
substantive representation (Pitkin 1967; Childs & Krook 2009; Swers 2013). While women’s
health policy is particularly complex, it does appear that women are more active among the top
members demonstrating entrepreneurial activity. This is an area I would like to pursue in future
research.
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CHAPTER 5: Expert Attention
Representative Rosa DeLauro (D-CT), a survivor of ovarian cancer, described her illness
as a motivation for her to seek a committee assignment addressing health related issues. When
she got to Congress, more than two twenty years ago, she joined with women members of both
parties to fight for women to be included in clinical trials at the National Institutes of Health
(NIH). She commented, “We thought we had settled that when I got here a while ago, and then
to our chagrin, we find out that that’s not the case and we are still, you know, dealing with this
issue.” Much of the battle over women’s health policy has been based on the battle for
inclusion in the discussion. Initially, women we largely excluded from health policy, barring their
role as mothers, and then the discussion became dominated by challenges of reproductive
rights. While reproductive health and reproductive rights are two sides of the same coin, the
focus of policy is slightly different.
In this chapter I will provide further discussion about the nature of women’s health
policy in the context of expert communities and administrative agencies. Roger Cobb, Jeannie
Keith-Ross and Marc Howard Ross (1976) describe agenda building as “the process by which
demands of various groups in the population are translated into items vying for serious
attention of public officials” (p. 126). The literature in agenda setting demonstrates that there
are multiple venues by which political actors and the public become aware of policies. In this
chapter, I investigate the dynamics of the medical establishment and women’s health policy
experts worked to carve out a niche for women’s health in the health policy arena.
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Considering the outside initiative model (Cobb, Ross and Ross 1976; Kingdon and
Thurber 1984; Rochertfort and Cobb, 1994) and Walker’s (1977) evaluation of the expert and
technical media, I open the story of women’s health by tracking the attention of the medical
establishment and academic and scholarly publications to women’s health policy. This allows
me to establish the identity of some of the key players in women’s health policy and how they
framed the issue. These include the Institute of Medicine, National Institutes of Health, Office
of the Surgeon General, Center for Disease Control, Department of Health and Human Services,
and the Agency for Healthcare Research and Quality. Additionally, I track publications among
the biomedical academic scholarly community, which would include important actors such as
the American Medical Association. I track attention in the professional and expert community
from 1945-2018.
Next, I look at how medical experts frame women’s health as a separate concern, noting
the initial focus of experts, the dialogue among experts, and how beliefs about women’s health
as a separate issue developed over time, taking care to note changes in policy core beliefs and
programmatic emphasis (Sabatier and Jenkins-Smith 1999). Finally, I consider how expert
attention relates to media, congressional, and presidential attention.

MEDICAL ESTABLISHMENT
In order to trace the influence of institutional actors within the medical establishment, I
turn to professionalized media with the weight of expertise. I have identified five key
organizations and government agencies that disseminate and contribute to the body of
research in the medical community: The Health and Medicine Division (HMD/IOM), division of
the National Academies of Sciences, Engineering, and Medicine, National Institute of Child
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Health and Human Development (National Institutes of Health- NIH), Office of the United States
Surgeon General (USSG), Centers for Disease Control and Prevention (CDC), and The Agency for
Healthcare Research and Quality (AHRQ).
The Health and Medicine Division (HMD) is a component of the National Academies of
Sciences, Engineering, and Medicine (the National Academies). HMD previously was the
Institute of Medicine (IOM). The National Academies are private, nonprofit institutions that
provide independent, objective research and inform public policy related to science,
technology, and medicine. The Health and Medicine Division (HMD), changed its name from the
Institute of Medicine (IOM) in 2016 to better reflect a broader emphasis on health matters,
rather than medicine explicitly. The fundamental charge of the HMD is to advise the nation on
how to improve health based upon evidence driven practice. Though Congress may charge the
HMD with a specific task or research initiative, the Academies are private, nonprofit
institutions. The work of the HMD makes recommendations on a wide array of health issues,
potentially influencing policy related to science, technology, and medicine. Publications by the
HMD/IOM are categorized by topic and I specifically focus on the women’s health sub-section
Figure 5.1 illustrates HMD/IOM research and publication activity in regard to women’s
health by year. We begin to see publications from the HMD/IOM in 1988, with a dramatic
increase in 1997, and in the period following there is a steady increase through 2017. There is a
punctuation in attention in 2003.
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Figure 5. 1 HMD/IOM Publications – Women’s Health
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Figure 5.1 HMD/IOM Publications - Women's Health

Year
HMD/IOM

In the mid-1950s, as a division of the National Institute of Health (NIH), the National
Institute of Child Health and Human Development (NICHD) was established. Fundamentally, the
tasks of the Institute (NICHD) were to promote better understanding of infant and childhood
development as well as to promote scholarship surrounding the issue of health through the life
course. The NICHD established research arms within universities, developed facilities to train
those working with individuals with developmental irregularities, and lead to the construction
of a dozen, independent research centers across the country dedicated to research in these
arenas.
The NICHD was formally renamed the Eunice Kennedy Shriver National Institute of Child
Health and Human Development in 2007 to honor the tireless dedication of Shriver in her
advocacy for those with intellectual and/or developmental delays and disabilities (Raju, Bock,
and Alexander 2008). Due to Shriver’s support, the medical community began to recognize that
research and specialization in the areas of human development was needed and the study of
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aberrant development in the physical, intellectual, and emotional health of children was
necessary. Both medical specialties, as well as the Institute generally, were influenced by
Shriver’s dedication. Today, the NICHD is tasked with enhancing the understanding of health
during pregnancy as well as preconception. Further, the NICHD evaluates how growth and
development should be considered throughout the life course, encourages better
understanding of the reproductive health of men and women, and promotes rehabilitation
medicine development to encourage an improved quality of life for those living with disabilities.
Research from the National Institutes of Health (NICH), specifically the National Institute
of Child Health and Human Development (NICHD) (https://www.nichd.nih.gov), also provides
regular contributions to science and medical care. According to the NICHD Annual Report
(2019), their work has “yielded safe and effective vaccines for childhood infections, developed
cutting-edge molecular imaging technologies, and provided new insights into the risks of
certain environmental exposures among populations such as pregnant women, among other
advances” (NICHD 2019). The NICHD generates regular public advisory research feature articles
to explain NICHD research findings and public health issues to the public. These are searchable,
using the NIH archive and the search term “women’s health.” Figure 5.2 illustrates NIH/NICHD
research and publication activity in regard to women’s health by year.
It appears that NIH attention to women’s health in particular does not appear in the
distribution until 1999. There is some activity from 1999 to 2006, but publications decrease
again in 2008. However, there are more dramatic increases in 2011 and 2015. In June of 1990,
The General Accounting Office (GAO) reports that women have been excluded from major
federally funded clinical studies and that the NIH is not enforcing its policy of including women
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(Glazer, 1994). In response to the GAO report, the NIH establishes the Office of Research on
Women’s Health in 1990, and women’s health publications increase shortly thereafter.
Women’s health is an integral focus of the NICHD. The Institute attempts to address the
comprehensive treatment of women’s health and topically has focused upon fertility and
infertility, maternal mortality, administration and menstrual problems, and pregnancy, among
other topics (Raju, Bock, and Alexander 2008). The Women’s Health office is dedicated to
understanding sex differences and the unique health realities of women to best ensure good
health and well-being.
The Office of Research on Women’s Health (ORWH) was established in September 1990
within the NIH to focus upon women’s health research. The historic deficit in research and the
growing understanding of the critical need for research on the health differences of sex and
gender led to the foundation of this office. The OWHR was the first United States Public Health
Service office that was specifically dedicated to promoting women’s health and evaluating sex
differences in research. The specific charges ORWH include the following: (1) to strengthen,
develop and increase research into diseases, disorders and conditions that are unique to, more
prevalent among, or more serious than women or for which there are different risk factors for
women then from there; (2) to ensure that women are appropriately represented in biomedical
and behavioral research studies, especially clinical trials, that are supported by the NIH; and (3)
to direct initiatives to increase the number of women in biomedical careers (Pinn 1994).
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Figure 5. 2 NIH Publications – Women’s Health
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Year
NIH/NICHD

Next, I consider publications from the U.S. Surgeon General (USSG) available through
the Surgeon General Collection at the National Library of Medicine. This index is searchable by
year, and I used the search term “women’s health” (https://www.surgeongeneral.gov). As part
of its Profiles in Science project, the National Library of Medicine (NLM) has digitized reports
and publications of the U.S Surgeon General (USSG) prior to 2000. The collection includes
reports, proceedings, and background papers.
The Public Health Reports (PHR) have been published since 1878 and are the official public
health journal of the US Surgeon General and the Public Health Service (PHS). The publications
from the Surgeon General and the PHS generally, are relied on for the rigor and evidence-based
approach. Said documents are often interdisciplinary in nature employing expertise from the
scientific, medical, and public health worlds. The reports from the Surgeon General often have
wide reaching impact on understanding, prevention, and practice of public health concerns.
Such timely and critical public health emergencies as the HIV/AIDS epidemic, tobacco use, other
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addictions, mental health including suicide prevention, societal and domestic violence, food
security, natural disasters, mental health among many others, have been recent topical
emphases. This journal is published bimonthly and is peer reviewed.
Figure 5.3 illustrates USSG publications and reports in regard to women’s health by year.
Publications from the Office of the USSG peak earlier than the IOM and NIH, beginning in the
mid-1960s. There are punctuations, however, in 1988 and 2001. The 1988 punctuation is
particularly interesting as the “Alcoholic Beverage Labeling Act of 1988” (ABL requires that a
health warning statement appear on the labels of alcohol beverages as a result of the Surgeon
General Warning regarding consuming alcohol during pregnancy (women should not drink
alcoholic beverages during pregnancy because of the risk of birth defect). The increase in 1966
coincides with the adoption of Medicare, and it is notable in 1990 that Dr. Antonia Novello was
elected as the first female Surgeon General (Biography, National Library of Medicine 2015).
Figure 5. 3 USSG Publications- Women’s Health
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The United States Public Health Service (PHS) is a division of the Department of Health
and Human Services and is dedicated to issues of the public health. First known as the Marine
Hospital Service (1798), the Public Health Service was renamed in 1912. The position of the
Surgeon General was established in 1871, originally known as the Supervising General. The US
Public Health Service Commissioned Corp is a uniformed, military branch that employs over
6,000 public health workers and is charged with the delivery of public health promotion and
disease prevention programs. In 1946 the Communicable Disease Center, now known as the
Centers for Disease Control (CDC) opened to first tackle malaria control in the Southeast United
States. Today the CDC has an extensive and varied practice area addressing all medical
processes from prevention, surveillance, treatment, and control.
I collected data in regard to publications produced by the Centers for Disease Control
and Prevention (CDC), using CDC Stacks (https://stacks.cdc.gov/welcome). CDC Stacks is a
digital archive of scientific research and literature published and archived by the CDC. I refined
the search function to include “all collections” and used the search term “women’s health.”
The Centers for Disease Control and Prevention publishes a variety of periodicals. These
include: the Morbidity and Mortality Weekly Report (MMWR), Emerging Infectious Diseases
(EID), and Preventing Chronic Disease (PCD). Further, the CDC publishes special reports, vital
statistics of United States, annual reports on vital and health statistics, recommendations for
research methods, and emerging and/or emergent public health concerns.
The CDC publishes a variety of public health papers and journals specific to women.
These include works related to preconception, maternal health, women’s aging, cervical,
uterine and breast cancers, violence against women, etc. Specifically, the CDC publishes the
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Journal of Women’s Health that tackles a myriad of issues impacting the health status of
women. This journal focuses on research and health issues impacting girls and women in the
US and beyond. The Journal and the Office of Women’s Health are attempting to ameliorate
historical health inequities. The CDC also produces a e-newsletter, Health Matters for Women,
that offers information about what is happening in women’s health at the CDC and related
agencies.
Figure 5.4 illustrates CDC publications and reports regarding women’s health by year.
The CDC reports on women’s health minimally until 1987 when there is a dramatic increase (80
publications), and this is repeated again in 2015 (117 publications). In 1986, the CDC began
surveillance of maternal mortality, which is defined as the death of a woman during pregnancy,
during childbirth, or within the time period immediately following termination of a pregnancy
(CDC Office of Research on Women’s Health 2013). In review of this data, the overall number of
CDC and Agency for Toxic Substances and Disease Registry publications increases dramatically
from the 1980s to current.
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Figure 5. 4 CDC Publications – Women’s Health
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Further, I examine the Agency for Healthcare Research and Quality (AHRQ), which publishes
Evidence Based Practice Reports and sponsors the development of various other reports to
assist public and private-sector organizations. Their mission is to improve the quality of health
care in the United States, using evidence-based practice (Agency for Healthcare Research and
Quality). These reports provide comprehensive, science-based information on common (yet
often very costly) medical conditions and new health care technologies. Evidenced Based
Practice Reports review all relevant scientific literature on a wide spectrum of clinical and
health services topics. The Agency for Healthcare Research and Quality is a division of US
Department of Health and Human Services. Specifically, the AHRQ surveils the nation’s health
delivery system, promotes best practice in developing and training healthcare systems and
professionals, and encourages best practices in the evaluation of the methods used to manage
data by providers and policymakers. The AHRQ publishes a variety of periodicals data
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explanations, including consumer guides, and other technical journals intended to offer
utilitarian guidance for a variety of healthcare organizations and providers.
My search results include released evidence reports, comparative effectiveness reviews,
technical briefs, Technology Assessment Program reports, and U.S. Preventive Services Task
Force information. I used the search term “women” (www.arhq.gov).
Figure 5.5 tracks publications by the AHRQ from 1945-2018. There are relatively few
publications across the time period, with only one punctuation occurring in 2012. This result
seems reasonable as assessment of the Patient Protection and Affordable Care Act would be
relevant at this time. Additionally, the AHRQ also published a special report in 2011 concerning
health care quality and disparities among women (Agency for Healthcare Research and Quality,
2012). Which may also account for an increase in attention to women’s health generally and
with regard to the evidence in this corresponding distribution.
Figure 5. 5 AHRQ Publications – Women’s Health
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ACADEMIC SCHOLARLY PUBLICATIONS
In order to get at academic scholarly and expert research, I conducted a search of
PubMed.gov, which is maintained by the U.S. National Library of Medicine National Institutes of
Health (https://www.ncbi.nlm.nih.gov/pubmed). PubMed.gov is comprised of more than 29
million citations from biomedical literature found on MEDLINE, in roughly 5,400 life science and
biomedical journals and online books. Citations include links to full-text content from PubMed
Central and other various publisher web sites from 1946-present. This source provides an
appropriate measure of scholarly activity during the time period studied. Using an advanced
search, I limit my search to publications for “women’s health.”
Figure 5.6 illustrates the number of scholarly publications from 1947-2018. Publications
begin to steadily rise from 1979 (125 publications) to 2018 (14,454 publications). There is a
period of more dramatic increase beginning in 2012. In the late 1980s, advocates fought to
increase the representation of women in clinical studies of diseases, disorders, and drug
treatments. Women’s health research in scholarly publications seems to reflect this shift
toward inclusion of women in medical research. From 1990 to 2017 scholarly publications in
medical journals (available through PubMed) increased about 5%, whereas publications related
to women's health specifically increase 272%. This increase for women’s health research is
significant and demonstrates a dramatic rise in focused expert attention.
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Figure 5. 6 PbuMed Publications – Women’s Health
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Table 5. 1 Scholarly Publications 1990-2017
Publications 1990-2017

# Published 1990

# Published 2017

% Change

All

388,191

16,626,705

5%

Women's Health

562

114,375

272%

EXPERT ATTENTION AND CONGRESSIONAL ATTENTION
In Figure 5.7, I compare presidential attention data gathered, using presidential papers
available through The American Presidency Project (Figure 3.17) and bill introductions, collected
using the legislative subject term “women’s health” on Congress.gov, as a measure of
congressional attention (Figure 3.14) to publications from policy experts, professional
organizations and administrative agencies in the medical establishment. (This includes all
publication data collected from the IOM, NIH, USSG, CDC, and AHRQ - Figures 5.2 - 5.5). It is
interesting that bill introductions seem to peak first in 1985, but publications in the medical
establishment follow closely with an uptick in 1987. Medical publications peak again in 2003
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and bill introductions follow in 2009, where we begin to see a dramatic increase in medical
publications. Presidential attention illustrates an overall increase, with a slight uptick in 2013.
The convergence of government and expert attention is informed by the following discussion of
the policy context. It is interesting to note that increased attention by one group is not
necessarily mirrored by the other. In this case, and in the case of public attention, one would
expect considerable lag time. The expert community is bound by research and publishing
limitations, and the President and Congress either respond or shift attention according to the
congressional calendar and election cycle. Further discussion of the policy environment and
political context is needed to best interpret these connections.
Figure 5. 7 Who Pays Attention to Women’s Health
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POLICY EVOLUTION
As the literature suggests, it is evident that women’s health, both by the government
and the medical established, was initially defined through childbirth. The American Medical
Association affirmed in 1883 that “women's health troubles are largely caused by their ovaries
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and other sexual organs” (Masci 2003). The treatment of women’s health through childbirth
dates from the mid-19th century when male doctors first defined childbirth as a surgical
procedure (Masci 2003). Until that time, female midwives had largely been responsible for
childbirth and “women’s ailments” (Msci 2003). All that changed, however, once social mores
permitted male doctors to examine women's genital areas. From the late 1950s to 1970s birth
defects caused by the drug thalidomide prompted medical professionals and federal agencies
to action to reduce the risks of experimental drugs.
As these concerns increased, women started to campaign for more responsive health
care (Glazer 1994). In 1970, a primer on women's health was published by Boston feminists.
Our Bodies, Ourselves was a 93-page booklet that dared to address sexuality and reproductive
health, including abortion. In response to the unsafe practices of thalidomide and mounting
social pressures, Congress created the National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research, which focused on issues and guidelines
limiting research on pregnant women and fetuses (PHSBBR). It was not until 1976, however,
that the National Women's Health Network was founded as a watchdog group to monitor and
influence federal health policies dealing with women. This coincides with the beginnings of
focused women’s health legislation in Congress (see chapter three). By the 1980s, women of
the baby-boom generation start to reach mid-life and experience breast cancer and other
illnesses at growing rates, and with the increasing numbers of female medical school graduates,
researchers begin questioning the amount of attention paid to women's health.
In 1983, the Assistant Secretary for Health Edward Brandt established a Public Health
Service Task Force on Women's Health Issues (Kirschstein 1991). Subsequently, The
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Department of Health and Human Services established the Coordinating Committee on
Women's Health (CCWH) to advise the Assistant Secretary for Health on activities to safeguard
and improve the physical and mental health of women in the United States (Kirschstein 1991).
In 1985, The Public Health Service Task Force on Women's Health Issues concluded that the
historical lack of attention to women's health concerns has “compromised the quality” of
health care that women receive (Glazer, 1994). As a result, the NIH developed new policies
encouraging applicants for research funding to include women in clinical trials.
By the late 1980s and early 1990s, attention to women’s health gained momentum,
both in terms of expert attention and congressional attention. Two critical events helped to
thrust women’s health issues into the medical, public, and congressional spotlight. Harvard
University reported in 1989 (Harvard’s Physicians Health Study) that taking an aspirin every
other day could prevent heart disease, most news reports implied that the results applied to all
adults. But the Physicians' Health Study involved 22,000 male doctors, and no women.
However, Harvard researchers noted that all the benefit was confined to men older than 50
(Glazer 1994). Then in June 1990 The Government Accountability Office (GAO) published a
report highlighting the lack of women included in federally funded clinical studies and the NIH.
This report served a springboard for much of the increased attention by women in Congress
and resulted in policy and regulation change for agencies (Kirschstein 1991).
By August 1990, Senator Barbara Mikulski (D-MD) introduced the Women's Health
Equity Act (WHEA). The WHEA was an omnibus bill authorizing additional funding for breast
cancer and other women's diseases and required a mandate that women be included in clinical
trials (Lee 2015). Representatives Patricia Schroeder (D-CO) and Olympia J. Snowe (R-ME)
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reintroduced the bill in 1991, but it never gained traction. Representatives Schroeder and
Snowe both demonstrated substantial entrepreneurial activity in advancing this policy as
evidenced in chapter four. In September 1990, the NIH established the new Office of Research
on Women’s Health (NIH 2018).
Many prominent women in the medical community believed that medical differences
between the sexes had been neglected by researchers (not just heart disease). Florence
Haseltine, director of the Center for Population Research at the National Institutes of Health
(NIH) in Bethesda, MD commented, “Basically, what we need to do is rethink how we look at
the disease process,” and “that there is a difference between men and women in itself is
interesting” (Glazer 1994).
In 1991, Bernadine Healy, the first female director of NIH, launched the Women's Health
Initiative (WHI), a $625 million study of some 160,0000 women (Glazer 1994). The NIH
Women’s Health Initiative was a 14-year study of women's health followed up by WHI
Extension Studies (2005-2010, 2010-2020). $. The initiative will examine three diseases of
crucial importance to women: heart disease, breast cancer and osteoporosis WHI has published
over 1,400 articles and approved and funded 289 ancillary studies (Women’s Health Initiative).
According to the report’s findings, the WHI has impacted women’s health in medical practice in
the U.S and around the world by helping women and their health care providers make more
informed decisions, particularly in regard to the use of hormone therapy and menopause
treatments (Women’s Health Initiative).
Under pressure from the Congressional Caucus for Women's Issues, led by
Representatives. Patricia Schroeder (D-CO) and Olympia Snowe (R-ME, among others, Congress
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required the NIH to include women in all applicable clinical trials of medical treatments. The
Food and Drug Administration (FDA) also issued guidelines last year encouraging researchers to
include women in tests of new drugs and lifted its 1977 ban on including women of childbearing
age in early studies (Lee 2015).
In 1992, Johnson, an assistant clinical professor of psychiatry at the University of
California-San Francisco, proposed in a “debate” in the Journal of Women's Health that a new
medical specialty be created and certified in women's health. She argued that “two or more
physicians are required to provide complete care [for women], an inefficient and expensive
process” (Glazer 1994). However, not all medical professionals were on the same page. Some
were discouraged by the legislation, especially the requirement that researchers include
enough women participants to perform a “valid analysis” of the differences between the sexes.
In a later response, New England Journal of Medicine Editor Marcia Angell (1992) expressed this
viewpoint when she protested that the requirements “assume that clinically important
differences between men and women are the rule rather than the exception -- a biologically
implausible assumption.”
With the election of President Bill Clinton in 1992, the women’s health debate began to
shift toward abortion issues. One of Clinton's first acts on January 22nd, the anniversary of the
Supreme Court's 1973 decision in Roe v. Wade, was to lift the executive orders banning
abortion counseling in federally funded family planning clinics and the use of fetal tissue for
medical research (1993 CQ Weekly Report, p. 182). This presidency fueled a resurgence in
attention to concerns over abortion, federal funding, and definition of family planning. The

132

controversial Clinton Health Care Reform (1993) package prompted women’s health issues
related to abortion to resurface.
Although though 1992 saw the most women elected into Congress, their policy fights for
women’s health care were often sidelined in favor of debate over funding or more divisive
rights issues surrounding abortion. With the election of President Clinton and the addition of
twenty-four women to the House (all of whom ran on pro-choice platforms) it was predicted
that the Freedom of Previous Choice Act would pass through Congress in the first six months of
that year (Bettelheim, 2009). This was not the case, however, as Congress balked at supporting
a number of the bill's key provisions and abortion debates concerning federal funding were
particularly relevant in the House (Bettelheim 2009).
However, June of 1993, President Clinton signed the NIH Revitalization Act, which legally
required the inclusion of women in clinical trials and research funded by the NIH. For the first
time in several years, NIH reauthorization passed with relatively little controversy. The NIH
Revitalization Act authorized $10.7 billion in spending, with a significant portion focused on
research of reproductive system cancers. The bill also increased the power of the Office of AIDS
Research and added programs for women and minorities (Rubin & Zuckman 1993). Following
this legislation, a panel appointed by the Institute of Medicine which recommended that
pregnant women be “presumed eligible” for participation in clinical studies as well (Glazer
1994).
During the Clinton - Bush campaign, abortion was not the only women’s health issue up
for debate, which was a clear sign of limited space on the agenda and issue crowding.
Democrats had long supported the Family and Medical Leave Act, and its passage in 1992
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reflected an important social policy difference between President Clinton and former President
George H. W. Bush. The bill passed both chambers in 1991 but idled in Congress until a
conference agreement cleared the following year. Bush vetoed the measure in September 1992
(Rubin & Zuckman 1993). The same bill passed Congress shortly after Clinton took office in
1993. It allows workers to take up to twelve weeks of unpaid leave during any twelve-month
period because of the birth or adoption of a child; the need to care for a child, spouse or parent
with a serious health condition; or the worker's own serious illness (Rubin & Zuckman 1993).
In 1998-1999, women’s health policy briefly returned to issues of funding and research.
The omnibus spending bill (HR4328) signed by President Clinton on October 21, 1999 allocated
$15.6 billion to the National Institutes of Health (Kirchhoff and Carey 1998). NIH funding an
authorization was again used as a vehicle for advancing women’s health through research. The
bill represented a 15% increase from the previous fiscal year and marked the beginning of a
five-year push to greatly expand the agency's budget (Kirchhoff and Carey 1998). Overall, the
bill provided about $290 billion in spending for health, education and labor programs.
The pattern of increased NIH funding was accompanied by increased pressure to
dedicate some of the NIH budget to research of specific diseases. Representative John Edward
Porter (R-IL)., 1998 chairman of the House Labor-HHS Appropriations Subcommittee, fought
efforts to earmark NIH funding. He believed, as did his predecessor, William Natcher (D- KY),
that those decisions should be left to experts. Women’s health concerns, however, have been
presented in very specific terms. For example, the 1999 NIH authorization included provisions
supported by Senator Alfonse M. D'Amato (R-NY) to require health insurers to cover breast
reconstruction after mastectomies.
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Just five years later, NIH reporting again brought women’s health concerns to the
forefront. A practice initially thought to protect women, using hormone replacement therapy
(HRT), actually increased the risk of breast cancer, heart disease and stroke. (Lawton, McLeod,
and Dowell 2003). The Women's Health Initiative study (WHI), sponsored by the US National
Institutes of Health (NIH), found that HRT significantly increases the risk of invasive breast
cancer. It also reported higher risks of heart attack, stroke, and blood clotting. The NIH took the
unusual step of halting the WHI trial and recommended that women stop taking HRT for mild
menopausal symptoms. (Lawton, McLeod, and Dowell 2003).
This step signaled a strong agency response not usually taken. For example, the National
Cancer Institute (NCI) waited until 2002 to declare that hormone-replacement therapy raised
women's cancer risks, although the NIH Women’s Health Study reported its findings a decade
earlier (Clemmitt 2009). And as early as 1994, research strongly linked talcum powder use to
ovarian cancer, especially in black women, the Food and Drug Administration (FDA) did not
issue an immediate response (Clemmitt 2009).
Today over thirty years have passed since The Public Health Service Task Force on
Women’s Health Issues first noted the historical lack of attention to women's health concerns.
In light of this policy review, and the previously discussed developments (chapters one – four),
medical research has often been the catalyst for funding and advancing women’s health policy.
Though other dimensions including reproductive health, abortion, and maternal care are very
much a part of the conversation. Congressional reauthorization of critical funding bills, the
efforts of women’s issues advocates, professional organizations of practitioners, and those
conducting research come together at this critical juncture. The work of the NIH Women’s
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Health Initiative and subsequent studies have changed the nature of health research and fueled
the expansion of a much broader and inclusive system. With the addition of the Affordable Care
Act (2010), access and measures of preventative medicine are more readily available to the
most vulnerable populations. The Kaiser Family Foundation, in particular, specifically focuses on
the challenges faced by women at risk for experiencing access barriers including: low income,
Medicaid recipients, the uninsured, as well as racial and ethnic minorities. The annual Kaiser
Women’s Health Survey is a nationally representative survey of women ages 18 to 64 on their
coverage, use, and access to health care services (Kaiser Women’s Health Survey 2017). Their
analysis has been important in preparing key policy briefs on key trends and issues that
disproportionately affect women and inform current policy debates. Many of these concerns
have implications across the health spectrum for both men and women. This work is indicative
of the evolution of women’s health policy from the mid-1980s.
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CHAPTER 6: Conclusions

In this chapter I will discuss the key findings of the research and summarize the overall
study. I also focus on questions of future research that I consider as a result of my investigation.
Ultimately, my work examines how women’s health care became an important facet of health
policy and continues to evolve today. The research in chapter three builds on the work of
Baumgartner and Jones’ (2005; 2013) Policy Agendas Project, creating a more defined picture of
health policy by including women’s health care. In chapter four, I track entrepreneurship and
explore elements of gender. Finally, in chapter five, I investigate women’s health policy in the
broader context of its history.

SUMMARY OF FINDINGS AND LIMITATIONS
In the first empirical chapter, three, I map how women’s health gained entrance to the
agenda. First, I mapped the overall health agenda, using data available through Baumgartner
and Jones’ Policy Agendas Project. They do not include women’s health as a discrete subtopic.
As I have established that women’s health care was first defined through policy related to
infants and children, I discussed The Policy Agendas Project data for health, specifically related
to health care for infants and children. This served as an indicator but did not fully describe the
specifics of women’s health policy. The final section of the chapter uses original research to
track the entry of women’s health on the agenda and compares the measures of attention
respectively.
My findings supplement the data made available by The Policy Agendas Project and
describes women’s health policy as part of the overall health agenda. I determine that 22% of
all health bill introductions are women’s health related, which is a little more than one in five.
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In regard to congressional hearings, women’s health represents about 16% of all health
hearings, and less than 10% of all health laws passed are directly related to women’s health. As
health professionals regularly observe health care practices as by divided by sex, congressional
attention is not proportionally representative of these distinctions.
Similarly, public attention does not appear to coincide with congressional attention, as
New York Times women’s health mentions have no relationship to the number of bills
introduced, congressional hearings, or passed legislation. There is a correlation between public
attention and presidential attention. In the case of presidential attention and bill introductions,
however, there is a slightly stronger correlation. I found that when presidential attention
increases so does the amount of legislation regarding women’s health care. Interestingly,
though, it appears as the number of bill introductions increases, the number of congressional
hearings decreases. This result potentially warrants further investigation, and begs the
question, why would Congress reduce entrepreneurial and oversight activity when presidential
attention increases? I offer possible explanations as to this result in the chapter, but a nuanced
look at congressional hearings may help to better understand this behavior.
For example, instead of merely tracking the frequency of hearings, one might also
account for hearing intensity. This could be accomplished by determining the length of
hearings, number of hearings, or even the number of pages that makeup the hearing transcript.
Using the current method, all hearings are treated equally and that is not as sensitive to the
variations of behavior across committees and over time.
In chapter four, the second empirical chapter, I note occurrences of political
entrepreneurship at the committee level as well as the individual level. To capture both
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dynamics, I measured the behavior of congressional committees and members of the House
and Senate. I analyzed entrepreneurial activity in three stages: bill sponsorship and legislative
introductions, hearing activity, and passed legislation. First, I tracked which committees
received referrals to analyze turf control (King 1997). Then I tracked which members sponsored
women’s health legislation and whether subsequent bills were referred to committees on
which they served. In future research I might also consider whether high ranking members
served on the committees or if members held leadership positions, as this demonstrates a
stronger indicator of entrepreneurship.
To examine hearing activity, I tracked which committees held the greatest number of
hearings in women’s health and which members testified most. For passed legislation, I
determined which members sponsored the most bills and if the number of co-sponsors was
related to whether a bill passes. After considering these measures of entrepreneurship, I also
focused on what role gender plays among women’s health entrepreneurs.
There are clearly dominant committees in the struggle for turf control in both the House
and Senate. In the House, the Committee on Energy and Commerce is referred over two thirds
of legislation introduced. Likewise, in the Senate, the Health, Education, Labor and Pensions
Committee receives referrals for more than half of all women’s health bills introduced. In the
House, Representatives Maloney, DeLauro, and Waxman are leaders in women’s health bill
sponsorship. Similarly, in the Senate, Senators Kennedy and Boxer emerge as women’s health
entrepreneurs. We see these players repeated in measures of hearing activity and passed
legislation.
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Co-sponsorship, specifically, is notable as there is a relationship between the number of
cosponsors per bill and the number of bills passed. The relationship is stronger in the Senate
than in the House. Wawro (2000), attributes co-sponsorship to practices of coalition building
and increased entrepreneurship activity. This finding is important not only for bill sponsors but
also for professional organizations and practitioners who generate and lobby legislation. I am
interested in co-sponsorships by congressional and party leadership as well. I offer a sample of
passed legislation but find very little evidence of leadership as co-sponsors. This may be a
function of the small sample size or just indicative of the nature of the data. Perhaps sponsor
gender would be a stronger indicator to predict legislative success. In either case, my evaluation
is holistic, and for the future I would proposed an evaluation of each bill passed and tracked by
congressional session.
I also evaluate the proportion of gender among top entrepreneurs in bill sponsorship,
hearing testimony, and passed legislation. Women demonstrate higher proportions among this
group. However, this result is incongruent to the percentage of women in each chamber. My
examination of entrepreneurial activity and gender disparity provides an impression of activity,
but formal modeling in future research is needed for determining definitive causal
relationships. It appears that there is a relationship between gender, party, and legislative
action. It would also be helpful to consider ideology as an additional measure. A multivariate
analysis similar to Sewers (2016) work would likely provide stronger causal explanations.
Finally, in the third empirical chapter (chapter five), I evaluate expert and technical
media to track attention of the medical establishment and academic and scholarly activity in
women’s health policy. First, I established key players in women’s health policy who produce
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publications as a measure of expert media, professional groups, and agencies. These included
the following: Institute of Medicine, National Institutes of Health, Office of the Surgeon
General, Center for Disease Control, Department of Health and Human Services, and the
Agency for Healthcare Research and Quality. Additionally, I tracked publications among the
biomedical scholarly community from 1945-2018.
Then, I considered whether expert attention follows a similar pattern in media coverage
of Congress and important changes in congressional behavior. I evaluated attention
publications from CQ Magazine (CQ Weekly Reports) and provided narrative discussion to
better understand the trends in attention. I evaluated this data relative to findings established
in chapter three to determine whether expert media relates to public attention and further
informs congressional and agency behavior.
I found that women’s health policy was particularly robust in the early 1990s, exhibiting
increases in activity across the measures of expert and technical media, as well as Congress.
This period was marked by considerable expansion for women’s health research. Scholarly and
scientific research seems to drive attention among all groups, but funding in Congress is a
necessary catalyst to help create policy change. Publications from the Office of the U.S. Surgeon
General (USSG) demonstrates a more defined trend line in terms of punctuation, but this is
likely a result of the nature of USSG tradition of reporting and the relatively small search
returns. In review of congressional, presidential, and medical establishment activity, it should
be noted that generally there is an upward trend. It is interesting that women’s health bill
introductions peak first in 1985, but publications in the medical establishment follow closely
with an uptick in 1987. Medical publications peak again in 2003 when the National Institute of
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Health reports the dangers of Hormone Replacement Therapy. There is an increase in bill
introductions which follows in 2009, where we begin to see an unmatched dramatic increase in
medical publications concerning women’s health.
The relatively higher increase in medical publications in the early 2000s does not
correspond with public or congressional attention and is noteworthy for future research. The
discussion on the policy evolution in chapter five describes the changes in current health
practice and research that result from changes in legislation. In many respects, women’s health
research is in its infancy compared to many other medical fields. Future research concerning
the policy evolution might uncover further discussion surrounding the importance of data in
clinical trials for women and what specific impacts the Patient Protection and Affordable Care
Act (2010) will yield for women’s health.

AVENUES FOR FUTURE RESEARCH
From its original conception, the women’s health definition has shifted, changed, and
arguably returned to its original narrative. Initially, women’s health policy was largely defined
by childbirth and reproductive health casting women as mothers and caregivers. Part of the
later discussion included attention to over population and concerns of birth control, and
eventually the discussion became focused on the debate over abortion. While each of these
dimensions remained on the agenda in some capacity, attention shifted as a new facet became
particularly salient to the public, government, and medical community. The debate over
abortion is difficult to constrain as wholly related to health.
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Depending on the particular venue, congressional committees for instance, the debate
may be related to the ethics of funding, religious and moral concerns, civil rights, or health and
safety of the mother. For example, if a bill is referred to the Judiciary Committee, one would
expect a debate on the merits of rights as opposed to the necessity of funding agency programs
related to patient education or safe practices. Later developments in women’s health centered
on a more holistic approach to women’s health with evidenced based medical research and
attention to funding for programs that expanded access, provided screenings, and supported
specialized cancer treatment. While I consider these dynamics, the focus is on who is paying
attention when, but not necessarily how they are paying attention where. Future research
building on the data collected might consider how committee venue alters attention to
women’s health and the type of policy created. A closer look at the relationship between
committees and administrative agencies would also provide an additional dynamic.

Agenda Crowding
In addition to the dimensions and definition of women’s health, I also consider agenda
capacity and how women’s health fits into the overall health agenda. In chapter three, I
determined that health policy garners a moderate amount of attention, when compared to say
defense policy. In comparison to all other policy topics tracked by Baumgartner and Jones in
The Policy Agendas Project, health is near the middle. I then use infants and children’s policy as
a first measure and substitute for women’s health. Infant and Children’s policy accounts for a
very small fraction of all health policy. This is potentially a result of the Agendas’ Project coding
system, but it is all an indicator of the limited agenda space. Women’s health accounts for an
even smaller fraction of the agenda. In chapter three I illustrate that 22% of all health bill
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introductions are women’s health related, and in terms of congressional hearings, women’s
health represents about 16% of all health hearings. Less than 10% of all health laws passed are
directly related to women’s health.
This result is demonstrating the competition among all other health topics vying for
attention. In some regards, abortion is included as part of women’s health policy but in others,
it could be treated as a separate policy issue. Women’s health bleeds over to other health
concerns of affordability and access, federal grant programs, and clinical research as women as
a group are targeted for entitlement programs and fulfill the role as mother and caregiver.
These large number of health issues vying for space on the agenda result in issue
crowding. Future research might include other facets of women’s health that are emerging and
competing for space. In particular, contraception has become especially relevant. Similar to
abortion, contraception has become an issue targeted by conservative religious groups. In 2012
Congress debated an amendment to allow health insurance plans to deny coverage for
provisions of medical services that run counter to the plan sponsor or employer's religious
beliefs (CQ Almanac 2012). For several weeks in early 2012, Republicans’ opposition to the rule
gained headlines and national attention.
The debate tapped into several contentious areas: the health care law, women's health
issues and religious freedom. Republican leaders maintained that the rule violated religious
freedoms of employers that did not qualify as religious institutions. Supporters, defended it as
necessary to protect women's health and an important part of the health care law's coverage of
preventive services. In early February, House Speaker John A. Boehner, R-Ohio, made a rare
floor speech pledging to undo the rule and put the Energy and Commerce Committee in charge
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of finding a legislative way to reverse it (CQ Almanac 2012). Ultimately House Republicans
stood their ground on the issue, but the Senate reversed the amendment and S 1813 passed
without Republican support. While contraception is not always tied to women’s health or even
religious freedom, the debate has certainly renewed since the passage of the Affordable Care
Act (2010), which brings women’s health policy back to a question of motherhood.
Future research including contraception as part of the agenda crowding component to
women’s health attention would add another, possibly more explanatory, dimension to the
narrative. As society progresses toward more egalitarian representation, both substantively an
descriptive, we can expect increased agenda crowding. As we expand the narrative to include
underrepresented groups in the health discussion, space will become more limited. As science
and society now challenge the traditional binary definitions of sex and gender, the proverbial
pandora’s box has opened. Health care professionals are first on the ground in response to
new notions of gender and we can expect that policy makers will have to respond. Gender
equity and emerging science place new demands on the policy process. This study brings
increased understanding to the ways in which women’s health issues gain entrance into the
formal agenda.
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APPENDIX
Bill sponsorship for top entrepreneurs sponsoring a total of 10 or more bills per congressional
session
Member (House)

#
Sponsored

Rep. Maloney, Carolyn B. [D-NY-14]

45

104th Congress (1995-1996)

2

105th Congress (1997-1998)

5

106th Congress (1999-2000)

5

107th Congress (2001-2002)

5

108th Congress (2003-2004)

7

109th Congress (2005-2006)

9

110th Congress (2007-2008)

8

111th Congress (2009-2010)

2

112th Congress (2011-2012)

2

Rep. DeLauro, Rosa L. [D-CT-3]

42

103rd Congress (1993-1994)

1

104th Congress (1995-1996)

1

105th Congress (1997-1998)

1

106th Congress (1999-2000)

2

107th Congress (2001-2002)

2

108th Congress (2003-2004)

2

109th Congress (2005-2006)

3

110th Congress (2007-2008)

5

111th Congress (2009-2010)

3

112th Congress (2011-2012)

4

113th Congress (2013-2014)

8

114th Congress (2015-2016)

6

115th Congress (2017-2018)

4

Rep. Waxman, Henry A. [D-CA-24]

39

100th Congress (1987-1988)

11

101st Congress (1989-1990)

1

102nd Congress (1991-1992)

9

96th Congress (1979-1980)

4

97th Congress (1981-1982)

5

98th Congress (1983-1984)

5

99th Congress (1985-1986)

4
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Rep. Lowey, Nita M. [D-NY-18]

28

103rd Congress (1993-1994)

1

104th Congress (1995-1996)

1

105th Congress (1997-1998)

5

106th Congress (1999-2000)

3

107th Congress (2001-2002)

1

108th Congress (2003-2004)

3

109th Congress (2005-2006)

6

110th Congress (2007-2008)

5

111th Congress (2009-2010)

3

Rep. Schroeder, Patricia [D-CO-1]

22

100th Congress (1987-1988)

2

101st Congress (1989-1990)

5

102nd Congress (1991-1992)

4

103rd Congress (1993-1994)

8

104th Congress (1995-1996)

3

Rep. Lee, Barbara [D-CA-9]

22

106th Congress (1999-2000)

1

107th Congress (2001-2002)

1

108th Congress (2003-2004)

3

Rep. Lee, Barbara [D-CA-9]
109th Congress (2005-2006)

4

110th Congress (2007-2008)

3

111th Congress (2009-2010)

5

112th Congress (2011-2012)

5

Rep. Morella, Constance A. [R-MD-8]

21

101st Congress (1989-1990)

2

102nd Congress (1991-1992)

2

103rd Congress (1993-1994)

3

104th Congress (1995-1996)

5

105th Congress (1997-1998)

3

106th Congress (1999-2000)

2

107th Congress (2001-2002)

4

Rep. Slaughter, Louise McIntosh [D-NY-28]

21

103rd Congress (1993-1994)

1

104th Congress (1995-1996)

2

105th Congress (1997-1998)

3

106th Congress (1999-2000)

1

107th Congress (2001-2002)

1
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108th Congress (2003-2004)

2

Rep. Slaughter, Louise McIntosh [D-NY-28]
109th Congress (2005-2006)

2

110th Congress (2007-2008)

4

111th Congress (2009-2010)

4

112th Congress (2011-2012)

1

Rep. Nadler, Jerrold [D-NY-8]

16

103rd Congress (1993-1994)

3

105th Congress (1997-1998)

2

106th Congress (1999-2000)

2

Rep. Nadler, Jerrold [D-NY-8]
107th Congress (2001-2002)

1

108th Congress (2003-2004)

2

109th Congress (2005-2006)

2

110th Congress (2007-2008)

1

111th Congress (2009-2010)

1

112th Congress (2011-2012)

2

Rep. Schakowsky, Janice D. [D-IL-9]

16

107th Congress (2001-2002)

2

108th Congress (2003-2004)

1

110th Congress (2007-2008)

3

111th Congress (2009-2010)

4

112th Congress (2011-2012)

2

113th Congress (2013-2014)

2

115th Congress (2017-2018)

1

116th Congress (2019-2020)

1

Rep. Pallone, Frank, Jr. [D-NJ-6]

15

105th Congress (1997-1998)

2

106th Congress (1999-2000)

2

107th Congress (2001-2002)

1

108th Congress (2003-2004)

1

109th Congress (2005-2006)

2

110th Congress (2007-2008)

1

111th Congress (2009-2010)

2

112th Congress (2011-2012)

1

113th Congress (2013-2014)

1

114th Congress (2015-2016)

2

Rep. Oakar, Mary Rose [D-OH-20]

15

100th Congress (1987-1988)

3

101st Congress (1989-1990)

3
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102nd Congress (1991-1992)

3

Rep. Oakar, Mary Rose [D-OH-20]
96th Congress (1979-1980)

1

97th Congress (1981-1982)

1

98th Congress (1983-1984)

1

99th Congress (1985-1986)

3

Rep. Jackson Lee, Sheila [D-TX-18]

12

112th Congress (2011-2012)

2

113th Congress (2013-2014)

2

114th Congress (2015-2016)

3

115th Congress (2017-2018)

5

Rep. Smith, Christopher H. [R-NJ-4]

12

107th Congress (2001-2002)

2

108th Congress (2003-2004)

1

109th Congress (2005-2006)

2

113th Congress (2013-2014)

2

114th Congress (2015-2016)

2

115th Congress (2017-2018)

1

116th Congress (2019-2020)

2

Rep. DeGette, Diana [D-CO-1]

12

107th Congress (2001-2002)

1

108th Congress (2003-2004)

1

109th Congress (2005-2006)

2

110th Congress (2007-2008)

3

111th Congress (2009-2010)

2

114th Congress (2015-2016)

2

115th Congress (2017-2018)

1

Rep. Miller, George [D-CA-7]

11

100th Congress (1987-1988)

2

102nd Congress (1991-1992)

2

106th Congress (1999-2000)

1

107th Congress (2001-2002)

2

111th Congress (2009-2010)

1

97th Congress (1981-1982)

1

99th Congress (1985-1986)

2

Rep. Collins, Cardiss [D-IL-7]

11

100th Congress (1987-1988)

2

101st Congress (1989-1990)

2

103rd Congress (1993-1994)

1

104th Congress (1995-1996)

1
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97th Congress (1981-1982)

1

Rep. Collins, Cardiss [D-IL-7]
98th Congress (1983-1984)

1

99th Congress (1985-1986)

3

Rep. Burgess, Michael C. [R-TX-26]

11

108th Congress (2003-2004)

2

109th Congress (2005-2006)

1

110th Congress (2007-2008)

2

113th Congress (2013-2014)

1

114th Congress (2015-2016)

4

115th Congress (2017-2018)

1

Rep. Dellums, Ronald V. [D-CA-8]

10

100th Congress (1987-1988)

1

101st Congress (1989-1990)

5

102nd Congress (1991-1992)

3

96th Congress (1979-1980)

1

Rep. Meng, Grace [D-NY-6]

10

114th Congress (2015-2016)

6

115th Congress (2017-2018)

3

116th Congress (2019-2020)

1

Rep. Mikulski, Barbara A. [D-MD-3]

10

96th Congress (1979-1980)

6

97th Congress (1981-1982)

2

98th Congress (1983-1984)

2

Member (Senate)

# Sponsored

Sen. Kennedy, Edward M. [D-MA]

40

100th Congress (1987-1988)

8

101st Congress (1989-1990)

1

102nd Congress (1991-1992)

5

103rd Congress (1993-1994)

6

105th Congress (1997-1998)

3

106th Congress (1999-2000)

5

107th Congress (2001-2002)

2

108th Congress (2003-2004)

1

109th Congress (2005-2006)

2

110th Congress (2007-2008)

1

95th Congress (1977-1978)

1

96th Congress (1979-1980)

1

99th Congress (1985-1986)

4
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Sen. Boxer, Barbara [D-CA]

39

104th Congress (1995-1996)

2

105th Congress (1997-1998)

4

106th Congress (1999-2000)

5

107th Congress (2001-2002)

4

108th Congress (2003-2004)

3

109th Congress (2005-2006)

2

110th Congress (2007-2008)

5

111th Congress (2009-2010)

5

112th Congress (2011-2012)

4

113th Congress (2013-2014)

2

114th Congress (2015-2016)

3

Sen. Snowe, Olympia J. [R-ME]

31

104th Congress (1995-1996)

2

105th Congress (1997-1998)

6

106th Congress (1999-2000)

5

107th Congress (2001-2002)

6

108th Congress (2003-2004)

4

109th Congress (2005-2006)

2

110th Congress (2007-2008)

4

111th Congress (2009-2010)

1

112th Congress (2011-2012)

1

Sen. Murray, Patty [D-WA]

28

105th Congress (1997-1998)

1

110th Congress (2007-2008)

2

111th Congress (2009-2010)

2

112th Congress (2011-2012)

2

113th Congress (2013-2014)

4

114th Congress (2015-2016)

5

115th Congress (2017-2018)

9

116th Congress (2019-2020)

3

Sen. Mikulski, Barbara A. [D-MD]

26

100th Congress (1987-1988)

2

101st Congress (1989-1990)

2

102nd Congress (1991-1992)

1

103rd Congress (1993-1994)

1

105th Congress (1997-1998)

1

107th Congress (2001-2002)

2

108th Congress (2003-2004)

5
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109th Congress (2005-2006)

3

Sen. Mikulski, Barbara A. [D-MD]
110th Congress (2007-2008)

3

111th Congress (2009-2010)

1

112th Congress (2011-2012)

2

114th Congress (2015-2016)

3

Sen. Durbin, Richard J. [D-IL]

23

107th Congress (2001-2002)

4

108th Congress (2003-2004)

3

109th Congress (2005-2006)

1

110th Congress (2007-2008)

3

111th Congress (2009-2010)

3

112th Congress (2011-2012)

3

113th Congress (2013-2014)

2

114th Congress (2015-2016)

2

115th Congress (2017-2018)

2

Sen. Harkin, Tom [D-IA]

23

100th Congress (1987-1988)

2

101st Congress (1989-1990)

2

102nd Congress (1991-1992)

2

105th Congress (1997-1998)

2

106th Congress (1999-2000)

2

107th Congress (2001-2002)

1

108th Congress (2003-2004)

2

109th Congress (2005-2006)

2

110th Congress (2007-2008)

2

111th Congress (2009-2010)

2

112th Congress (2011-2012)

2

113th Congress (2013-2014)

2

Sen. Stabenow, Debbie [D-MI]

21

108th Congress (2003-2004)

1

109th Congress (2005-2006)

1

110th Congress (2007-2008)

2

111th Congress (2009-2010)

4

112th Congress (2011-2012)

4

113th Congress (2013-2014)

3

114th Congress (2015-2016)

2

115th Congress (2017-2018)

4

Sen. Inouye, Daniel K. [D-HI]

17

100th Congress (1987-1988)

2
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102nd Congress (1991-1992)

1

Sen. Inouye, Daniel K. [D-HI]
107th Congress (2001-2002)

2

108th Congress (2003-2004)

1

109th Congress (2005-2006)

1

110th Congress (2007-2008)

1

96th Congress (1979-1980)

2

97th Congress (1981-1982)

2

98th Congress (1983-1984)

2

99th Congress (1985-1986)

3

Sen. Hatch, Orrin G. [R-UT]

16

100th Congress (1987-1988)

1

103rd Congress (1993-1994)

2

107th Congress (2001-2002)

1

108th Congress (2003-2004)

1

111th Congress (2009-2010)

1

112th Congress (2011-2012)

1

113th Congress (2013-2014)

1

114th Congress (2015-2016)

1

115th Congress (2017-2018)

1

97th Congress (1981-1982)

2

98th Congress (1983-1984)

2

99th Congress (1985-1986)

2

Sen. Clinton, Hillary Rodham [D-NY]

15

107th Congress (2001-2002)

1

109th Congress (2005-2006)

5

110th Congress (2007-2008)

9

Sen. Menendez, Robert [D-NJ]

13

109th Congress (2005-2006)

2

110th Congress (2007-2008)

1

111th Congress (2009-2010)

3

112th Congress (2011-2012)

1

113th Congress (2013-2014)

2

114th Congress (2015-2016)

2

115th Congress (2017-2018)

2

Sen. Casey, Robert P., Jr. [D-PA]

13

111th Congress (2009-2010)

2

112th Congress (2011-2012)

2

113th Congress (2013-2014)

3

114th Congress (2015-2016)

4
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115th Congress (2017-2018)

2

Sen. Daschle, Thomas A. [D-SD]

13

100th Congress (1987-1988)

1

105th Congress (1997-1998)

4

106th Congress (1999-2000)

4

107th Congress (2001-2002)

1

108th Congress (2003-2004)

3

Sen. Feinstein, Dianne [D-CA]

13

105th Congress (1997-1998)

2

106th Congress (1999-2000)

1

107th Congress (2001-2002)

2

108th Congress (2003-2004)

1

112th Congress (2011-2012)

1

113th Congress (2013-2014)

2

114th Congress (2015-2016)

3

115th Congress (2017-2018)

1

Sen. Leahy, Patrick J. [D-VT]

13

100th Congress (1987-1988)

1

105th Congress (1997-1998)

1

106th Congress (1999-2000)

1

107th Congress (2001-2002)

1

108th Congress (2003-2004)

2

109th Congress (2005-2006)

1

110th Congress (2007-2008)

1

112th Congress (2011-2012)

2

113th Congress (2013-2014)

3

Sen. Bingaman, Jeff [D-NM]

12

103rd Congress (1993-1994)

1

107th Congress (2001-2002)

4

108th Congress (2003-2004)

1

109th Congress (2005-2006)

2

110th Congress (2007-2008)

1

111th Congress (2009-2010)

2

112th Congress (2011-2012)

1

Sen. Biden, Joseph R., Jr. [D-DE]

12

102nd Congress (1991-1992)

1

105th Congress (1997-1998)

2

107th Congress (2001-2002)

1

108th Congress (2003-2004)

1

109th Congress (2005-2006)

3
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110th Congress (2007-2008)

4

Sen. Gillibrand, Kirsten E. [D-NY]

11

111th Congress (2009-2010)

2

112th Congress (2011-2012)

4

113th Congress (2013-2014)

2

115th Congress (2017-2018)

2

116th Congress (2019-2020)

1

Sen. Akaka, Daniel K. [D-HI]

10

103rd Congress (1993-1994)

1

104th Congress (1995-1996)

1

105th Congress (1997-1998)

1

106th Congress (1999-2000)

1

109th Congress (2005-2006)

1

110th Congress (2007-2008)

1

111th Congress (2009-2010)

3

112th Congress (2011-2012)

1

Sen. Dodd, Christopher J. [D-CT]

10

100th Congress (1987-1988)

1

107th Congress (2001-2002)

1

108th Congress (2003-2004)

1

109th Congress (2005-2006)

2

110th Congress (2007-2008)

1

111th Congress (2009-2010)

2

98th Congress (1983-1984)

1

99th Congress (1985-1986)

1

Sen. Rockefeller, John D., IV [D-WV]

10

101st Congress (1989-1990)

1

103rd Congress (1993-1994)

2

107th Congress (2001-2002)

1

108th Congress (2003-2004)

1

110th Congress (2007-2008)

2

111th Congress (2009-2010)

1

112th Congress (2011-2012)

1

113th Congress (2013-2014)

1

Sen. Shaheen, Jeanne [D-NH]

10

111th Congress (2009-2010)

2

112th Congress (2011-2012)

1

113th Congress (2013-2014)

2

114th Congress (2015-2016)

2

115th Congress (2017-2018)

3
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Sen. Cranston, Alan [D-CA]

10

100th Congress (1987-1988)

1

101st Congress (1989-1990)

1

102nd Congress (1991-1992)

2

96th Congress (1979-1980)

1

97th Congress (1981-1982)

1

98th Congress (1983-1984)

2

99th Congress (1985-1986)

2

Sen. Klobuchar, Amy [D-MN]

10

111th Congress (2009-2010)

1

113th Congress (2013-2014)

3

114th Congress (2015-2016)

4

115th Congress (2017-2018)

2

Sen. Murkowski, Lisa [R-AK]

10

109th Congress (2005-2006)

1

111th Congress (2009-2010)

3

112th Congress (2011-2012)

2

113th Congress (2013-2014)

2

114th Congress (2015-2016)

2

Sen. Chafee, John H. [R-RI]

10

100th Congress (1987-1988)

2

102nd Congress (1991-1992)

1

103rd Congress (1993-1994)

1

105th Congress (1997-1998)

2

106th Congress (1999-2000)

2

97th Congress (1981-1982)

1

99th Congress (1985-1986)

1
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